Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2016 | Apr. 28, 2016 | |
Document and Entity Information | ||
Entity Registrant Name | MFA FINANCIAL, INC. | |
Entity Central Index Key | 1,055,160 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2016 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 371,072,639 | |
Document Fiscal Year Focus | 2,016 | |
Document Fiscal Period Focus | Q1 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 | |
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities: | |||
Mortgage-backed securities and credit risk securities | $ 10,861,443 | $ 11,356,643 | |
Securities obtained and pledged as collateral, at fair value | 513,409 | 507,443 | |
Residential whole loans, at carrying value ($200,854 and $93,692 pledged as collateral, respectively) | 376,235 | 271,845 | |
Residential whole loans, at fair value ($609,769 and $585,971 pledged as collateral, respectively) | 647,360 | 623,276 | |
Cash and cash equivalents | 146,236 | 165,007 | |
Restricted cash | 123,676 | 71,538 | |
Other assets | 176,082 | 166,799 | |
Total Assets | 12,844,441 | 13,162,551 | |
Liabilities: | |||
Repurchase agreements and other advances | 9,143,645 | 9,387,622 | |
Securitized debt | [1] | 11,821 | 21,868 |
Obligation to return securities obtained as collateral, at fair value | 513,409 | 507,443 | |
8% Senior Notes due 2042 (“Senior Notes”) | 96,706 | 96,697 | |
Other liabilities | 217,214 | 181,660 | |
Total Liabilities | $ 9,982,795 | $ 10,195,290 | |
Commitments and contingencies (See Note 14) | |||
Stockholders’ Equity: | |||
Preferred stock, $.01 par value; 7.50% Series B cumulative redeemable; 8,050 shares authorized; 8,000 shares issued and outstanding ($200,000 aggregate liquidation preference) | $ 80 | $ 80 | |
Common stock, $.01 par value; 886,950 shares authorized; 370,977 and 370,584 shares issued and outstanding, respectively | 3,710 | 3,706 | |
Additional paid-in capital, in excess of par | 3,019,891 | 3,019,956 | |
Accumulated deficit | (572,445) | (572,332) | |
Accumulated other comprehensive income | 410,410 | 515,851 | |
Total Stockholders’ Equity | 2,861,646 | 2,967,261 | |
Total Liabilities and Stockholders’ Equity | 12,844,441 | 13,162,551 | |
Agency Mortgage Backed Securities | |||
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities: | |||
Mortgage-backed securities and credit risk securities | 4,544,883 | 4,752,244 | |
Non-Agency MBS | |||
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities: | |||
Mortgage-backed securities and credit risk securities | 6,100,757 | 6,420,817 | |
Non-Agency MBS | Non-Agency MBS | |||
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities: | |||
Mortgage-backed securities and credit risk securities | 5,902,305 | 5,822,519 | |
Non-Agency MBS | Non-Agency MBS Transferred to Consolidated VIEs | |||
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities: | |||
Mortgage-backed securities and credit risk securities | [2] | 198,452 | 598,298 |
CRT securities | |||
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities: | |||
Mortgage-backed securities and credit risk securities | $ 215,803 | $ 183,582 | |
[1] | Securitized debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that eliminate on consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 14 and 19 for further discussion.) | ||
[2] | Non-Agency MBS transferred to consolidated VIEs represent assets of the consolidated VIEs that can be used only to settle the obligations of each respective VIE. |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) | 3 Months Ended | |
Mar. 31, 2016 | Dec. 31, 2015 | |
Residential whole loans, at carrying value, pledged as collateral (in dollars) | $ 200,854,000 | $ 93,692,000 |
Residential whole loans, at fair value, pledged as collateral (in dollars) | $ 609,769,000 | $ 585,971,000 |
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 8,050,000 | 8,050,000 |
Preferred stock, dividend rate | 7.50% | |
Preferred stock, shares issued | 8,000,000 | 8,000,000 |
Preferred stock, shares outstanding | 8,000,000 | 8,000,000 |
Preferred stock, aggregate liquidation preference (in dollars) | $ 200,000,000 | $ 200,000,000 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 886,950,000 | 886,950,000 |
Common stock, shares issued | 370,977,000 | 370,584,000 |
Common stock, shares outstanding | 370,977,000 | 370,584,000 |
Senior Notes | ||
Stated interest rate (percent) | 8.00% | 8.00% |
Agency Mortgage Backed Securities | ||
Securities, at fair value, pledged as collateral | $ 4,317,158,000 | $ 4,532,094,000 |
Non-Agency MBS | ||
Securities, at fair value, pledged as collateral | 5,003,131,000 | 4,874,372,000 |
CRT securities | ||
Securities, at fair value, pledged as collateral | $ 196,350,000 | $ 170,352,000 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Interest Income: | ||
Residential whole loans held at carrying value | $ 4,496 | $ 3,591 |
Cash and cash equivalent investments | 140 | 27 |
Interest Income | 117,477 | 129,942 |
Interest Expense: | ||
Repurchase agreements and other advances | 45,395 | 41,182 |
Senior Notes and other interest expense | 2,205 | 2,758 |
Interest Expense | 47,600 | 43,940 |
Net Interest Income | 69,877 | 86,002 |
Other-Than-Temporary Impairments: | ||
Total other-than-temporary impairment losses | 0 | (395) |
Portion of loss reclassed from other comprehensive income | 0 | (12) |
Net Impairment Losses Recognized in Earnings | 0 | (407) |
Other Income, net: | ||
Net gain on residential whole loans held at fair value | 11,881 | 2,034 |
Gain on sales of MBS | 9,745 | 6,435 |
Other, net | 1,026 | 311 |
Other Income, net | 22,652 | 8,780 |
Operating and Other Expense: | ||
Compensation and benefits | 7,407 | 6,746 |
Other general and administrative expense | 3,918 | 3,457 |
Loan servicing and other related operating expenses | 3,134 | 1,999 |
Operating and Other Expense | 14,459 | 12,202 |
Net Income | 78,070 | 82,173 |
Less Preferred Stock Dividends | 3,750 | 3,750 |
Net Income Available to Common Stock and Participating Securities | $ 74,320 | $ 78,423 |
Earnings per Common Share - Basic and Diluted (in dollars per share) | $ 0.20 | $ 0.21 |
Dividends Declared per Share of Common Stock (in dollars per share) | $ 0.20 | $ 0.20 |
Agency Mortgage Backed Securities | ||
Interest Income: | ||
Securities | $ 23,997 | $ 31,673 |
Non-Agency MBS | Non-Agency MBS | ||
Interest Income: | ||
Securities | 80,305 | 81,248 |
Non-Agency MBS | Non-Agency MBS Transferred to Consolidated VIEs | ||
Interest Income: | ||
Securities | 5,847 | 12,043 |
CRT securities | ||
Interest Income: | ||
Securities | $ 2,692 | $ 1,360 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS)/INCOME (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Net income | $ 78,070 | $ 82,173 |
Other Comprehensive (Loss)/Income: | ||
Reclassification adjustment for MBS sales included in net income | (10,485) | (6,423) |
Reclassification adjustment for other-than-temporary impairments included in net income | 0 | (407) |
Unrealized loss on derivative hedging instruments, net | (49,342) | (32,367) |
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | 4,537 |
Other Comprehensive (Loss)/Income | (105,441) | 4,375 |
Comprehensive (loss)/income before preferred stock dividends | (27,371) | 86,548 |
Dividends declared on preferred stock | (3,750) | (3,750) |
Comprehensive (Loss)/Income Available to Common Stock and Participating Securities | (31,121) | 82,798 |
Agency Mortgage Backed Securities | ||
Other Comprehensive (Loss)/Income: | ||
Unrealized (loss)/gain, net | 13,226 | 12,885 |
Non-Agency MBS | ||
Other Comprehensive (Loss)/Income: | ||
Unrealized (loss)/gain, net | $ (58,840) | $ 26,150 |
CONSOLIDATED STATEMENTS OF CHAN
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands | Total | Preferred StockPreferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Income | ||
Balance (in shares) at Dec. 31, 2014 | 8,000,000 | 370,084,000 | ||||||
Balance at Dec. 31, 2014 | $ 3,203,272 | $ 80 | $ 3,701 | $ 3,013,634 | $ (568,596) | $ 754,453 | ||
Increase (Decrease) in Stockholders' Equity | ||||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 4,537 | (4,537) | 4,537 | |||||
Net income | 82,173 | 82,173 | ||||||
Issuance of common stock, net of expenses | [1] | 312 | 312 | |||||
Issuance of common stock, net of expenses (in shares) | [1] | 61,000 | ||||||
Repurchase of shares of common stock | [1] | (151) | (151) | |||||
Repurchase of shares of common stock (in shares) | [1] | (11,000) | ||||||
Equity based compensation expense | 912 | 912 | ||||||
Accrued dividends attributable to stock-based awards | (113) | (113) | ||||||
Dividends declared on common stock | (74,072) | (74,072) | ||||||
Dividends declared on preferred stock | (3,750) | (3,750) | ||||||
Dividends attributable to dividend equivalents | (249) | (249) | ||||||
Change in unrealized losses on MBS, net | 32,205 | 32,205 | ||||||
Change in unrealized losses on derivative hedging instruments, net | (32,367) | (32,367) | ||||||
Balance (in shares) at Mar. 31, 2015 | 8,000,000 | 370,134,000 | ||||||
Balance at Mar. 31, 2015 | 3,208,172 | $ 80 | $ 3,701 | 3,014,594 | (569,031) | 758,828 | ||
Increase (Decrease) in Stockholders' Equity | ||||||||
Adjustments Related to Tax Withholding for Share-based Compensation | $ 87 | |||||||
Shares Paid for Tax Withholding for Share Based Compensation (in shares) | 11,074 | |||||||
Balance (in shares) at Dec. 31, 2015 | 8,000,000 | 370,584,000 | ||||||
Balance at Dec. 31, 2015 | 2,967,261 | $ 80 | $ 3,706 | 3,019,956 | (572,332) | 515,851 | ||
Increase (Decrease) in Stockholders' Equity | ||||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | |||||||
Net income | 78,070 | 78,070 | ||||||
Issuance of common stock, net of expenses | [1] | 306 | $ 4 | 302 | ||||
Issuance of common stock, net of expenses (in shares) | [1] | 589,000 | ||||||
Repurchase of shares of common stock | [1] | $ (1,324) | (1,324) | |||||
Repurchase of shares of common stock (in shares) | 0 | (196,000) | [1] | |||||
Equity based compensation expense | $ 1,130 | 1,130 | ||||||
Accrued dividends attributable to stock-based awards | (173) | (173) | ||||||
Dividends declared on common stock | (74,215) | (74,215) | ||||||
Dividends declared on preferred stock | (3,750) | (3,750) | ||||||
Dividends attributable to dividend equivalents | (218) | (218) | ||||||
Change in unrealized losses on MBS, net | (56,099) | (56,099) | ||||||
Change in unrealized losses on derivative hedging instruments, net | (49,342) | (49,342) | ||||||
Balance (in shares) at Mar. 31, 2016 | 8,000,000 | 370,977,000 | ||||||
Balance at Mar. 31, 2016 | $ 2,861,646 | $ 80 | $ 3,710 | $ 3,019,891 | $ (572,445) | $ 410,410 | ||
Increase (Decrease) in Stockholders' Equity | ||||||||
Adjustments Related to Tax Withholding for Share-based Compensation | $ 1,300 | |||||||
Shares Paid for Tax Withholding for Share Based Compensation (in shares) | 196,333 | |||||||
[1] | For the three months ended March 31, 2016 and 2015, includes approximately $1.3 million (196,333 shares) and $87,000 (11,074 shares), respectively surrendered for tax purposes related to equity-based compensation awards. |
CONSOLIDATED STATEMENTS OF CHA7
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) (Parenthetical) - $ / shares | Apr. 15, 2013 | Mar. 31, 2016 | Mar. 31, 2015 |
Preferred Stock, dividend rate | 7.50% | 7.50% | |
Preferred Stock | Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share | |||
Preferred Stock, dividend rate | 7.50% | 7.50% | 7.50% |
Preferred Stock, liquidation preference per share (in dollars per share) | $ 25 | $ 25 | $ 25 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Cash Flows From Operating Activities: | ||
Net income | $ 78,070 | $ 82,173 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Gain on sales of MBS | (9,745) | (6,435) |
(Gain)/loss on sales of real estate owned | 509 | (26) |
Other-than-temporary impairment charges | 0 | 407 |
Accretion of purchase discounts on MBS and CRT securities and residential whole loans | (22,083) | (25,254) |
Amortization of purchase premiums on MBS | 8,143 | 9,122 |
Depreciation and amortization on real estate, fixed assets and other assets | 272 | 115 |
Equity-based compensation expense | 1,134 | 912 |
Unrealized gain on residential whole loans at fair value | (6,226) | (602) |
Increase in other assets | (6,259) | (13,910) |
(Decrease)/increase in other liabilities | (3,798) | 4,693 |
Net cash provided by operating activities | 38,999 | 51,247 |
Cash Flows From Investing Activities: | ||
Principal payments on MBS and CRT securities | 807,349 | 588,088 |
Proceeds from sales of MBS | 32,034 | 10,845 |
Purchases of MBS and CRT securities | (375,404) | (518,127) |
Purchases of residential whole loans and capitalized advances | (165,510) | (40,168) |
Principal payments on residential whole loans | 21,666 | 6,260 |
Proceeds from sales of real estate owned | 6,157 | 581 |
Redemption of Federal Home Loan Bank stock | 10,475 | 0 |
Additions to leasehold improvements, furniture and fixtures | (56) | (158) |
Net cash provided by investing activities | 336,711 | 47,321 |
Cash Flows From Financing Activities: | ||
Principal payments on repurchase agreements and other advances | (19,776,510) | (23,325,613) |
Proceeds from borrowings under repurchase agreements and other advances | 19,532,131 | 23,348,218 |
Principal payments on securitized debt | (10,133) | (19,186) |
Payments made for margin calls on repurchase agreements and interest rate swap agreements (“Swaps”) | (117,800) | (98,000) |
Proceeds from reverse margin calls on repurchase agreements and Swaps | 55,700 | 60,000 |
Proceeds from issuances of common stock | 306 | 312 |
Dividends paid on preferred stock | (3,750) | (3,750) |
Dividends paid on common stock and dividend equivalents | (74,425) | (74,269) |
Net cash used in financing activities | (394,481) | (112,288) |
Net decrease in cash and cash equivalents | (18,771) | (13,720) |
Cash and cash equivalents at beginning of period | 165,007 | 182,437 |
Cash and cash equivalents at end of period | 146,236 | 168,717 |
Non-cash Investing and Financing Activities: | ||
MBS and CRT securities recorded upon adoption of revised accounting standard for repurchase agreement financing | 0 | 1,917,813 |
Repurchase agreements recorded upon adoption of revised accounting standard for repurchase agreement financing | 0 | 1,519,593 |
Net (decrease)/increase in securities obtained as collateral/obligation to return securities obtained as collateral | (5,175) | 20,990 |
Transfer from residential whole loans to real estate owned | 22,280 | 3,448 |
Dividends and dividend equivalents declared and unpaid | $ 74,583 | $ 74,581 |
Organization
Organization | 3 Months Ended |
Mar. 31, 2016 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization | Organization MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998. The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes. In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders. The Company has elected to treat certain of its subsidiaries as a taxable REIT subsidiary (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate related business. (See Notes 2 ( o ) and 15 ) |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2016 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies ( a ) Basis of Presentation and Consolidation The interim unaudited consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted according to these SEC rules and regulations. Management believes that the disclosures included in these interim unaudited consolidated financial statements are adequate to make the information presented not misleading. The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 . In the opinion of management, all normal and recurring adjustments necessary to present fairly the financial condition of the Company at March 31, 2016 and results of operations for all periods presented have been made. The results of operations for the three months ended March 31, 2016 should not be construed as indicative of the results to be expected for the full year. The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition. Management has made significant estimates in several areas, including other-than-temporary impairment (“OTTI”) on MBS (See Note 3 ), valuation of MBS and CRT securities (See Notes 3 and 18 ), income recognition and valuation of residential whole loans (See Notes 4 and 18 ), valuation of derivative instruments (See Notes 6 and 18 ) and income recognition on certain Non-Agency MBS purchased at a discount (See Note 3 ). In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest (See Note 2 ( o )). Actual results could differ from those estimates. The Company has one reportable segment as we manage our business and analyze and report our results of operations on the basis of one operating segment; investing, on a leveraged basis, in residential mortgage assets. The consolidated financial statements of the Company include the accounts of all subsidiaries; significant intercompany accounts and transactions have been eliminated. In addition, the Company consolidates the special purpose entities created to facilitate the resecuritization transactions completed in prior years and the acquisition of residential whole loans. Certain prior period amounts have been reclassified to conform to the current period presentation. ( b ) MBS (including Non-Agency MBS transferred to consolidated VIEs) and CRT Securities The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any U.S. Government agency or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities that are issued by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Mac and the principal payments received are based on the performance of loans in a reference pool of recently securitized MBS. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including if the loans in the reference pool experience delinquencies exceeding specified thresholds. Designation The Company generally intends to hold its MBS until maturity; however, from time to time, it may sell any of its securities as part of the overall management of its business. As a result, all of the Company’s MBS are designated as “available-for-sale” (“AFS”) and, accordingly, are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method. The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting more appropriately reflects the risk sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statement of operations. Revenue Recognition, Premium Amortization and Discount Accretion Interest income on securities is accrued based on the outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity. Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs. (See Note 3 ) Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income. The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors. If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time. Conversely, if the performance of a security with a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result. Determination of Fair Value for MBS and CRT Securities In determining the fair value of the Company’s MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. (See Note 18 ) Impairments/OTTI When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired. The Company assesses its impaired securities on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.” If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date. If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the OTTI related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets. Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings. Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings. However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income. The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections. As a result, the timing and amount of OTTIs constitute material estimates that are susceptible to significant change. (See Note 3 ) Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes. The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS. The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, Fair Isaac Corporation (“FICO”) scores at loan origination, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations, as well as reports by credit rating agencies, such as Moody’s Investors Services, Inc. (“Moody’s”), Standard & Poor’s Corporation (“S&P”), or Fitch, Inc. (collectively, “Rating Agencies”), general market assessments, and dialogue with market participants. As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS. In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date. The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes. Impairment assessment for Non-Agency MBS and CRT Securities that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date. The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR. Balance Sheet Presentation The Company’s MBS and CRT Securities pledged as collateral against repurchase agreements, Federal Home Loan Bank advances and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically. Purchases and sales of securities are recorded on the trade date. ( c ) Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral The Company has obtained securities as collateral under collateralized financing arrangements in connection with its financing strategy for Non-Agency MBS. Securities obtained as collateral in connection with these transactions are recorded on the Company’s consolidated balance sheets as an asset along with a liability representing the obligation to return the collateral obtained, at fair value. While beneficial ownership of securities obtained remains with the counterparty, the Company has the right to sell the collateral obtained or to pledge it as part of a subsequent collateralized financing transaction. (See Note 2 ( k ) for Repurchase Agreements and Reverse Repurchase Agreements) ( d ) Residential Whole Loans Residential whole loans included in the Company’s consolidated balance sheets are comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below under “Residential Whole Loans at Carrying Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The accounting model described below under “Residential Whole Loans at Fair Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed. The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically. Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Residential Whole Loans at Carrying Value Notwithstanding that the majority of these loans are considered to be performing substantially in accordance with their current contractual terms and conditions, the Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of the borrowers have previously experienced payment delinquencies and the amount owed on the mortgage loan may exceed the value of the property pledged as collateral. Consequently, the Company has assessed that these loans have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to credit worthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Such loans are initially recorded at fair value with no allowance for loan losses. Subsequent to acquisition, the recorded amount reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition. Under the application of this accounting model the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loans basis for loans not aggregated into pools, the Company estimates at acquisition and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected is referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans. A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. A significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield. (See Notes 4 and 19 ) Residential Whole Loans at Fair Value Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Given the significant uncertainty associated with estimating the timing of and amount of cash flows associated with these loans that will be collected, and that the cash flows ultimately collected may be dependent on the value of the property securing the loan, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns from these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. (See Notes 4 and 18 ) ( e ) Cash and Cash Equivalents Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less. Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement and/or Swap counterparties as a result of reverse margin calls (i.e., margin calls made by the Company). The Company did not hold any cash pledged by its counterparties at March 31, 2016 or December 31, 2015 . The Company’s investments in overnight money market funds, which are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency, were $129.3 million and $120.4 million at March 31, 2016 and December 31, 2015 , respectively. (See Notes 10 and 18 ) ( f ) Restricted Cash Restricted cash represents the Company’s cash held by its counterparties as collateral or otherwise in connection with the Company’s Swaps and/or repurchase agreements. Restricted cash is not available to the Company for general corporate purposes, but may be applied against amounts due to counterparties to the Company’s repurchase agreements and/or Swaps, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the Swap or repurchase agreement. The Company had aggregate restricted cash held as collateral or otherwise in connection with its Swaps and repurchase agreements of $123.7 million and $71.5 million at March 31, 2016 and December 31, 2015 , respectively. (See Notes 6 , 9 , 10 and 18 ) ( g ) Goodwill At March 31, 2016 and December 31, 2015 , the Company had goodwill of $7.2 million , which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998. Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level. Through March 31, 2016 , the Company had not recognized any impairment against its goodwill. Goodwill is included in Other assets on the Company’s consolidated balance sheets. ( h ) Real Estate Owned (“REO”) REO represents real estate acquired by the Company, including through foreclosure or deed in lieu of foreclosure, and is initially recorded at fair value less estimated selling costs. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 7 ) ( i ) Depreciation Leasehold Improvements and Other Depreciable Assets Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term. Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase. ( j ) Resecuritization and Other Debt Issuance Costs Resecuritization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various resecuritization transactions completed by the Company. Other debt issuance and related costs include costs incurred by the Company in connection with issuing Senior Notes and certain other repurchase agreement financings. These costs may include underwriting, rating agency, legal, accounting and other fees. Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For resecuritization financings, amortization is based upon the actual repayments of the associated beneficial interests issued to third parties. For Senior Notes and other repurchase agreement financings, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations. ( k ) Repurchase Agreements and Other Advances Repurchase Agreements The Company finances the holdings of a significant portion of its MBS and CRT securities with repurchase agreements. Under repurchase agreements, the Company sells securities to a lender and agrees to repurchase the same securities in the future for a price that is higher than the original sale price. The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender. Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender. With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms. Margin calls, whereby a lender requires that the Company pledge additional securities or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions. The Company also may make margin calls on counterparties when collateral values increase. The Company’s repurchase financings typically have terms ranging from one month to six months at inception, but may also have longer or shorter terms. Should a counterparty decide not to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation. If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable or such collateral. (See Notes 9 , 10 and 18 ) In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company has entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty. Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price. The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower. In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement. No net cash was exchanged between the Company and counterparty at the inception of the transactions. Securities obtained and pledged as collateral are recorded as an asset on the Company’s consolidated balance sheets. Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis. Both the Company and the counterparty have the right to make daily margin calls based on changes in the value of the collateral obtained and/or pledged. The Company’s liability to the counterparty in connection with this financing arrangement is recorded on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.” (See Note 2 ( c )) Federal Home Loan Bank (“FHLB”) Advances FHLB advances are secured financing transactions and are carried at their contractual amounts. The ability to borrow from the FHLB is subject to the Company’s continued creditworthiness, pledging of sufficient eligible collateral to secure advances, and compliance with certain agreements with the FHLB. The amount of collateral pledged to the FHLB to secure advances is subject to periodic adjustment based on changes in the fair value of the collateral. Accrued interest payable on FHLB advances is included in Other liabilities on the Company’s consolidated balance sheets. (See Notes 9 , 10 and 18 ) In addition, as a condition to membership in the FHLB, the Company’s wholly-owned subsidiary, MFA Insurance, Inc. (“MFA Insurance”) is required to purchase and hold a certain amount of FHLB stock, which is based, in part, upon the outstanding principal balance of advances from the FHLB. FHLB stock is considered a non-marketable investment, is carried at cost and is subject to recoverability testing under applicable accounting standards. This stock can only be redeemed or sold at its par value, and only to the FHLB. Accordingly, when evaluating FHLB stock for impairment, the Company considers the ultimate recoverability of the par value rather than recognizing temporary declines in value. FHLB stock is included in Other assets on the Company’s consolidated balance sheets. ( l ) Equity-Based Compensation Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date. With respect to awards granted in 2009 and prior years, the Company applied a zero forfeiture rate for these awards, as they were granted to a limited number of employees, and historical forfeitures have been minimal. Forfeitures, or an indication that forfeitures are expected to occur, may result in a revised forfeiture rate and would be accounted for prospectively as a change in estimate. During 2010, the Company granted certain restricted stock units (“RSUs”) that vested after either two or four years of service and provided that certain criteria were met, which were based on a formula that included changes in the Company’s closing stock price over a two - or four -year period and dividends declared on the Company’s common stock during those periods. From 2011 through 2013, the Company granted certain RSUs that vested annually over a one or three -year period, provided that certain criteria were met, which were based on a formula tied to the Company’s achievement of average total stockholder return during that three -year period. During 2014, 2015 and the first quarter of 2016, the Company made grants of RSUs certain of which cliff vest after a three -year period and certain of which cliff vest after a three -year period, subject to the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholder return during that three -year period. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards. Specifically, the uncertainty regarding the achievement of the market condition |
MBS and CRT Securities
MBS and CRT Securities | 3 Months Ended |
Mar. 31, 2016 | |
Investments, Debt and Equity Securities [Abstract] | |
MBS and CRT Securities | MBS and CRT Securities Agency and Non-Agency MBS The Company’s MBS are comprised of Agency MBS and Non-Agency MBS which include MBS issued prior to 2008 (“Legacy Non-Agency MBS”). These MBS are secured by: (i) hybrid mortgages (“Hybrids”), which have interest rates that are fixed for a specified period of time and, thereafter, generally adjust annually to an increment over a specified interest rate index; (ii) adjustable-rate mortgages (“ARMs”); (iii) mortgages that have interest rates that reset more frequently (collectively, “ARM-MBS”); and (iv) 15 year and longer-term fixed rate mortgages. In addition, the Company’s MBS are also comprised of MBS secured by re-performing/non-performing loans (“RPL/NPL MBS”), where the cash flows of the bond may not reflect the contractual cash flows of the underlying collateral. The Company’s RPL/NPL MBS are structured with a contractual coupon step-up feature where the coupon steps-up 300 basis points at 36 months from issuance or sooner. The Company pledges a significant portion of its MBS as collateral against its borrowings under repurchase agreements, FHLB advances and Swaps. (See Note 10 ) Agency MBS: Agency MBS are guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae. The payment of principal and/or interest on Ginnie Mae MBS is explicitly backed by the full faith and credit of the U.S. Government. Since the third quarter of 2008, Fannie Mae and Freddie Mac have been under the conservatorship of the Federal Housing Finance Agency, which significantly strengthened the backing for these government-sponsored entities. Non-Agency MBS (including Non-Agency MBS transferred to consolidated VIEs): The Company’s Non-Agency MBS are secured by pools of residential mortgages which are not guaranteed by an agency of the U.S. Government or any federally chartered corporation. Credit risk associated with Non-Agency MBS is regularly assessed as new information regarding the underlying collateral becomes available and based on updated estimates of cash flows generated by the underlying collateral. CRT Securities CRT securities are debt obligations issued by Fannie Mae and Freddie Mac. While the coupon payments are paid by Fannie Mae or Freddie Mac on a monthly basis, the payment of principal is dependent on the performance of loans in a reference pool of MBS securitized by Fannie Mae or Freddie Mac. As principal on loans in the reference pool are paid, principal payments on the securities are made and the principal balances of the securities are reduced. Consequently, CRT securities mirror the payment and prepayment behavior of the mortgage loans in the reference pool. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including if the loans in the reference pool experience delinquencies exceeding specified thresholds. The Company assesses the credit risk associated with CRT securities by assessing the current and expected future performance of the associated reference pool. The Company pledges a significant portion of its CRT securities as collateral against its borrowings under repurchase agreements. (See Note 10 ) The following tables present certain information about the Company’s MBS and CRT securities at March 31, 2016 and December 31, 2015 : March 31, 2016 (In Thousands) Principal/ Current Face Purchase Premiums Accretable Purchase Discounts Discount Designated as Credit Reserve and OTTI (1) Amortized Cost (2) Fair Value Gross Unrealized Gains Gross Unrealized Losses Net Unrealized Gain/(Loss) Agency MBS: Fannie Mae $ 3,512,731 $ 132,452 $ (57 ) $ — $ 3,645,126 $ 3,684,575 $ 54,304 $ (14,855 ) $ 39,449 Freddie Mac 816,393 31,343 — — 848,854 851,230 7,358 (4,982 ) 2,376 Ginnie Mae 8,740 155 — — 8,895 9,078 183 — 183 Total Agency MBS 4,337,864 163,950 (57 ) — 4,502,875 4,544,883 61,845 (19,837 ) 42,008 Non-Agency MBS: Expected to Recover Par (3)(4) 2,774,846 66 (28,004 ) — 2,746,908 2,747,272 19,377 (19,013 ) 364 Expected to Recover Less than Par (3) 3,876,544 — (253,327 ) (757,564 ) 2,865,653 3,353,485 499,855 (12,023 ) 487,832 Total Non-Agency MBS (5) 6,651,390 66 (281,331 ) (757,564 ) 5,612,561 6,100,757 519,232 (31,036 ) 488,196 Total MBS 10,989,254 164,016 (281,388 ) (757,564 ) 10,115,436 10,645,640 581,077 (50,873 ) 530,204 CRT securities (6) 222,085 — (6,466 ) — 215,619 215,803 1,668 (1,484 ) 184 Total MBS and CRT securities $ 11,211,339 $ 164,016 $ (287,854 ) $ (757,564 ) $ 10,331,055 $ 10,861,443 $ 582,745 $ (52,357 ) $ 530,388 December 31, 2015 (In Thousands) Principal/ Current Face Purchase Premiums Accretable Purchase Discounts Discount Designated as Credit Reserve and OTTI (1) Amortized Cost (2) Fair Value Gross Unrealized Gains Gross Unrealized Losses Net Unrealized Gain/(Loss) Agency MBS: Fannie Mae $ 3,690,020 $ 139,243 $ (59 ) $ — $ 3,829,204 $ 3,865,485 $ 62,111 $ (25,830 ) $ 36,281 Freddie Mac 851,087 32,680 — — 884,798 877,109 6,906 (14,595 ) (7,689 ) Ginnie Mae 9,296 164 — — 9,460 9,650 190 — 190 Total Agency MBS 4,550,403 172,087 (59 ) — 4,723,462 4,752,244 69,207 (40,425 ) 28,782 Non-Agency MBS: Expected to Recover Par (3)(4) 2,906,878 73 (31,576 ) — 2,875,375 2,878,532 23,300 (20,143 ) 3,157 Expected to Recover Less than Par (3) 4,054,615 — (280,606 ) (787,541 ) 2,986,468 3,542,285 564,031 (8,214 ) 555,817 Total Non-Agency MBS (5) 6,961,493 73 (312,182 ) (787,541 ) 5,861,843 6,420,817 587,331 (28,357 ) 558,974 Total MBS 11,511,896 172,160 (312,241 ) (787,541 ) 10,585,305 11,173,061 656,538 (68,782 ) 587,756 CRT securities (6) 192,000 — (5,689 ) — 186,311 183,582 418 (3,147 ) (2,729 ) Total MBS and CRT securities $ 11,703,896 $ 172,160 $ (317,930 ) $ (787,541 ) $ 10,771,616 $ 11,356,643 $ 656,956 $ (71,929 ) $ 585,027 (1) Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income. Amounts disclosed at March 31, 2016 reflect Credit Reserve of $736.4 million and OTTI of $21.2 million . Amounts disclosed at December 31, 2015 reflect Credit Reserve of $766.0 million and OTTI of $21.5 million . (2) Includes principal payments receivable of $1.1 million and $1.0 million at March 31, 2016 and December 31, 2015 , respectively, which are not included in the Principal/Current Face. (3) Based on managemen t ’ s current estimates of future principal cash flows expected to be received. (4) At March 31, 2016 RPL/NPL MBS had a $2.515 billion Principal/Current face, $2.514 billion amortized cost and $2.496 billion fair value. At December 31, 2015 , RPL/NPL MBS had a $2.648 billion Principal/Current face, $2.645 billion amortized cost and $2.626 billion fair value. (5) At March 31, 2016 and December 31, 2015 , the Company expected to recover approximately 89% and 89% , respectively, of the then-current face amount of Non-Agency MBS. (6) Amounts disclosed at March 31, 2016 includes CRT securities with a fair value of $92.9 million for which the fair value option has been elected. Such securities have gross unrealized gains of approximately $1.4 million , gross unrealized losses of approximately $132,000 and net unrealized gains of approximately $1.2 million at March 31, 2016 . Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $62.2 million for which the fair value option has been elected. Such securities have gross unrealized gains of approximately $332,000 , gross unrealized losses of approximately $555,000 and net unrealized losses of approximately $223,000 at December 31, 2015 . Unrealized Losses on MBS and CRT Securities The following table presents information about the Company’s MBS and CRT securities that were in an unrealized loss position at March 31, 2016 : Unrealized Loss Position For: Less than 12 Months 12 Months or more Total Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses (Dollars in Thousands) Agency MBS: Fannie Mae $ 566,376 $ 4,507 95 $ 976,991 $ 10,348 129 $ 1,543,367 $ 14,855 Freddie Mac 4,523 1 1 517,333 4,981 92 521,856 4,982 Total Agency MBS 570,899 4,508 96 1,494,324 15,329 221 2,065,223 19,837 Non-Agency MBS: Expected to Recover Par (1) 1,841,079 15,689 55 181,507 3,324 10 2,022,586 19,013 Expected to Recover Less than Par (1) 276,920 7,233 43 67,129 4,790 15 344,049 12,023 Total Non-Agency MBS 2,117,999 22,922 98 248,636 8,114 25 2,366,635 31,036 Total MBS 2,688,898 27,430 194 1,742,960 23,443 246 4,431,858 50,873 CRT securities (2) 95,402 1,071 23 4,588 413 1 99,990 1,484 Total MBS and CRT securities $ 2,784,300 $ 28,501 217 $ 1,747,548 $ 23,856 247 $ 4,531,848 $ 52,357 (1) Based on management’s current estimates of future principal cash flows expected to be received. (2) Amounts disclosed at March 31, 2016 includes CRT securities with a fair value of $24.7 million for which the fair value option has been elected. Such securities have unrealized losses of $132,000 at March 31, 2016 . At March 31, 2016 , the Company did not intend to sell any of its investments that were in an unrealized loss position, and it is “more likely than not” that the Company will not be required to sell these securities before recovery of their amortized cost basis, which may be at their maturity. With respect to Non-Agency MBS held by consolidated VIEs, the ability of any entity to cause the sale to a third-party by the VIE prior to the maturity of these Non-Agency MBS is either specifically precluded or is limited to specified events of default, none of which has occurred to date. Gross unrealized losses on the Company’s Agency MBS were $19.8 million at March 31, 2016 . Agency MBS are issued by Government Sponsored Entities (“GSEs”) and enjoy either the implicit or explicit backing of the full faith and credit of the U.S. Government. While the Company’s Agency MBS are not rated by any rating agency, they are currently perceived by market participants to be of high credit quality, with risk of default limited to the unlikely event that the U.S. Government would not continue to support the GSEs. Given the credit quality inherent in Agency MBS, the Company does not consider any of the current impairments on its Agency MBS to be credit related. In assessing whether it is more likely than not that it will be required to sell any impaired security before its anticipated recovery, which may be at its maturity, the Company considers for each impaired security, the significance of each investment, the amount of impairment, the projected future performance of such impaired securities, as well as the Company’s current and anticipated leverage capacity and liquidity position. Based on these analyses, the Company determined that at March 31, 2016 any unrealized losses on its Agency MBS were temporary. Unrealized losses on the Company’s Non-Agency MBS (including Non-Agency MBS transferred to consolidated VIEs) were $31.0 million at March 31, 2016 , of which $17.8 million were RPL/NPL MBS and $13.2 million were Legacy Non-Agency MBS at March 31, 2016 . Based upon the most recent evaluation, the Company does not consider these unrealized losses to be indicative of OTTI and does not believe that these unrealized losses are credit related, but are rather a reflection of current market yields and/or market place bid-ask spreads. The Company has reviewed its Non-Agency MBS that are in an unrealized loss position to identify those securities with losses that are other-than-temporary based on an assessment of changes in expected cash flows for such securities, which considers recent bond performance and, where possible, expected future performance of the underlying collateral. The Company did no t recognize any credit-related OTTI losses through earnings related to its MBS during the three months ended March 31, 2016 . The Company recognized credit-related OTTI losses through earnings related to its Non-Agency MBS of $407,000 during the three months ended March 31, 2015 . Non-Agency MBS on which OTTI is recognized have experienced, or are expected to experience, credit-related adverse cash flow changes. The Company’s estimate of cash flows for these Non-Agency MBS is based on its review of the underlying mortgage loans securing these MBS. The Company considers information available about the structure of the securitization, including structural credit enhancement, if any, and the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, FICO scores at loan origination, year of origination, LTVs, geographic concentrations, as well as Rating Agency reports, general market assessments, and dialogue with market participants. Changes in the Company’s evaluation of each of these factors impacts the cash flows expected to be collected at the OTTI assessment date. For Non-Agency MBS purchased at a discount to par that were assessed for and had no OTTI recorded this period, such cash flow estimates indicated that the amount of expected losses decreased compared to the previous OTTI assessment date. These positive cash flow changes are primarily driven by recent improvements in LTVs due to loan amortization and home price appreciation, which, in turn, positively impacts the Company’s estimates of default rates and loss severities for the underlying collateral. In addition, voluntary prepayments (i.e., loans that prepay in full with no loss) have generally trended higher for these MBS which also positively impacts the Company’s estimate of expected loss. Overall, the combination of higher voluntary prepayments and lower LTVs supports the Company’s assessment that such MBS are not other-than-temporarily impaired. The following table presents the composition of OTTI charges recorded by the Company for the three months ended March 31, 2016 and 2015 : Three Months Ended (In Thousands) 2016 2015 Total OTTI losses $ — $ (395 ) OTTI reclassified from OCI — (12 ) OTTI recognized in earnings $ — $ (407 ) The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI. Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded. Three Months Ended (In Thousands) 2016 2015 Credit loss component of OTTI at beginning of period $ 36,820 $ 36,115 Additions for credit related OTTI not previously recognized — 395 Subsequent additional credit related OTTI recorded — 12 Credit loss component of OTTI at end of period $ 36,820 $ 36,522 Purchase Discounts on Non-Agency MBS The following tables present the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the three months ended March 31, 2016 and 2015 : Three Months Ended Three Months Ended (In Thousands) Discount Designated as Credit Reserve and OTTI Accretable Discount (1) Discount Designated as Credit Reserve and OTTI Accretable Discount (1) Balance at beginning of period $ (787,541 ) $ (312,182 ) $ (900,557 ) $ (399,564 ) Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing — — (15,543 ) 1,832 Accretion of discount — 21,406 — 24,800 Realized credit losses 18,050 — 19,624 — Purchases (4,294 ) 1,606 (34 ) (3,410 ) Sales 12,020 12,040 1,049 9,969 Net impairment losses recognized in earnings — — (407 ) — Transfers/release of credit reserve 4,201 (4,201 ) 22,335 (22,335 ) Balance at end of period $ (757,564 ) $ (281,331 ) $ (873,533 ) $ (388,708 ) (1) Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security. Impact of AFS Securities on AOCI The following table presents the impact of the Company’s AFS securities on its AOCI for the three months ended March 31, 2016 and 2015 : Three Months Ended March 31, (In Thousands) 2016 2015 AOCI from AFS securities: Unrealized gain on AFS securities at beginning of period $ 585,250 $ 813,515 Unrealized gain on Agency MBS, net 13,226 12,885 Unrealized (loss)/gain on Non-Agency MBS, net (58,840 ) 26,150 Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing — 4,537 Reclassification adjustment for MBS sales included in net income (10,485 ) (6,423 ) Reclassification adjustment for OTTI included in net income — (407 ) Change in AOCI from AFS securities (56,099 ) 36,742 Balance at end of period $ 529,151 $ 850,257 Sales of MBS During the three months ended March 31, 2016 , the Company sold certain Non-Agency MBS for $32.0 million realizing gross gains of $9.7 million . During the three months ended March 31, 2015 , the Company sold certain Non-Agency MBS for $10.8 million , realizing gross gains of $6.4 million . The Company has no continuing involvement with any of the sold MBS. Interest Income on MBS and CRT Securities The following table presents the components of interest income on the Company’s MBS and CRT securities for the three months ended March 31, 2016 and 2015 : Three Months Ended March 31, (In Thousands) 2016 2015 Agency MBS Coupon interest $ 32,132 $ 40,743 Effective yield adjustment (1) (8,135 ) (9,070 ) Interest income $ 23,997 $ 31,673 Legacy Non-Agency MBS Coupon interest $ 40,309 $ 49,356 Effective yield adjustment (2) 19,913 24,406 Interest income $ 60,222 $ 73,762 RPL/NPL MBS Coupon interest $ 24,370 $ 19,185 Effective yield adjustment (2) 1,560 344 Interest income $ 25,930 $ 19,529 CRT securities Coupon interest $ 2,356 $ 1,202 Effective yield adjustment (2) 336 158 Interest income $ 2,692 $ 1,360 (1) Includes amortization of premium paid net of accretion of purchase discount. For Agency MBS, interest income is recorded at an effective yield, which reflects net premium amortization based on actual prepayment activity. (2) The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield. |
Residential Whole Loans
Residential Whole Loans | 3 Months Ended |
Mar. 31, 2016 | |
Investments, Debt and Equity Securities [Abstract] | |
Residential Whole Loans | Residential Whole Loans Included on the Company’s consolidated balance sheets at March 31, 2016 and December 31, 2015 , are approximately $1.024 billion and $895.1 million , respectively, of residential whole loans arising from the Company’s 100% equity interest in certificates issued by certain trusts established to acquire the loans. Based on its evaluation of these interests and other factors, the Company has determined that the trusts are required to be consolidated for financial reporting purposes. Residential Whole Loans at Carrying Value Residential whole loans at carrying value totaled approximately $376.2 million and $271.8 million at March 31, 2016 and December 31, 2015 , respectively. The carrying value reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. The carrying value is reduced by any allowance for loan losses established subsequent to acquisition. The Company recorded an allowance for loan losses of approximately $1.1 million on its residential whole loan pools held at carrying value as of March 31, 2016 . For the three months ended March 31, 2016 and March 31, 2015 , a net (reversal of)/provision for loan losses of approximately $(37,000) and $327,000 was recorded, respectively, which is included in Operating and Other expense on the Company’s consolidated statements of operations. The following table presents the activity in the Company’s allowance for loan losses on its residential whole loan pools at carrying value for the three months ended March 31, 2016 and 2015 : (In Thousands) Three Months Ended March 31, 2016 March 31, 2015 Balance at the beginning of period $ 1,165 $ 137 (Reversal of)/Provisions for loan losses (37 ) 327 Balance at the end of period $ 1,128 $ 464 The following table presents information regarding estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the residential whole loans held at carrying value acquired by the Company for the three months ended March 31, 2016 and 2015 : (In Thousands) Three Months Ended March 31, 2016 March 31, 2015 Contractually required principal and interest $ 199,092 $ 78,799 Contractual cash flows not expected to be collected (non-accretable yield) (28,663 ) (13,357 ) Expected cash flows to be collected 170,429 65,442 Interest component of expected cash flows (accretable yield) (58,509 ) (26,840 ) Fair value at the date of acquisition $ 111,920 $ 38,602 The following table presents accretable yield activity for the Company’s residential whole loans held at carrying value for the three months ended March 31, 2016 and 2015 : (In Thousands) Three Months Ended March 31, 2016 March 31, 2015 Balance at beginning of period $ 175,271 $ 133,012 Additions 58,509 26,840 Accretion (4,436 ) (3,468 ) Reclassifications to non-accretable difference, net 64 (1,433 ) Balance at end of period $ 229,408 $ 154,951 Accretable yield for residential whole loans is the excess of loan cash flows expected to be collected over the purchase price. The cash flows expected to be collected represents the Company’s estimate of the amount and timing of undiscounted principal and interest cash flows. Additions include accretable yield estimates for purchases made during the period and reclassification to accretable yield from non-accretable yield. Accretable yield is reduced by accretion during the period. The reclassifications between accretable and non-accretable yield and the accretion of interest income are based on changes in estimates regarding loan performance and the value of the underlying real estate securing the loans. In future periods, as the Company updates estimates of cash flows expected to be collected from the loans and the underlying collateral, the accretable yield may change. Therefore, the amount of accretable income recorded during the three months ended March 31, 2016 is not necessarily indicative of future results. Residential Whole Loans at Fair Value Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. The following table presents information regarding the Company’s residential whole loans at fair value at March 31, 2016 and December 31, 2015 : (Dollars in Thousands) March 31, 2016 December 31, 2015 Outstanding principal balance $ 810,263 $ 786,330 Aggregate fair value $ 647,360 $ 623,276 Number of loans 3,086 3,143 During the three months ended March 31, 2016 and 2015 , the Company recorded net gains on residential whole loans held at fair value of $11.9 million and $2.0 million , respectively. The following table presents the components of Net gain on residential whole loans held at fair value for the three months ended March 31, 2016 and 2015 : (In Thousands) Three Months Ended March 31, 2016 March 31, 2015 Coupon payments and other income received $ 4,401 $ 1,321 Net unrealized gains 6,226 345 Net gain on payoff/liquidation of loans 1,254 368 Total $ 11,881 $ 2,034 |
Interest Receivable
Interest Receivable | 3 Months Ended |
Mar. 31, 2016 | |
Receivables [Abstract] | |
Interest Receivable | Interest Receivable The following table presents the Company’s interest receivable by investment category at March 31, 2016 and December 31, 2015 : (In Thousands) March 31, 2016 December 31, 2015 MBS interest receivable: Fannie Mae $ 8,640 $ 8,999 Freddie Mac 2,091 2,177 Ginnie Mae 15 15 Non-Agency MBS 14,853 15,438 Total MBS interest receivable 25,599 26,629 Residential whole loans 3,298 2,259 CRT securities 196 92 Money market and other investments 33 22 Total interest receivable $ 29,126 $ 29,002 |
Derivative Instruments
Derivative Instruments | 3 Months Ended |
Mar. 31, 2016 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments | Derivative Instruments The Company’s derivative instruments are currently comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with its borrowings. Prior to 2015, the Company had also entered into Linked Transactions, which were not designated as hedging instruments. (See Note 2 ( p ), and below) The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 Derivative Instrument Designation Balance Sheet Location Notional Amount Fair Value Notional Amount Fair Value (In Thousands) Non-cleared legacy Swaps (1) Hedging Assets $ 300,000 $ 152 $ 450,000 $ 1,127 Non-cleared legacy Swaps (1) Hedging Liabilities $ 150,000 $ (117 ) $ 50,000 $ (59 ) Cleared Swaps (2) Hedging Liabilities $ 2,550,000 $ (118,776 ) $ 2,550,000 $ (70,467 ) (1) Non-cleared legacy Swaps include Swaps executed and settled bilaterally with counterparties without the use of an organized exchange or central clearing house. (2) Cleared Swaps include Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties. Swaps Consistent with market practice, the Company has agreements with its Swap counterparties that provide for the posting of collateral based on the fair values of its derivative contracts. Through this margining process, either the Company or its derivative counterparty may be required to pledge cash or securities as collateral. In addition, Swaps novated to and cleared by a central clearing house are subject to initial margin requirements. Certain derivative contracts provide for cross collateralization with repurchase agreements with the same counterparty. A number of the Company’s Swap contracts include financial covenants, which, if breached, could cause an event of default or early termination event to occur under such agreements. Such financial covenants include minimum net worth requirements and maximum debt-to-equity ratios. If the Company were to cause an event of default or trigger an early termination event pursuant to one of its Swap contracts, the counterparty to such agreement may have the option to terminate all of its outstanding Swap contracts with the Company and, if applicable, any close-out amount due to the counterparty upon termination of the Swap contracts would be immediately payable by the Company. The Company was in compliance with all of its financial covenants through March 31, 2016 . At March 31, 2016 , the aggregate fair value of assets needed to immediately settle Swap contracts that were in a liability position to the Company, if so required, was approximately $120.2 million , including accrued interest payable of approximately $1.3 million . The following table presents the assets pledged as collateral against the Company’s Swap contracts at March 31, 2016 and December 31, 2015 : (In Thousands) March 31, 2016 December 31, 2015 Agency MBS, at fair value $ 36,927 $ 38,569 Restricted cash 118,264 70,573 Total assets pledged against Swaps $ 155,191 $ 109,142 The use of derivative hedging instruments exposes the Company to counterparty credit risk. In the event of a default by a derivative counterparty, the Company may not receive payments to which it is entitled under its derivative agreements, and may have difficulty recovering its assets pledged as collateral against such agreements. If, during the term of a derivative contract, a counterparty should file for bankruptcy, the Company may experience difficulty recovering its assets pledged as collateral which could result in the Company having an unsecured claim against such counterparty’s assets for the difference between the fair value of the derivative and the fair value of the collateral pledged to such counterparty. The Company’s derivative hedging instruments, or a portion thereof, could become ineffective in the future if the associated repurchase agreements that such derivatives hedge fail to exist or fail to have terms that match those of the derivatives that hedge such borrowings. At March 31, 2016 , all of the Company’s derivatives were deemed effective for hedging purposes and no derivatives were terminated during the three months ended March 31, 2016 and 2015 . The Company’s Swaps designated as hedging transactions have the effect of modifying the repricing characteristics of the Company’s repurchase agreements and cash flows for such liabilities. To date, no cost has been incurred at the inception of a Swap (except for certain transaction fees related to entering into Swaps cleared though a central clearing house), pursuant to which the Company agrees to pay a fixed rate of interest and receive a variable interest rate, generally based on one -month or three -month London Interbank Offered Rate (“LIBOR”), on the notional amount of the Swap. The Company did not recognize any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness during the three months ended March 31, 2016 and 2015 . At March 31, 2016 , the Company had Swaps designated in hedging relationships with an aggregate notional amount of $3.000 billion , which had net unrealized losses of $118.7 million , and extended 43 months on average with a maximum term of approximately 89 months . The following table presents certain information with respect to the Company’s Swap activity during the three months ended March 31, 2016 : (Dollars in Thousands) Three Months Ended New Swaps: Aggregate notional amount $ — Weighted average fixed-pay rate — % Initial maturity date N/A Number of new Swaps — Swaps amortized/expired: Aggregate notional amount $ 50,000 Weighted average fixed-pay rate 2.13 % The following table presents information about the Company’s Swaps at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 Notional Amount Weighted Average Fixed-Pay Interest Rate Weighted Average Variable Interest Rate (2) Notional Amount Weighted Average Fixed-Pay Interest Rate Weighted Average Variable Interest Rate (2) Maturity (1) (Dollars in Thousands) Within 30 days $ — — % — % $ 50,000 2.13 % 0.42 % Over 6 months to 12 months 150,000 0.54 0.44 100,000 0.48 0.32 Over 12 months to 24 months 300,000 0.57 0.44 350,000 0.58 0.27 Over 24 months to 36 months 650,000 1.53 0.44 550,000 1.49 0.32 Over 36 months to 48 months 100,000 1.71 0.43 200,000 1.71 0.42 Over 48 months to 60 months 1,600,000 2.22 0.44 1,500,000 2.22 0.36 Over 60 months to 72 months 100,000 2.21 0.44 200,000 2.20 0.30 Over 84 months (3) 100,000 2.75 0.43 100,000 2.75 0.40 Total Swaps $ 3,000,000 1.82 % 0.44 % $ 3,050,000 1.82 % 0.34 % (1) Each maturity category reflects contractual amortization and/or maturity of notional amounts. (2) Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one -month or three -month LIBOR, respectively. (3) Reflects one Swap with a maturity date of July 2023. The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the three months ended March 31, 2016 and 2015 : Three Months Ended (Dollars in Thousands) 2016 2015 Interest expense attributable to Swaps $ 10,650 $ 15,382 Weighted average Swap rate paid 1.82 % 1.84 % Weighted average Swap rate received 0.42 % 0.17 % Impact of Derivative Hedging Instruments on AOCI The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the three months ended March 31, 2016 and 2015 : Three Months Ended (In Thousands) 2016 2015 AOCI from derivative hedging instruments: Balance at beginning of period $ (69,399 ) $ (59,062 ) Unrealized loss on Swaps, net (49,342 ) (32,367 ) Balance at end of period $ (118,741 ) $ (91,429 ) Counterparty Credit Risk from Use of Swaps By using Swaps, the Company is exposed to counterparty credit risk if counterparties to the derivative contracts do not perform as expected. If a counterparty fails to perform, the Company’s counterparty credit risk is equal to the amount reported as a derivative asset on its consolidated balance sheets to the extent that amount exceeds collateral obtained from the counterparty or, if in a net liability position, the extent to which collateral posted exceeds the liability to the counterparty. The amounts reported as a derivative asset/(liability) are derivative contracts in a gain/(loss) position, and to the extent subject to master netting arrangements, net of derivatives in a loss/(gain) position with the same counterparty and collateral received/(pledged). The Company attempts to minimize counterparty credit risk through credit approvals, limits, monitoring procedures, executing master netting arrangements and obtaining collateral, where appropriate. Counterparty credit risk related to the Company’s Swaps is considered in determining the fair value of such derivatives and in its assessment of hedge effectiveness. Linked Transactions Prior to January 1, 2015, the Company’s Linked Transactions had been evaluated on a combined basis, reported as forward (derivative) instruments and presented as assets on the Company’s consolidated balance sheets at fair value. The fair value of Linked Transactions reflected the value of the underlying Non-Agency MBS, linked repurchase agreement borrowings and accrued interest receivable/payable on such instruments. The Company’s Linked Transactions were not designated as hedging instruments and, as a result, the change in the fair value and net interest income from Linked Transactions had been reported in Other Income, net on the Company’s consolidated statements of operations. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. An entity is required to present changes in accounting for transactions outstanding on the effective date as a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. Accordingly, on adoption of the new standard on January 1, 2015, the Company reclassified $1.913 billion of Non-Agency MBS and $4.6 million of CRT securities that were previously reported as a component of Linked Transactions to Non-Agency MBS and CRT securities, respectively on the consolidated balance sheet. In addition, liabilities of $1.520 billion that were previously presented as a component of Linked Transactions were reclassified to Repurchase agreements on the consolidated balance sheet. Furthermore, an amount of $4.5 million representing net unrealized gains on securities previously reported as a component of Linked Transactions as of December 31, 2014 was reclassified from Accumulated deficit to AOCI. These reclassification adjustments had no net impact on the Company’s overall Total Stockholders’ Equity. |
Real Estate Owned
Real Estate Owned | 3 Months Ended |
Mar. 31, 2016 | |
Real Estate [Abstract] | |
Real Estate Owned | Real Estate Owned At March 31, 2016 , the Company had 270 REO properties with an aggregate carrying value of $43.3 million . At December 31, 2015 , the Company had 182 REO properties with an aggregate carrying value of $28.0 million . During the three months ended March 31, 2016 and 2015 , the Company did not acquire any residential properties in connection with the acquisition of residential whole loans. During the three months ended March 31, 2016 and 2015 , the Company reclassified 138 and 25 mortgage loans to REO at an aggregate estimated fair value less estimated selling costs of $22.3 million and $4.0 million , respectively at the time of transfer. Such transfers occur when the Company takes possession of the property by foreclosing on the borrower or completes a “deed-in-lieu of foreclosure” transaction. At March 31, 2016 , $42.1 million of residential real estate property was held by the Company that was acquired either through a completed foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement. In addition, formal foreclosure proceedings were in process with respect to $18.7 million of residential whole loans at carrying value and $366.6 million of residential whole loans at fair value at March 31, 2016 . During the three months ended March 31, 2016 and 2015 , the Company sold 50 and five REO properties for consideration of $6.2 million and $581,000 , realizing net gains of approximately $509,000 and net losses of approximately $26,000 , respectively, which are included in Other, net on the Company’s consolidated statements of operations. In addition, following an updated assessment of liquidation amounts expected to be realized that was performed on all REO held at the end of the quarter a downward adjustment of approximately $1.8 million was recorded to reflect certain REO properties at the lower of cost or estimated fair value as of March 31, 2016 . The Company did not record a lower of cost or estimated fair value adjustment on its REO properties during the quarter ended March 31, 2015. The following table presents the activity in the Company’s REO for the three months ended March 31, 2016 and 2015 : (In Thousands) Three Months Ended March 31, 2016 March 31, 2015 Balance at beginning of period $ 28,026 $ 5,492 Adjustments to record at lower of cost or fair value (1,777 ) — Transfer from residential whole loans (1) 22,280 3,448 Purchases and capital improvements 410 — Disposals (5,648 ) (607 ) Balance at end of period $ 43,291 $ 8,333 (1) Includes net gain recorded on transfer of approximately $441,000 and $285,000 , respectively, for the three months ended March 31, 2016 and 2015 . Real estate owned is included in Other assets in the Company’s consolidated balance sheets. |
Other Assets
Other Assets | 3 Months Ended |
Mar. 31, 2016 | |
Other Assets [Abstract] | |
Other Assets | Other Assets The following table presents the components of the Company’s Other assets at March 31, 2016 and December 31, 2015 : (In Thousands) March 31, 2016 December 31, 2015 REO $ 43,291 $ 28,026 Interest receivable 29,126 29,002 Swaps, at fair value 152 1,127 Goodwill 7,189 7,189 Prepaid and other assets 96,324 101,455 Total Other Assets $ 176,082 $ 166,799 |
Repurchase Agreements and Other
Repurchase Agreements and Other Advances | 3 Months Ended |
Mar. 31, 2016 | |
Disclosure of Repurchase Agreements [Abstract] | |
Repurchase Agreements and Other Advances | Repurchase Agreements and Other Advances Repurchase Agreements The Company’s repurchase agreements are accounted for as secured borrowings and are collateralized by the Company’s MBS, U.S. Treasury securities (obtained as part of a reverse repurchase agreement), CRT securities, residential whole loans and cash, and bear interest that is generally LIBOR-based. (See Notes 2 ( k ) and 10 ) At March 31, 2016 , the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 20 days and an effective repricing period of 16 months , including the impact of related Swaps. At December 31, 2015 , the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 21 days and an effective repricing period of 18 months , including the impact of related Swaps. The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at March 31, 2016 and December 31, 2015 : (Dollars in Thousands) March 31, December 31, Repurchase agreement borrowings secured by Agency MBS $ 2,851,997 $ 2,727,542 Fair value of Agency MBS pledged as collateral under repurchase agreements $ 2,994,028 $ 2,881,049 Weighted average haircut on Agency MBS (1) 4.69 % 4.67 % Repurchase agreement borrowings secured by Legacy Non-Agency MBS $ 1,954,499 $ 1,960,222 Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase agreements (2) $ 2,692,830 $ 2,818,968 Weighted average haircut on Legacy Non-Agency MBS (1) 24.27 % 25.42 % Repurchase agreement borrowings secured by RPL/NPL MBS $ 1,911,483 $ 2,080,163 Fair value of RPL/NPL MBS pledged as collateral under repurchase agreements $ 2,496,165 $ 2,625,866 Weighted average haircut on RPL/NPL MBS (1) 23.49 % 21.37 % Repurchase agreements secured by U.S. Treasuries $ 504,999 $ 504,760 Fair value of U.S. Treasuries pledged as collateral under repurchase agreements $ 513,409 $ 507,443 Weighted average haircut on U.S. Treasuries (1) 1.59 % 1.60 % Repurchase agreements secured by CRT securities $ 139,409 $ 128,465 Fair value of CRT securities pledged as collateral under repurchase agreements $ 196,350 $ 170,352 Weighted average haircut on CRT securities (1) 24.91 % 25.04 % Repurchase agreements secured by residential whole loans (3) $ 589,136 $ 487,750 Fair value of residential whole loans pledged as collateral under repurchase agreements $ 815,745 $ 684,136 Weighted average haircut on residential whole loans (1) 26.05 % 27.69 % (1) Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount. (2) Includes $185.9 million and $570.5 million of Legacy Non-Agency MBS acquired from consolidated VIEs at March 31, 2016 and December 31, 2015 , respectively, that are eliminated from the Company’s consolidated balance sheets. (3) Excludes $878,000 and $1.3 million of unamortized debt issuance costs at March 31, 2016 and December 31, 2015 , respectively. The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 Balance Weighted Average Interest Rate Balance Weighted Average Interest Rate Time Until Interest Rate Reset (Dollars in Thousands) Within 30 days $ 7,079,968 1.44 % $ 7,054,483 1.44 % Over 30 days to 3 months 772,091 2.00 734,955 1.79 Over 3 months to 12 months 99,464 2.36 99,464 2.36 Total repurchase agreements 7,951,523 1.51 % 7,888,902 1.48 % Less debt issuance costs 878 1,280 Total repurchase agreements less debt issuance costs $ 7,950,645 $ 7,887,622 The following table presents contractual maturity information about the Company’s borrowings under repurchase agreements, all of which are accounted for as secured borrowings, at March 31, 2016 and does not reflect the impact of derivative contracts that hedge such repurchase agreements: March 31, 2016 Contractual Maturity Agency MBS Legacy Non-Agency MBS RPL/NPL MBS U.S. Treasuries CRT Securities Residential Whole Loans Total (1) Weighted Average Interest Rate (Dollars in Thousands) Overnight $ — $ — $ — $ — $ — $ — $ — — % Within 30 days 2,851,997 933,113 1,429,721 504,999 122,861 — 5,842,691 1.23 Over 30 days to 3 months — 581,487 73,376 — 16,548 — 671,411 2.02 Over 3 months to 12 months — 439,899 408,386 — — 410,578 1,258,863 2.29 Over 12 months — — — — — 178,558 178,558 3.13 Total $ 2,851,997 $ 1,954,499 $ 1,911,483 $ 504,999 $ 139,409 $ 589,136 $ 7,951,523 1.51 % Gross amount of recognized liabilities for repurchase agreements in Note 11 $ 7,951,523 Amounts related to repurchase agreements not included in offsetting disclosure in Note 11 $ — (1) Excludes $878,000 of unamortized debt issuance costs at March 31, 2016 . The Company had repurchase agreements with 27 counterparties at both March 31, 2016 and December 31, 2015 , respectively. The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at March 31, 2016 : March 31, 2016 Counterparty Rating (1) Amount at Risk (2) Weighted Average Months to Maturity for Repurchase Agreements Percent of Stockholders’ Equity Counterparty (Dollars in Thousands) Wells Fargo (3) AA-/Aa2/AA $ 350,432 6 12.3 % Credit Suisse BBB+/Aa2/A 343,366 1 12.0 RBC (4) AA-/Aa3/AA 269,663 2 9.4 Goldman Sachs BBB+/A3/A 183,706 5 6.4 UBS (5) A/A1/A 166,961 16 5.8 (1) As rated at March 31, 2016 by S&P, Moody’s and Fitch, Inc., respectively. The counterparty rating presented is the lowest published for these entities. (2) The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities. (3) Includes $284.9 million at risk with Wells Fargo Bank, NA and $65.5 million at risk with Wells Fargo Securities LLC. (4) Includes $225.3 million at risk with RBC Barbados, $37.7 million at risk with Royal Bank of Canada and $6.7 million at risk with RBC Capital Markets LLC. Counterparty ratings are not published for RBC Barbados and RBC Capital Markets LLC. (5) Includes Non-Agency MBS pledged as collateral with contemporaneous repurchase and reverse repurchase agreements. FHLB Advances As of March 31, 2016 , MFA Insurance had $1.193 billion in outstanding long-term secured FHLB advances with a weighted average borrowing rate of 0.55% and a weighted average term to maturity of 4.55 years . However, MFA Insurance is required by recent amendments to FHLB membership regulations to terminate its membership and repay the outstanding advances by February 19, 2017. Interest payable on outstanding FHLB advances at March 31, 2016 totaled approximately $472,000 , and is included in Accrued interest payable on the Company’s consolidated balance sheets. |
Collateral Positions
Collateral Positions | 3 Months Ended |
Mar. 31, 2016 | |
Collateral Positions | |
Collateral Positions | Collateral Positions The Company pledges securities or cash as collateral to its counterparties pursuant to its borrowings under repurchase agreements, FHLB advances and its derivative contracts that are in an unrealized loss position, and it receives securities or cash as collateral pursuant to financing provided under reverse repurchase agreements and certain of its derivative contracts in an unrealized gain position. The Company exchanges collateral with its counterparties based on changes in the fair value, notional amount and term of the associated repurchase agreements, FHLB advances and derivative contracts, as applicable. Through this margining process, either the Company or its counterparty may be required to pledge cash or securities as collateral. In addition, Swaps novated to and cleared by a central clearing house are subject to initial margin requirements. When the Company’s pledged collateral exceeds the required margin, the Company may initiate a reverse margin call, at which time the counterparty may either return the excess collateral, or provide collateral to the Company in the form of cash or equivalent securities. The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements, derivative hedging instruments and FHLB advances at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 (In Thousands) Assets Pledged Collateral Held Assets Pledged Collateral Held Derivative Hedging Instruments: Agency MBS $ 36,927 $ — $ 38,569 $ — Cash (1) 118,264 — 70,573 — 155,191 — 109,142 — Repurchase Agreement Borrowings: Agency MBS 2,994,028 — 2,881,049 — Legacy Non-Agency MBS (2)(3) 2,692,830 — 2,818,968 — RPL/NPL MBS 2,496,165 — 2,625,866 — U.S. Treasury securities 513,409 — 507,443 — CRT securities 196,350 — 170,352 — Residential whole loans 815,745 — 684,136 — Cash (1) 5,412 — 965 — 9,713,939 — 9,688,779 — FHLB Advances: Agency MBS 1,286,203 — 1,612,476 — 1,286,203 — 1,612,476 — Reverse Repurchase Agreements: U.S. Treasury securities — 513,409 — 507,443 — 513,409 — 507,443 Total $ 11,155,333 $ 513,409 $ 11,410,397 $ 507,443 (1) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets. (2) Includes $185.9 million and $570.5 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at March 31, 2016 and December 31, 2015 , respectively, that are eliminated from the Company’s consolidated balance sheets. (3) In addition, at March 31, 2016 and December 31, 2015 , $675.5 million and $726.7 million of Legacy Non-Agency MBS, respectively, are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty. The following table presents detailed information about the Company’s assets pledged as collateral pursuant to its borrowings under repurchase agreements and other advances, and derivative hedging instruments at March 31, 2016 : March 31, 2016 Assets Pledged Under Repurchase Agreements and Other Advances Assets Pledged Against Derivative Hedging Instruments Total Fair Value of Assets Pledged and Accrued Interest (In Thousands) Fair Value Amortized Cost Accrued Interest on Pledged Assets Fair Value/ Carrying Value Amortized Cost Accrued Interest on Pledged Assets Agency MBS (1) $ 4,280,231 $ 4,241,609 $ 10,111 $ 36,927 $ 37,174 $ 75 $ 4,327,344 Legacy Non-Agency MBS (2)(3) 2,692,830 2,272,910 9,961 — — — 2,702,791 RPL/NPL MBS 2,496,165 2,513,829 1,393 — — — 2,497,558 U.S. Treasuries 513,409 513,409 — — — — 513,409 CRT securities 196,350 196,695 176 — — — 196,526 Residential whole loans 815,745 798,377 1,609 — — — 817,354 Cash (4) 5,412 5,412 — 118,264 118,264 — 123,676 Total $ 11,000,142 $ 10,542,241 $ 23,250 $ 155,191 $ 155,438 $ 75 $ 11,178,658 (1) Includes Agency MBS pledged under FHLB advances with an aggregate fair value of $1.286 billion , aggregate amortized cost of $1.275 billion and aggregate accrued interest of approximately $3.1 million at March 31, 2016 . (2) Includes $185.9 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at March 31, 2016 , that are eliminated from the Company’s consolidated balance sheets. (3) In addition, at March 31, 2016 , $675.5 million of Legacy Non-Agency MBS are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty. (4) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets. |
Offsetting Assets and Liabiliti
Offsetting Assets and Liabilities | 3 Months Ended |
Mar. 31, 2016 | |
Offsetting [Abstract] | |
Offsetting Assets and Liabilities | Offsetting Assets and Liabilities The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at March 31, 2016 and December 31, 2015 : Offsetting of Financial Assets and Derivative Assets Gross Amounts of Recognized Assets Gross Amounts Offset in the Consolidated Balance Sheets Net Amounts of Assets Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount (In Thousands) Financial Instruments Cash Collateral Received March 31, 2016 Swaps, at fair value $ 152 $ — $ 152 $ (152 ) $ — $ — Total $ 152 $ — $ 152 $ (152 ) $ — $ — December 31, 2015 Swaps, at fair value $ 1,127 $ — $ 1,127 $ (1,127 ) $ — $ — Total $ 1,127 $ — $ 1,127 $ (1,127 ) $ — $ — Offsetting of Financial Liabilities and Derivative Liabilities Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Consolidated Balance Sheets Net Amounts of Liabilities Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount (In Thousands) Financial Instruments (1) Cash Collateral Pledged (1) March 31, 2016 Swaps, at fair value (2) $ 118,893 $ — $ 118,893 $ (629 ) $ (118,264 ) $ — Repurchase agreements and other advances (3) (4) 9,144,523 — 9,144,523 (9,139,111 ) (5,412 ) — Total $ 9,263,416 $ — $ 9,263,416 $ (9,139,740 ) $ (123,676 ) $ — December 31, 2015 Swaps, at fair value (2) $ 70,526 $ — $ 70,526 $ — $ (70,526 ) $ — Repurchase agreements and other advances (3) (4) 9,388,902 — 9,388,902 (9,387,937 ) (965 ) — Total $ 9,459,428 $ — $ 9,459,428 $ (9,387,937 ) $ (71,491 ) $ — (1) Amounts disclosed in the Financial Instruments column of the table above represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements and other advances, and derivative transactions. Amounts disclosed in the Cash Collateral Pledged column of the table above represent amounts pledged as collateral against derivative transactions and repurchase agreements, and exclude excess collateral of $47,000 at December 31, 2015 . (2) The fair value of securities pledged against the Company’s Swaps was $36.9 million and $38.6 million at March 31, 2016 and December 31, 2015 , respectively. (3) The fair value of financial instruments pledged against the Company’s repurchase agreements and other advances was $10.995 billion and $11.300 billion at March 31, 2016 and December 31, 2015 , respectively. (4) Excludes $878,000 and $1.3 million of unamortized debt issuance costs at March 31, 2016 and December 31, 2015 , respectively. Nature of Setoff Rights In the Company’s consolidated balance sheets, all balances associated with the repurchase agreement and derivative transactions are presented on a gross basis. Certain of the Company’s repurchase agreement and derivative transactions are governed by underlying agreements that generally provide for a right of setoff in the event of default or in the event of a bankruptcy of either party to the transaction. For one repurchase agreement counterparty, the underlying agreements provide for an unconditional right of setoff. |
Senior Notes
Senior Notes | 3 Months Ended |
Mar. 31, 2016 | |
Debt Disclosure [Abstract] | |
Senior Notes | Senior Notes On April 11, 2012 the Company issued $100.0 million in aggregate principal amount of its Senior Notes in an underwritten public offering. The total net proceeds to the Company from the offering of the Senior Notes were approximately $96.6 million , after deducting offering expenses and the underwriting discount. The Senior Notes bear interest at a fixed rate of 8.00% per year, paid quarterly in arrears on January 15, April 15, July 15 and October 15 of each year and will mature on April 15, 2042. The Senior Notes have an effective interest rate, including the impact of amortization to interest expense of debt issuance costs, of 8.31% . The Company may redeem the Senior Notes, in whole or in part, at any time on or after April 15, 2017 at a redemption price equal to 100% of the principal amount redeemed plus accrued and unpaid interest to, but not excluding, the redemption date. The Senior Notes are the Company’s senior unsecured obligations and are subordinate to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements, obligation to return securities obtained as collateral, and other financing arrangements, to the extent of the value of the collateral securing such indebtedness. |
Other Liabilities
Other Liabilities | 3 Months Ended |
Mar. 31, 2016 | |
Other Liabilities [Abstract] | |
Other Liabilities | Other Liabilities The following table presents the components of the Company’s Other liabilities at March 31, 2016 and December 31, 2015 : (In Thousands) March 31, 2016 December 31, 2015 Accrued interest payable $ 13,402 $ 16,949 Swaps, at fair value 118,893 70,526 Dividends and dividend equivalents payable 74,583 74,575 Accrued expenses and other liabilities 10,336 19,610 Total Other Liabilities $ 217,214 $ 181,660 |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2016 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies ( a ) Lease Commitments The Company pays monthly rent pursuant to two operating leases. The lease term for the Company’s headquarters in New York, New York extends through May 31, 2020. The lease provides for aggregate cash payments ranging over time of approximately $2.5 million per year, paid on a monthly basis, exclusive of escalation charges. In addition, as part of this lease agreement, the Company has provided the landlord a $785,000 irrevocable standby letter of credit fully collateralized by cash. The letter of credit may be drawn upon by the landlord in the event that the Company defaults under certain terms of the lease. In addition, the Company has a lease through December 31, 2016 for its off-site back-up facility located in Rockville Centre, New York, which provides for, among other things, lease payments totaling $30,000 , annually. ( b ) Representations and Warranties in Connection with Resecuritization Transactions In connection with the resecuritization transactions engaged in by the Company (See Note 19 for further discussion), the Company has the obligation under certain circumstances to repurchase assets from its VIEs upon breach of certain representations and warranties. |
Stockholders' Equity
Stockholders' Equity | 3 Months Ended |
Mar. 31, 2016 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity | Stockholders’ Equity ( a ) Preferred Stock Issuance of 7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”) On April 15, 2013, the Company completed the issuance of 8.0 million shares of its Series B Preferred Stock with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The Company’s Series B Preferred Stock is entitled to receive a dividend at a rate of 7.50% per year on the $25.00 liquidation preference before the Company’s common stock is paid any dividends and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series B Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series B Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends (whether or not authorized or declared) exclusively at the Company’s option commencing on April 15, 2018 (subject to the Company’s right, under limited circumstances, to redeem the Series B Preferred Stock prior to that date in order to preserve its qualification as a REIT and upon certain specified change in control transactions in which the Company’s common stock and the acquiring or surviving entity common securities would not be listed on the New York Stock Exchange (the “NYSE”), the NYSE MKT or NASDAQ, or any successor exchange. The Series B Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six or more quarterly periods (whether or not consecutive). Under such circumstances, the Series B Preferred Stock will be entitled to vote to elect two additional directors to the Company’s Board of Directors (the “Board”), until all unpaid dividends have been paid or declared and set apart for payment. In addition, certain material and adverse changes to the terms of the Series B Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock. The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2016 through March 31, 2016 : Declaration Date Record Date Payment Date Dividend Per Share February 12, 2016 February 29, 2016 March 31, 2016 $ 0.46875 ( b ) Dividends on Common Stock The following table presents cash dividends declared by the Company on its common stock from January 1, 2016 through March 31, 2016 : Declaration Date (1) Record Date Payment Date Dividend Per Share March 11, 2016 March 28, 2016 April 29, 2016 $ 0.20 (1) (1) At March 31, 2016 , the Company had accrued dividends and dividend equivalents payable of $74.6 million related to the common stock dividend declared on March 11, 2016 . ( c ) Discount Waiver, Direct Stock Purchase and Dividend Reinvestment Plan (“DRSPP”) On August 8, 2013, the Company filed a shelf registration statement on Form S-3 with the SEC under the Securities Act of 1933, as amended (the “1933 Act”), for the purpose of registering additional common stock for sale through its DRSPP. Pursuant to Rule 462(e) of the 1933 Act, this shelf registration statement became effective automatically upon filing with the SEC and, when combined with the unused portion of the Company’s previous DRSPP shelf registration statements, registered an aggregate of 15 million shares of common stock. The Company’s DRSPP is designed to provide existing stockholders and new investors with a convenient and economical way to purchase shares of common stock through the automatic reinvestment of dividends and/or optional cash investments. At March 31, 2016 , 6.8 million shares of common stock remained available for issuance pursuant to the DRSPP shelf registration statement. During the three months ended March 31, 2016 , the Company issued 47,674 shares of common stock through the DRSPP, raising net proceeds of approximately $302,000 . From the inception of the DRSPP in September 2003 through March 31, 2016 , the Company issued 30,776,666 shares pursuant to the DRSPP, raising net proceeds of $258.6 million . ( d ) Stock Repurchase Program As previously disclosed, in August 2005, the Company’s Board authorized a stock repurchase program (the “Repurchase Program”) to repurchase up to 4.0 million shares of its outstanding common stock. The Board reaffirmed such authorization in May 2010. In December 2013, the Board increased the number of shares authorized under the Repurchase Program to an aggregate of 10.0 million . Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization. Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as the Company deems appropriate, (including, in our discretion, through the use of one or more plans adopted under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) using available cash resources. Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock. The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice. The Company did not repurchase any shares of its common stock during the three months ended March 31, 2016 . At March 31, 2016 , 6,616,355 shares remained authorized for repurchase under the Repurchase Program. ( e ) Accumulated Other Comprehensive Income/(Loss) The following table presents changes in the balances of each component of the Company’s AOCI for the three months ended March 31, 2016 : Three Months Ended (In Thousands) Net Unrealized Gain/(Loss) on AFS Securities Net Unrealized Loss on Swaps Total AOCI Balance at beginning of period $ 585,250 $ (69,399 ) $ 515,851 OCI before reclassifications (45,614 ) (49,342 ) (94,956 ) Amounts reclassified from AOCI (1) (10,485 ) — (10,485 ) Net OCI during the period (2) (56,099 ) (49,342 ) (105,441 ) Balance at end of period $ 529,151 $ (118,741 ) $ 410,410 (1) See separate table below for details about these reclassifications. (2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss). The following table presents changes in the balances of each component of the Company’s AOCI for the three months ended March 31, 2015 : Three Months Ended (In Thousands) Net Unrealized Net Total AOCI Balance at beginning of period $ 813,515 $ (59,062 ) $ 754,453 OCI before reclassifications 39,035 (32,367 ) 6,668 Amounts reclassified from AOCI (1) (6,830 ) — (6,830 ) Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing 4,537 — 4,537 Net OCI during the period (2) 36,742 (32,367 ) 4,375 Balance at end of period $ 850,257 $ (91,429 ) $ 758,828 (1) See separate table below for details about these reclassifications. (2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss). The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three months ended March 31, 2016 : Three Months Ended Details about AOCI Components Amounts Reclassified from AOCI Affected Line Item in the Statement Where Net Income Is Presented (In Thousands) AFS Securities: Realized gain on sale of securities $ (10,485 ) Gain on sales of MBS Total AFS Securities $ (10,485 ) Total reclassifications for period $ (10,485 ) The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three months ended March 31, 2015 : Three Months Ended Details about AOCI Components Amounts Affected Line Item in the Statement (In Thousands) AFS Securities: Realized gain on sale of securities $ (6,423 ) Gain on sales of MBS OTTI recognized in earnings (407 ) Net impairment losses recognized in earnings Total AFS Securities $ (6,830 ) Total reclassifications for period $ (6,830 ) At March 31, 2016 and December 31, 2015 , the Company had unrealized losses recorded in AOCI of $1.7 million and $1.3 million , respectively on securities for which OTTI had been recognized in earnings in prior periods. |
EPS Calculation
EPS Calculation | 3 Months Ended |
Mar. 31, 2016 | |
Earnings Per Share [Abstract] | |
EPS Calculation | EPS Calculation The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the three months ended March 31, 2016 and 2015 : Three Months Ended (In Thousands, Except Per Share Amounts) 2016 2015 Numerator: Net income $ 78,070 $ 82,173 Dividends declared on preferred stock (3,750 ) (3,750 ) Dividends, dividend equivalents and undistributed earnings allocated to participating securities (395 ) (395 ) Net income to common stockholders - basic and diluted $ 73,925 $ 78,028 Denominator: Weighted average common shares for basic and diluted earnings per share (1) 370,942 371,910 Basic and diluted earnings per share $ 0.20 $ 0.21 (1) At March 31, 2016 , the Company had an aggregate of 2.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the three months ended March 31, 2016 , as their inclusion would have been anti-dilutive. These equity instruments were comprised of approximately 96,000 shares of restricted common stock with a weighted average grant date fair value of $7.37 and approximately 2.0 million RSUs with a weighted average grant date fair value of $6.82 . These equity instruments may have a dilutive impact on future EPS. |
Equity Compensation, Employment
Equity Compensation, Employment Agreements and Other Benefit Plans | 3 Months Ended |
Mar. 31, 2016 | |
Compensation Related Costs [Abstract] | |
Equity Compensation, Employment Agreements and Other Benefit Plans | Equity Compensation, Employment Agreements and Other Benefit Plans ( a ) Equity Compensation Plan In accordance with the terms of the Company’s Equity Compensation Plan (the “Equity Plan”), which was adopted by the Company’s stockholders on May 21, 2015 (and which amended and restated the Company’s 2010 Equity Compensation Plan), directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan. Subject to certain exceptions, stock-based awards relating to a maximum of 12.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count towards this limit. At March 31, 2016 , approximately 8.8 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan. A participant may generally not receive stock-based awards in excess of 1,500,000 shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock. Unless previously terminated by the Board, awards may be granted under the Equity Plan until May 20, 2025. Dividend Equivalents A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock. Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules, as the Compensation Committee of the Board (the “Compensation Committee”) shall determine in its discretion. Payments made on the Company’s outstanding dividend equivalent rights that have been granted as a separate instrument are charged to Stockholders’ Equity when common stock dividends are declared to the extent that such equivalents are expected to vest. The Company made payments in respect of such separate instruments of approximately $1,600 and $5,000 during the three months ended March 31, 2016 and 2015 , respectively. At March 31, 2016 , there were 8,215 dividend equivalent rights outstanding, which had been awarded separately from, but in connection with, grants of RSUs made in prior years. A 0% forfeiture rate was assumed with respect to such dividend equivalent rights outstanding at March 31, 2016 . At March 31, 2016 , the Company had unrecognized compensation expense of approximately $22,000 related to such dividend equivalent rights, which are scheduled to elapse over a weighted average period of 3 months . Options The Company did not grant any stock options during the three months ended March 31, 2016 and 2015 . At March 31, 2016 , the Company had no stock options outstanding. Restricted Stock The Company did no t award any shares of restricted common stock during the three months ended March 31, 2016 and 2015 . At March 31, 2016 and December 31, 2015 , the Company had unrecognized compensation expense of $654,000 and $807,000 , respectively, related to the unvested shares of restricted common stock. The Company had accrued dividends payable of approximately $167,000 and $193,000 on unvested shares of restricted stock at March 31, 2016 and December 31, 2015 , respectively. The unrecognized compensation expense at March 31, 2016 is expected to be recognized over a weighted average period of 1.3 years . Restricted Stock Units Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date. Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of March 31, 2016 are designated to be settled in shares of the Company’s common stock. The Company granted 615,000 and 590,000 RSUs during the three months ended March 31, 2016 and 2015 . During the three months ended March 31, 2016 an aggregate of 10,000 RSUs were forfeited. There were no RSUs forfeited during the three months ended March 31, 2015 . All RSUs outstanding at March 31, 2016 may be entitled to receive dividend equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled. At March 31, 2016 and December 31, 2015 , the Company had unrecognized compensation expense of $7.1 million and $4.0 million , respectively, related to RSUs. The unrecognized compensation expense at March 31, 2016 is expected to be recognized over a weighted average period of 2.1 years . A 0% forfeiture rate was assumed with respect to unvested RSUs at March 31, 2016 . Expense Recognized for Equity-Based Compensation Instruments The following table presents the Company’s expenses related to its equity-based compensation instruments for the three months ended March 31, 2016 and 2015 : Three Months Ended (In Thousands) 2016 2015 Restricted shares of common stock $ 152 $ 246 RSUs 960 646 Dividend equivalent rights 22 20 Total $ 1,134 $ 912 ( b ) Employment Agreements At March 31, 2016 , the Company had employment agreements with four of its officers, with varying terms that provide for, among other things, base salary, bonus and change-in-control payments upon the occurrence of certain triggering events. ( c ) Deferred Compensation Plans The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation. The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders. Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company. Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock. Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time. The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded. Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company. The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date. The following table presents the Company’s expenses related to its Deferred Plans for its non-employee directors and senior officers for the three months ended March 31, 2016 and 2015 : Three Months Ended (In Thousands) 2016 2015 Non-employee directors $ 49 $ (8 ) Total $ 49 $ (8 ) The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through March 31, 2016 and December 31, 2015 that had not been distributed and the Company’s associated liability for such deferrals at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 (In Thousands) Undistributed Income Deferred (1) Liability Under Deferred Plans Undistributed Income Deferred (1) Liability Under Deferred Plans Non-employee directors $ 638 $ 654 $ 601 $ 614 Total $ 638 $ 654 $ 601 $ 614 (1) Represents the cumulative amounts that were deferred by participants through March 31, 2016 and December 31, 2015 , which had not been distributed through such respective date. ( d ) Savings Plan The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code. Subject to certain restrictions, all of the Company’s employees are eligible to make tax-deferred contributions to the Savings Plan subject to limitations under applicable law. Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan. The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2% , subject to a maximum as provided by the Code. The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100% . For the three months ended March 31, 2016 and 2015 , the Company recognized expenses for matching contributions of $86,000 and $75,000 , respectively. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 3 Months Ended |
Mar. 31, 2016 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | Fair Value of Financial Instruments A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of valuation hierarchy are defined as follows: Level 1 — Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 — Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement. The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy. Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral The fair value of U.S. Treasury securities obtained as collateral and the associated obligation to return securities obtained as collateral are based upon prices obtained from a third-party pricing service, which are indicative of market activity. Securities obtained as collateral are classified as Level 1 in the fair value hierarchy. MBS and CRT securities The Company determines the fair value of its Agency MBS, based upon prices obtained from third-party pricing services, which are indicative of market activity and repurchase agreement counterparties. For Agency MBS, the valuation methodology of the Company’s third-party pricing services incorporate commonly used market pricing methods, trading activity observed in the marketplace and other data inputs. The methodology also considers the underlying characteristics of each security, which are also observable inputs, including: collateral vintage, coupon, maturity date, loan age, reset date, collateral type, periodic and life cap, geography, and prepayment speeds. Management analyzes pricing data received from third-party pricing services and compares it to other indications of fair value including data received from repurchase agreement counterparties and its own observations of trading activity observed in the marketplace. In determining the fair value of its Non-Agency MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants. In valuing Non-Agency MBS, the Company understands that pricing services use observable inputs that include, in addition to trading activity observed in the marketplace, loan delinquency data, credit enhancement levels and vintage, which are taken into account to assign pricing factors such as spread and prepayment assumptions. For tranches of Legacy Non-Agency MBS that are cross-collateralized, performance of all collateral groups involved in the tranche are considered. The Company collects and considers current market intelligence on all major markets, including benchmark security evaluations and bid-lists from various sources, when available. The Company’s MBS and CRT securities are valued using various market data points as described above, which management considers directly or indirectly observable parameters. Accordingly, the Company’s MBS and CRT securities are classified as Level 2 in the fair value hierarchy. Residential Whole Loans, at Fair Value The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. The Company’s residential whole loans held at fair value are classified as Level 3 in the fair value hierarchy. Swaps The Company determines the fair value of non-centrally cleared Swaps considering valuations obtained from a third-party pricing service. For Swaps that are cleared by a central clearing house valuations provided by the clearing house are used. All valuations obtained are tested with internally developed models that apply readily observable market parameters. The Company considers the creditworthiness of both the Company and its counterparties, along with collateral provisions contained in each derivative agreement, from the perspective of both the Company and its counterparties. All of the Company’s Swaps are subject either to bilateral collateral arrangements, or for cleared Swaps, to the clearing house’s margin requirements. Consequently, no credit valuation adjustment was made in determining the fair value of such instruments. Swaps are classified as Level 2 in the fair value hierarchy. The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of March 31, 2016 and December 31, 2015 , on the consolidated balance sheets by the valuation hierarchy, as previously described: Fair Value at March 31, 2016 (In Thousands) Level 1 Level 2 Level 3 Total Assets: Agency MBS $ — $ 4,544,883 $ — $ 4,544,883 Non-Agency MBS, including MBS transferred to consolidated VIEs — 6,100,757 — 6,100,757 CRT securities — 215,803 — 215,803 Securities obtained and pledged as collateral 513,409 — — 513,409 Residential whole loans, at fair value — — 647,360 647,360 Swaps — 152 — 152 Total assets carried at fair value $ 513,409 $ 10,861,595 $ 647,360 $ 12,022,364 Liabilities: Swaps $ — $ 118,893 $ — $ 118,893 Obligation to return securities obtained as collateral 513,409 — — 513,409 Total liabilities carried at fair value $ 513,409 $ 118,893 $ — $ 632,302 Fair Value at December 31, 2015 (In Thousands) Level 1 Level 2 Level 3 Total Assets: Agency MBS $ — $ 4,752,244 $ — $ 4,752,244 Non-Agency MBS, including MBS transferred to consolidated VIEs — 6,420,817 — 6,420,817 CRT securities — 183,582 — 183,582 Securities obtained and pledged as collateral 507,443 — — 507,443 Residential whole loans, at fair value — — 623,276 623,276 Swaps — 1,127 — 1,127 Total assets carried at fair value $ 507,443 $ 11,357,770 $ 623,276 $ 12,488,489 Liabilities: Swaps $ — $ 70,526 $ — $ 70,526 Obligation to return securities obtained as collateral 507,443 — — 507,443 Total liabilities carried at fair value $ 507,443 $ 70,526 $ — $ 577,969 The following table presents additional information for the three months ended March 31, 2016 and 2015 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis. Changes in Level 3 Assets Measured at Fair Value on a Recurring Basis Residential Whole Loans, at Fair Value Three Months Ended (In Thousands) 2016 2015 Balance at beginning of period $ 623,276 $ 143,472 Purchases and capitalized advances 53,590 4,725 Changes in fair value recorded in Net gain on residential whole loans held at fair value 6,226 602 Collection of principal, net of liquidation gains/losses (14,602 ) (2,176 ) Transfer to REO (21,130 ) (3,163 ) Balance at end of period $ 647,360 $ 143,460 The Company did not transfer any assets or liabilities from one level to another during the three months ended March 31, 2016 and 2015 . The following table presents a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of March 31, 2016 and December 31, 2015 : Fair Value Methodology for Level 3 Financial Instruments March 31, 2016 (Dollars in Thousands) Fair Value (1) Valuation Technique Unobservable Input Weighted Average (2) Range Residential whole loans, at fair value $ 165,177 Discounted cash flow Discount rate 6.5 % 5.0-7.7% Prepayment rate 7.1 % 0.3-11.5% Default rate 2.7 % 0.0-8.3% Loss severity 13.8 % 0.0-79.1% $ 435,971 Liquidation model Discount rate 7.8 % 6.8-42.0% Annual change in home prices 1.1 % (6.1)-5.8% Liquidation timeline (in years) 1.6 0.7-4.4 Current value of underlying properties $ 623 $14-$4,200 Total $ 601,148 December 31, 2015 (Dollars in Thousands) Fair Value (1) Valuation Technique Unobservable Input Weighted Average (2) Range Residential whole loans, at fair value $ 113,166 Discounted cash flow Discount rate 7.0 % 6.0-8.7% Prepayment rate 6.6 % 0.3-11.1% Default rate 3.1 % 0.0-9.1% Loss severity 17.0 % 10.0-79.4% $ 392,557 Liquidation model Discount rate 6.9 % 6.8-10.0% Annual change in home prices 1.3 % (5.5)-6.1% Liquidation timeline (in years) 1.6 0.7-4.4 Current value of underlying properties $ 626 $14-$3,500 Total $ 505,723 (1) Excludes approximately $46.2 million and $117.6 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at March 31, 2016 and December 31, 2015 , respectively. (2) Amounts are weighted based on the fair value of the underlying loan. The following table presents the difference between the fair value and the aggregate unpaid principal balance of the Company’s residential whole loans for which the fair value option was elected, at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 (In Thousands) Fair Value Unpaid Principal Balance Difference Fair Value Unpaid Principal Balance Difference Residential whole loans, at fair value Total loans $ 647,360 $ 810,263 $ (162,903 ) $ 623,276 $ 786,330 $ (163,054 ) Loans 90 days or more past due $ 498,989 $ 639,747 $ (140,758 ) $ 493,640 $ 637,459 $ (143,819 ) Changes to the valuation methodologies used with respect to the Company’s financial instruments are reviewed by management to ensure any such changes result in appropriate exit price valuations. The Company will refine its valuation methodologies as markets and products develop and pricing methodologies evolve. The methods described above may produce fair value estimates that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with those used by market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The Company uses inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced. The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future. The following table presents the carrying values and estimated fair values of the Company’s financial instruments at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value (In Thousands) Financial Assets: Agency MBS $ 4,544,883 $ 4,544,883 $ 4,752,244 $ 4,752,244 Non-Agency MBS, including MBS transferred to consolidated VIEs 6,100,757 6,100,757 6,420,817 6,420,817 CRT securities 215,803 215,803 183,582 183,582 Securities obtained and pledged as collateral 513,409 513,409 507,443 507,443 Residential whole loans, at carrying value 376,235 392,924 271,845 289,696 Residential whole loans, at fair value 647,360 647,360 623,276 623,276 Cash and cash equivalents 146,236 146,236 165,007 165,007 Restricted cash 123,676 123,676 71,538 71,538 Swaps 152 152 1,127 1,127 Financial Liabilities (1) : Repurchase agreements 7,950,645 7,952,474 7,887,622 7,828,115 FHLB advances 1,193,000 1,193,000 1,500,000 1,500,000 Securitized debt 11,821 11,924 21,868 22,057 Obligation to return securities obtained as collateral 513,409 513,409 507,443 507,443 Senior Notes 96,706 100,351 96,697 99,391 Swaps 118,893 118,893 70,526 70,526 (1) Carrying value of Senior Notes, Securitized debt and certain Repurchase agreements is net of associated debt issuance costs. In addition to the methodologies used to determine the fair value of the Company’s financial assets and liabilities reported at fair value on a recurring basis, as previously described, the following methods and assumptions were used by the Company in arriving at the fair value of the Company’s other financial instruments presented in the above table: Residential Whole Loans at Carrying Value: The Company determines the fair value of its residential whole loans held at carrying value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. The Company’s residential whole loans held at carrying value are classified as Level 3 in the fair value hierarchy. Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents and restricted cash are comprised of cash held in overnight money market investments and demand deposit accounts. At March 31, 2016 and December 31, 2015 , the Company’s money market funds were invested in securities issued by the U.S. Government, or its agencies, instrumentalities, and sponsored entities, and repurchase agreements involving the securities described above. Given the overnight term and assessed credit risk, the Company’s investments in money market funds are determined to have a fair value equal to their carrying value. Repurchase Agreements: The fair value of repurchase agreements reflects the present value of the contractual cash flows discounted at market interest rates at the valuation date for repurchase agreements with a term equivalent to the remaining term to interest rate repricing, which may be at maturity. Such interest rates are estimated based on LIBOR rates observed in the market. The Company’s repurchase agreements are classified as Level 2 in the fair value hierarchy. FHLB Advances: FHLB advances reflect collateralized borrowings at variable market interest rates that reset on a monthly basis. Accordingly, the carrying amount of FHLB advances are considered to approximate fair value. The Company’s FHLB advances are classified as Level 2 in the fair value hierarchy. Securitized Debt: In determining the fair value of securitized debt, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants. Accordingly, the Company’s securitized debt is classified as Level 2 in the fair value hierarchy. Senior Notes: The fair value of the Senior Notes is determined using the end of day market price quoted on the NYSE at the reporting date. The Company’s Senior Notes are classified as Level 1 in the fair value hierarchy. |
Use of Special Purpose Entities
Use of Special Purpose Entities and Variable Interest Entities | 3 Months Ended |
Mar. 31, 2016 | |
Use of Special Purpose Entities and Variable Interest Entities | |
Use of Special Purpose Entities and Variable Interest Entities | Use of Special Purpose Entities and Variable Interest Entities A Special Purpose Entity (“SPE”) is an entity designed to fulfill a specific limited need of the company that organized it. SPEs are often used to facilitate transactions that involve securitizing financial assets or resecuritizing previously securitized financial assets. The objective of such transactions may include obtaining non-recourse financing, obtaining liquidity or refinancing the underlying securitized financial assets on improved terms. Securitization involves transferring assets to a SPE to convert all or a portion of those assets into cash before they would have been realized in the normal course of business, through the SPE’s issuance of debt or equity instruments. Investors in an SPE usually have recourse only to the assets in the SPE and, depending on the overall structure of the transaction, may benefit from various forms of credit enhancement such as over-collateralization in the form of excess assets in the SPE, priority with respect to receipt of cash flows relative to holders of other debt or equity instruments issued by the SPE, or a line of credit or other form of liquidity agreement that is designed with the objective of ensuring that investors receive principal and/or interest cash flow on the investment in accordance with the terms of their investment agreement. Resecuritization transactions The Company has entered into several resecuritization transactions that resulted in the Company consolidating as VIEs the SPEs that were created to facilitate the transactions and to which the underlying assets in connection with the resecuritizations were transferred. See Note 2 ( r ) for a discussion of the accounting policies applied to the consolidation of VIEs and transfers of financial assets in connection with resecuritization transactions. The following table summarizes the key details of the resecuritization transactions in which the Company participated as of March 31, 2016 : (Dollars in Thousands) February 2012 Name of Trust (Consolidated as a VIE) WFMLT Series Principal value of Non-Agency MBS sold $ 433,347 Face amount of Bonds issued by the VIE and purchased by 3rd party investors $ 186,691 Outstanding amount of Senior Bonds at March 31, 2016 $ 11,924 Pass-through rate for Senior Bonds issued 2.85 % Face amount of Senior Support Certificates received by the Company (1) $ 216,603 Cash received $ 186,691 Notional amount acquired of non-rated, interest only senior certificates $ 186,691 Unamortized deferred costs $ 103 (1) Provides credit support for the sequential Senior Non-Agency MBS sold to third-party investors in resecuritization transactions (“Senior Bonds”). The Company engaged in these transactions primarily for the purpose of obtaining non-recourse financing on a portion of its Non-Agency MBS portfolio, as well as refinancing a portion of its Non-Agency MBS portfolio on improved terms. Notwithstanding the Company’s participation in these transactions, the risks facing the Company are largely unchanged as the Company remains economically exposed to the first loss position on the underlying MBS transferred to the VIEs. The activities that can be performed by an entity created to facilitate a resecuritization transaction are generally specified in the entity’s formation documents. Those documents do not permit the entity, any beneficial interest holder in the entity, or any other party associated with the entity to cause the entity to sell or replace the assets held by the entity, or limit such ability to when specific events of default occur. The Company concluded that the entities created to facilitate these resecuritization transactions are VIEs. The Company then completed an analysis of whether each VIE created to facilitate the resecuritization transaction should be consolidated by the Company, based on consideration of its involvement in each VIE, including the design and purpose of the SPE, and whether its involvement reflected a controlling financial interest that resulted in the Company being deemed the primary beneficiary of each VIE. In determining whether the Company would be considered the primary beneficiary, the following factors were assessed: • Whether the Company has both the power to direct the activities that most significantly impact the economic performance of the VIE; and • Whether the Company has a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE. Based on its evaluation of the factors discussed above, including its involvement in the purpose and design of the entity, the Company determined that it was required to consolidate each VIE created to facilitate these resecuritization transactions. As of March 31, 2016 and December 31, 2015 , the aggregate fair value of the Non-Agency MBS that were resecuritized as described above was $198.5 million and $598.3 million , respectively. These assets are included in the Company’s consolidated balance sheets and disclosed as “Non-Agency MBS transferred to consolidated VIEs, at fair value”. As of March 31, 2016 and December 31, 2015 , the aggregate outstanding balance of Senior Bonds issued by consolidated VIEs was $11.9 million and $22.1 million , respectively. These Senior Bonds are included in the Company’s consolidated balance sheets and disclosed as “Securitized debt.” The holders of the Senior Bonds have no recourse to the general credit of the Company, but the Company does have the obligation, under certain circumstances to repurchase assets from the VIE upon the breach of certain representations and warranties in relation to the Non-Agency MBS sold to the VIE. In the absence of such a breach, the Company has no obligation to provide any other explicit or implicit support to any VIE. During the quarter, the Company entered into an agreement to amend the Trust Agreement of the DMSI 2010-RS2 Trust (the “Trust”) in order to facilitate the unwind of this resecuritization transaction. Concurrent with the amendment to the Trust Agreement, the Company entered into a transaction to exchange the remaining beneficial interests issued by the Trust and held by the Company for the underlying securities that had previously been transferred to and held by the Trust. The Company expects, following completion of any final Trust distributions, the remaining beneficial interests will be cancelled and the Trust terminated . For financial reporting purposes, the exchange transaction did not result in any gain or loss to the Company as this resecuritization was accounted for as a financing transaction. However, for purposes of determining REIT taxable income, this resecuritization transaction was originally accounted for as a sale of the underlying securities to the Trust and acquisition of beneficial interests issued by the Trust. Because the fair value of the underlying securities received exceeded the Company’s tax basis in the remaining beneficial interests at the exchange date, the unwind of this resecuritization structure resulted in the Company recognizing taxable income currently estimated to be approximately $70.9 million or $0.19 per common share. In addition, the underlying securities originally transferred as part of this resecuritization are reported as Non-Agency MBS in the Company’s consolidated balance sheets at March 31, 2016 and interest income from the underlying securities from the date of exchange transaction through March 31, 2016 is reported as Interest income from Non-Agency MBS in the Company’s consolidated statements of operations. Prior to the completion of the Company’s first resecuritization transaction in October 2010, the Company had not transferred assets to VIEs or QSPEs and, other than acquiring MBS issued by such entities, it had no other involvement with VIEs or QSPEs. Residential Whole Loans Included on the Company’s consolidated balance sheets as of March 31, 2016 and December 31, 2015 is a total of $1.024 billion and $895.1 million of residential whole loans, of which approximately $376.2 million and $271.8 million are reported at carrying value and $647.4 million and $623.3 million are reported at fair value, respectively. The inclusion of these assets arises from the Company’s 100% equity interest in certain trusts established to acquire the loans. Based on its evaluation of its 100% interest in these trusts and other factors, the Company has determined that the trusts are required to be consolidated for financial reporting purposes. During the three months ended March 31, 2016 and 2015 , approximately $4.5 million and $3.6 million , respectively, of interest income was recognized from residential whole loans reported at carrying value which is included in Interest Income on the Company’s consolidated statements of operations. In addition, the Company recognized net gains of approximately $11.9 million and $2.0 million , on residential whole loans held at fair value during the three months ended March 31, 2016 and 2015 , respectively, which amounts are included in Other Income, net on the Company’s consolidated statements of operations. (See Note 4 ) |
Summary of Significant Accoun28
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2016 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Consolidation | Basis of Presentation and Consolidation The interim unaudited consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted according to these SEC rules and regulations. Management believes that the disclosures included in these interim unaudited consolidated financial statements are adequate to make the information presented not misleading. The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 . In the opinion of management, all normal and recurring adjustments necessary to present fairly the financial condition of the Company at March 31, 2016 and results of operations for all periods presented have been made. The results of operations for the three months ended March 31, 2016 should not be construed as indicative of the results to be expected for the full year. The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition. Management has made significant estimates in several areas, including other-than-temporary impairment (“OTTI”) on MBS (See Note 3 ), valuation of MBS and CRT securities (See Notes 3 and 18 ), income recognition and valuation of residential whole loans (See Notes 4 and 18 ), valuation of derivative instruments (See Notes 6 and 18 ) and income recognition on certain Non-Agency MBS purchased at a discount (See Note 3 ). In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest (See Note 2 ( o )). Actual results could differ from those estimates. The Company has one reportable segment as we manage our business and analyze and report our results of operations on the basis of one operating segment; investing, on a leveraged basis, in residential mortgage assets. The consolidated financial statements of the Company include the accounts of all subsidiaries; significant intercompany accounts and transactions have been eliminated. In addition, the Company consolidates the special purpose entities created to facilitate the resecuritization transactions completed in prior years and the acquisition of residential whole loans. Certain prior period amounts have been reclassified to conform to the current period presentation. |
MBS (including Non-Agency MBS transferred to a consolidated VIEs) and CRT Securities | MBS (including Non-Agency MBS transferred to consolidated VIEs) and CRT Securities The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any U.S. Government agency or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities that are issued by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Mac and the principal payments received are based on the performance of loans in a reference pool of recently securitized MBS. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including if the loans in the reference pool experience delinquencies exceeding specified thresholds. Designation The Company generally intends to hold its MBS until maturity; however, from time to time, it may sell any of its securities as part of the overall management of its business. As a result, all of the Company’s MBS are designated as “available-for-sale” (“AFS”) and, accordingly, are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method. The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting more appropriately reflects the risk sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statement of operations. Revenue Recognition, Premium Amortization and Discount Accretion Interest income on securities is accrued based on the outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity. Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs. (See Note 3 ) Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income. The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors. If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time. Conversely, if the performance of a security with a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result. Determination of Fair Value for MBS and CRT Securities In determining the fair value of the Company’s MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. (See Note 18 ) Impairments/OTTI When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired. The Company assesses its impaired securities on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.” If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date. If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the OTTI related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets. Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings. Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings. However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income. The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections. As a result, the timing and amount of OTTIs constitute material estimates that are susceptible to significant change. (See Note 3 ) Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes. The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS. The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, Fair Isaac Corporation (“FICO”) scores at loan origination, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations, as well as reports by credit rating agencies, such as Moody’s Investors Services, Inc. (“Moody’s”), Standard & Poor’s Corporation (“S&P”), or Fitch, Inc. (collectively, “Rating Agencies”), general market assessments, and dialogue with market participants. As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS. In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date. The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes. Impairment assessment for Non-Agency MBS and CRT Securities that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date. The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR. Balance Sheet Presentation The Company’s MBS and CRT Securities pledged as collateral against repurchase agreements, Federal Home Loan Bank advances and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically. Purchases and sales of securities are recorded on the trade date. |
Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral | Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral The Company has obtained securities as collateral under collateralized financing arrangements in connection with its financing strategy for Non-Agency MBS. Securities obtained as collateral in connection with these transactions are recorded on the Company’s consolidated balance sheets as an asset along with a liability representing the obligation to return the collateral obtained, at fair value. While beneficial ownership of securities obtained remains with the counterparty, the Company has the right to sell the collateral obtained or to pledge it as part of a subsequent collateralized financing transaction. (See Note 2 ( k ) for Repurchase Agreements and Reverse Repurchase Agreements) |
Residential Whole Loans | Residential Whole Loans Residential whole loans included in the Company’s consolidated balance sheets are comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below under “Residential Whole Loans at Carrying Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The accounting model described below under “Residential Whole Loans at Fair Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed. The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically. Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Residential Whole Loans at Carrying Value Notwithstanding that the majority of these loans are considered to be performing substantially in accordance with their current contractual terms and conditions, the Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of the borrowers have previously experienced payment delinquencies and the amount owed on the mortgage loan may exceed the value of the property pledged as collateral. Consequently, the Company has assessed that these loans have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to credit worthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Such loans are initially recorded at fair value with no allowance for loan losses. Subsequent to acquisition, the recorded amount reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition. Under the application of this accounting model the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loans basis for loans not aggregated into pools, the Company estimates at acquisition and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected is referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans. A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. A significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield. (See Notes 4 and 19 ) Residential Whole Loans at Fair Value Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Given the significant uncertainty associated with estimating the timing of and amount of cash flows associated with these loans that will be collected, and that the cash flows ultimately collected may be dependent on the value of the property securing the loan, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns from these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. (See Notes 4 and 18 ) |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less. Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement and/or Swap counterparties as a result of reverse margin calls (i.e., margin calls made by the Company). The Company did not hold any cash pledged by its counterparties at March 31, 2016 or December 31, 2015 . |
Restricted Cash | Restricted Cash Restricted cash represents the Company’s cash held by its counterparties as collateral or otherwise in connection with the Company’s Swaps and/or repurchase agreements. Restricted cash is not available to the Company for general corporate purposes, but may be applied against amounts due to counterparties to the Company’s repurchase agreements and/or Swaps, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the Swap or repurchase agreement. |
Goodwill | Goodwill At March 31, 2016 and December 31, 2015 , the Company had goodwill of $7.2 million , which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998. Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level. Through March 31, 2016 , the Company had not recognized any impairment against its goodwill. Goodwill is included in Other assets on the Company’s consolidated balance sheets. |
Real Estate Owned (REO) | Real Estate Owned (“REO”) REO represents real estate acquired by the Company, including through foreclosure or deed in lieu of foreclosure, and is initially recorded at fair value less estimated selling costs. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 7 ) |
Depreciation | Depreciation Leasehold Improvements and Other Depreciable Assets Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term. Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase. |
Resecuritization and Other Debt Issuance Costs | Resecuritization and Other Debt Issuance Costs Resecuritization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various resecuritization transactions completed by the Company. Other debt issuance and related costs include costs incurred by the Company in connection with issuing Senior Notes and certain other repurchase agreement financings. These costs may include underwriting, rating agency, legal, accounting and other fees. Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For resecuritization financings, amortization is based upon the actual repayments of the associated beneficial interests issued to third parties. For Senior Notes and other repurchase agreement financings, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations. |
Repurchase Agreements and Other Advances | Repurchase Agreements and Other Advances Repurchase Agreements The Company finances the holdings of a significant portion of its MBS and CRT securities with repurchase agreements. Under repurchase agreements, the Company sells securities to a lender and agrees to repurchase the same securities in the future for a price that is higher than the original sale price. The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender. Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender. With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms. Margin calls, whereby a lender requires that the Company pledge additional securities or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions. The Company also may make margin calls on counterparties when collateral values increase. The Company’s repurchase financings typically have terms ranging from one month to six months at inception, but may also have longer or shorter terms. Should a counterparty decide not to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation. If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable or such collateral. (See Notes 9 , 10 and 18 ) In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company has entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty. Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price. The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower. In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement. No net cash was exchanged between the Company and counterparty at the inception of the transactions. Securities obtained and pledged as collateral are recorded as an asset on the Company’s consolidated balance sheets. Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis. Both the Company and the counterparty have the right to make daily margin calls based on changes in the value of the collateral obtained and/or pledged. The Company’s liability to the counterparty in connection with this financing arrangement is recorded on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.” (See Note 2 ( c )) Federal Home Loan Bank (“FHLB”) Advances FHLB advances are secured financing transactions and are carried at their contractual amounts. The ability to borrow from the FHLB is subject to the Company’s continued creditworthiness, pledging of sufficient eligible collateral to secure advances, and compliance with certain agreements with the FHLB. The amount of collateral pledged to the FHLB to secure advances is subject to periodic adjustment based on changes in the fair value of the collateral. Accrued interest payable on FHLB advances is included in Other liabilities on the Company’s consolidated balance sheets. (See Notes 9 , 10 and 18 ) In addition, as a condition to membership in the FHLB, the Company’s wholly-owned subsidiary, MFA Insurance, Inc. (“MFA Insurance”) is required to purchase and hold a certain amount of FHLB stock, which is based, in part, upon the outstanding principal balance of advances from the FHLB. FHLB stock is considered a non-marketable investment, is carried at cost and is subject to recoverability testing under applicable accounting standards. This stock can only be redeemed or sold at its par value, and only to the FHLB. Accordingly, when evaluating FHLB stock for impairment, the Company considers the ultimate recoverability of the par value rather than recognizing temporary declines in value. FHLB stock is included in Other assets on the Company’s consolidated balance sheets. |
Equity-Based Compensation | Equity-Based Compensation Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date. With respect to awards granted in 2009 and prior years, the Company applied a zero forfeiture rate for these awards, as they were granted to a limited number of employees, and historical forfeitures have been minimal. Forfeitures, or an indication that forfeitures are expected to occur, may result in a revised forfeiture rate and would be accounted for prospectively as a change in estimate. During 2010, the Company granted certain restricted stock units (“RSUs”) that vested after either two or four years of service and provided that certain criteria were met, which were based on a formula that included changes in the Company’s closing stock price over a two - or four -year period and dividends declared on the Company’s common stock during those periods. From 2011 through 2013, the Company granted certain RSUs that vested annually over a one or three -year period, provided that certain criteria were met, which were based on a formula tied to the Company’s achievement of average total stockholder return during that three -year period. During 2014, 2015 and the first quarter of 2016, the Company made grants of RSUs certain of which cliff vest after a three -year period and certain of which cliff vest after a three -year period, subject to the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholder return during that three -year period. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards. Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which in addition to estimates regarding the amount of RSUs expected to be forfeited during the associated service period, determined the amount of compensation expense recognized. The amount of compensation expense recognized was not dependent on whether the market condition was or will be achieved, while differences in actual forfeiture experience relative to estimated forfeitures results in adjustments to the timing and amount of compensation expense recognized. The Company has awarded dividend equivalents that may be granted as a separate instrument or may be a right associated with the grant of another equity-based award. Compensation expense for separately awarded dividend equivalents is based on the grant date fair value of such awards and is recognized over the vesting period. Payments pursuant to these dividend equivalents are charged to Stockholders’ Equity. Payments pursuant to dividend equivalents that are attached to equity based awards are charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest. Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards do not or are not expected to vest and grantees are not required to return payments of dividends or dividend equivalents to the Company. (See Notes 2 ( m ) and 17 ) |
Earnings per Common Share (EPS) | Earnings per Common Share (“EPS”) Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and other securities that participate in dividends, such as the Company’s unvested restricted stock and RSUs that have non-forfeitable rights to dividends and dividend equivalents attached to/associated with RSUs and vested stock options to arrive at total common equivalent shares. In applying the two-class method, earnings are allocated to both shares of common stock and securities that participate in dividends based on their respective weighted-average shares outstanding for the period. For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of dilutive unexercised stock options and RSUs outstanding that are unvested and have dividends that are subject to forfeiture using the treasury stock method. Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments, are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period. (See Note 16 ) |
Comprehensive Income/(Loss) | Comprehensive Income/(Loss) The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments, (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and de-designated derivative hedging instruments and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock. |
U.S. Federal Income Taxes | U.S. Federal Income Taxes The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”) and the corresponding provisions of state law. The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code. As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe. Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year. As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements. Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations. In addition, the Company has elected to treat certain of its subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business may be conducted through one or more TRS, its income earned by TRS may be subject to corporate income taxation. To maintain the Company’s REIT election, no more than 25% (or, for 2018 and subsequent taxable years, 20%) of the value of a REIT’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U. S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No deferred tax benefit was recorded by the Company for the three months ended March 31, 2016 and 2015 , as a valuation allowance for the full amount of the associated deferred tax asset was recognized as its recovery is not considered more likely than not. Based on its analysis of any potential uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of March 31, 2016 , December 31, 2015 , or March 31, 2015 . The Company filed its 2014 tax return prior to September 15, 2015. The Company’s tax returns for tax years 2010 through 2014 are open to examination. |
Derivative Financial Instruments | Derivative Financial Instruments The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments are currently comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with its borrowings. Prior to 2015, the Company’s derivative financial instruments also included Linked Transactions, which were not designated as hedging instruments. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting (See Note 6 ). Swaps The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions. The Company assesses, both at inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.” Swaps are carried on the Company’s consolidated balance sheets at fair value, as assets, if their fair value is positive, or as liabilities, if their fair value is negative. Changes in the fair value of the Company’s Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective. Changes in fair value for any ineffective amount of a Swap are recognized in earnings. The Company has not recognized any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness. The Company discontinues hedge accounting on a prospective basis and recognizes changes in fair value through earnings when: (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate. Although permitted under certain circumstances, the Company does not offset cash collateral receivables or payables against its net derivative positions. (See Notes 6 , 10 and 18 ) Linked Transactions Prior to 2015, it was presumed that the initial transfer of a financial asset (i.e., the purchase of an MBS by the Company) and contemporaneous repurchase financing of such security with the same counterparty were considered part of the same arrangement, or a “linked transaction,” unless certain criteria were met. The two components of a linked transaction (security purchase and repurchase financing) were not reported separately but were evaluated on a combined basis and reported as a forward (derivative) contract and were presented as “Linked Transactions” on the Company’s consolidated balance sheets. Changes in the fair value of the assets and liabilities underlying Linked Transactions and associated interest income and expense were reported as “Unrealized net gains/(losses) and net interest income from Linked Transactions” on the Company’s consolidated statements of operations and were not included in OCI. However, if certain criteria were met, the initial transfer (i.e., the purchase of a security by the Company) and repurchase financing were not treated as a Linked Transaction and would have been evaluated and reported separately as an MBS purchase and MBS repurchase financing. When or if a transaction was no longer considered to be linked, the security and repurchase financing were reported on a gross basis. In this case, the fair value of the MBS at the time the transactions were no longer considered linked became the cost basis of the MBS, and the income recognition yield for such MBS was calculated prospectively using this new cost basis. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting as described above. This resulted in changes subsequent to January 1, 2015 to the presentation of assets and liabilities, and revenues and expenses of Non-Agency MBS and associated repurchase agreements that had been accounted for as Linked Transactions prior to that date. The changes include the presentation of Non-Agency MBS and associated repurchase agreements as separate assets and liabilities, rather than on a combined basis on the Company’s consolidated balance sheets. In addition, starting in 2015, interest income related to the securities and interest expense related to the associated repurchase agreements are separately presented and included in the determination of the Company’s net interest income on its consolidated statement of operations. Further, the previous treatment of Linked Transactions as forward (derivative) instruments recorded at fair value at the end of each period, with changes in fair value included in net income, was discontinued and effective January 1, 2015 MBS that were previously accounted for as components of Linked Transactions are accounted for on a consistent basis with other MBS held by the Company as AFS securities. (See Note 6 ) |
Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities | Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability. The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability. This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value. In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its residential whole loans and CRT securities at time of acquisition. Subsequent changes in the fair value of these loans and CRT securities are reported in Net gain on residential whole loans held at fair value and Other income, net respectively on the Company’s consolidated statements of operations. A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable. (See Notes 2 ( d ), 4 and 18 ) |
Variable Interest Entities | Variable Interest Entities An entity is referred to as a VIE if it meets at least one of the following criteria: (i) the entity has equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionally few voting rights. The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE. The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE. The Company has entered into resecuritization transactions which result in the Company consolidating the VIEs that were created to facilitate the transactions and to which the underlying assets in connection with the resecuritizations were transferred. In determining the accounting treatment to be applied to these resecuritization transactions, the Company concluded that the entities used to facilitate these transactions were VIEs and that they should be consolidated. If the Company had determined that consolidation was not required, it would have then assessed whether the transfer of the underlying assets would qualify as a sale or should be accounted for as secured financings under GAAP. Prior to the completion of its initial resecuritization transaction in October 2010, the Company had not transferred assets to VIEs or Qualifying Special Purpose Entities (“QSPEs”) and other than acquiring MBS issued by such entities, had no other involvement with VIEs or QSPEs. (See Note 19 ) The Company also includes in its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and /or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance. |
Offering Costs Related to Issuance and Redemption of Preferred Stock | Offering Costs Related to Issuance and Redemption of Preferred Stock Offering costs related to issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS. |
New Accounting Standards and Interpretations | New Accounting Standards and Interpretations Accounting Standards Adopted in 2016 Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-03, Simplifying the Presentation of Debt Issuance Costs (or ASU 2015-03). The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with the presentation of debt issued at a discount. The recognition and measurement guidance of debt issuance costs are not affected by the amendments in this ASU. ASU 2015-03 requires retrospective application and was effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. While the Company’s adoption of ASU 2015-03 beginning on January 1, 2016, did not have a material impact on the Company’s financial position, it did result in changes, subsequent to adoption, to the presentation of assets and liabilities prior to that date. On adoption of the new standard on January 1, 2016, the Company reclassified debt issuance costs of $3.3 million related to Senior Notes, $1.3 million related to repurchase agreements and $189,000 related to its Securitized debt from Other assets and present them as a reduction in the corresponding liability on its consolidated balance sheet. Consolidation - Amendments to the Consolidation Analysis In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis (or ASU 2015-02). The amendments in this ASU change the way reporting enterprises evaluate whether (a) they should consolidate limited partnerships and similar entities, (b) fees paid to a decision maker or service provider are variable interests in a VIE, and (c) variable interests in a VIE held by related parties of the reporting enterprise require the reporting enterprise to consolidate the VIE. It also eliminates the VIE consolidation model based on majority exposure to variability that applied to certain investment companies and similar entities. At the effective date, all previous consolidation analyses that the guidance affects must be reconsidered. ASU 2015-02 was effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The Company’s adoption of ASU 2015-02 on January 1, 2016 did not have an impact on the Company’s consolidated financial statements. |
MBS and CRT Securities (Tables)
MBS and CRT Securities (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of information about MBS and CRT Securities | The following tables present certain information about the Company’s MBS and CRT securities at March 31, 2016 and December 31, 2015 : March 31, 2016 (In Thousands) Principal/ Current Face Purchase Premiums Accretable Purchase Discounts Discount Designated as Credit Reserve and OTTI (1) Amortized Cost (2) Fair Value Gross Unrealized Gains Gross Unrealized Losses Net Unrealized Gain/(Loss) Agency MBS: Fannie Mae $ 3,512,731 $ 132,452 $ (57 ) $ — $ 3,645,126 $ 3,684,575 $ 54,304 $ (14,855 ) $ 39,449 Freddie Mac 816,393 31,343 — — 848,854 851,230 7,358 (4,982 ) 2,376 Ginnie Mae 8,740 155 — — 8,895 9,078 183 — 183 Total Agency MBS 4,337,864 163,950 (57 ) — 4,502,875 4,544,883 61,845 (19,837 ) 42,008 Non-Agency MBS: Expected to Recover Par (3)(4) 2,774,846 66 (28,004 ) — 2,746,908 2,747,272 19,377 (19,013 ) 364 Expected to Recover Less than Par (3) 3,876,544 — (253,327 ) (757,564 ) 2,865,653 3,353,485 499,855 (12,023 ) 487,832 Total Non-Agency MBS (5) 6,651,390 66 (281,331 ) (757,564 ) 5,612,561 6,100,757 519,232 (31,036 ) 488,196 Total MBS 10,989,254 164,016 (281,388 ) (757,564 ) 10,115,436 10,645,640 581,077 (50,873 ) 530,204 CRT securities (6) 222,085 — (6,466 ) — 215,619 215,803 1,668 (1,484 ) 184 Total MBS and CRT securities $ 11,211,339 $ 164,016 $ (287,854 ) $ (757,564 ) $ 10,331,055 $ 10,861,443 $ 582,745 $ (52,357 ) $ 530,388 December 31, 2015 (In Thousands) Principal/ Current Face Purchase Premiums Accretable Purchase Discounts Discount Designated as Credit Reserve and OTTI (1) Amortized Cost (2) Fair Value Gross Unrealized Gains Gross Unrealized Losses Net Unrealized Gain/(Loss) Agency MBS: Fannie Mae $ 3,690,020 $ 139,243 $ (59 ) $ — $ 3,829,204 $ 3,865,485 $ 62,111 $ (25,830 ) $ 36,281 Freddie Mac 851,087 32,680 — — 884,798 877,109 6,906 (14,595 ) (7,689 ) Ginnie Mae 9,296 164 — — 9,460 9,650 190 — 190 Total Agency MBS 4,550,403 172,087 (59 ) — 4,723,462 4,752,244 69,207 (40,425 ) 28,782 Non-Agency MBS: Expected to Recover Par (3)(4) 2,906,878 73 (31,576 ) — 2,875,375 2,878,532 23,300 (20,143 ) 3,157 Expected to Recover Less than Par (3) 4,054,615 — (280,606 ) (787,541 ) 2,986,468 3,542,285 564,031 (8,214 ) 555,817 Total Non-Agency MBS (5) 6,961,493 73 (312,182 ) (787,541 ) 5,861,843 6,420,817 587,331 (28,357 ) 558,974 Total MBS 11,511,896 172,160 (312,241 ) (787,541 ) 10,585,305 11,173,061 656,538 (68,782 ) 587,756 CRT securities (6) 192,000 — (5,689 ) — 186,311 183,582 418 (3,147 ) (2,729 ) Total MBS and CRT securities $ 11,703,896 $ 172,160 $ (317,930 ) $ (787,541 ) $ 10,771,616 $ 11,356,643 $ 656,956 $ (71,929 ) $ 585,027 (1) Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income. Amounts disclosed at March 31, 2016 reflect Credit Reserve of $736.4 million and OTTI of $21.2 million . Amounts disclosed at December 31, 2015 reflect Credit Reserve of $766.0 million and OTTI of $21.5 million . (2) Includes principal payments receivable of $1.1 million and $1.0 million at March 31, 2016 and December 31, 2015 , respectively, which are not included in the Principal/Current Face. (3) Based on managemen t ’ s current estimates of future principal cash flows expected to be received. (4) At March 31, 2016 RPL/NPL MBS had a $2.515 billion Principal/Current face, $2.514 billion amortized cost and $2.496 billion fair value. At December 31, 2015 , RPL/NPL MBS had a $2.648 billion Principal/Current face, $2.645 billion amortized cost and $2.626 billion fair value. (5) At March 31, 2016 and December 31, 2015 , the Company expected to recover approximately 89% and 89% , respectively, of the then-current face amount of Non-Agency MBS. (6) Amounts disclosed at March 31, 2016 includes CRT securities with a fair value of $92.9 million for which the fair value option has been elected. Such securities have gross unrealized gains of approximately $1.4 million , gross unrealized losses of approximately $132,000 and net unrealized gains of approximately $1.2 million at March 31, 2016 . Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $62.2 million for which the fair value option has been elected. Such securities have gross unrealized gains of approximately $332,000 , gross unrealized losses of approximately $555,000 and net unrealized losses of approximately $223,000 at December 31, 2015 . |
Schedule of information about MBS and CRT Securities that were in an unrealized loss position | The following table presents information about the Company’s MBS and CRT securities that were in an unrealized loss position at March 31, 2016 : Unrealized Loss Position For: Less than 12 Months 12 Months or more Total Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses (Dollars in Thousands) Agency MBS: Fannie Mae $ 566,376 $ 4,507 95 $ 976,991 $ 10,348 129 $ 1,543,367 $ 14,855 Freddie Mac 4,523 1 1 517,333 4,981 92 521,856 4,982 Total Agency MBS 570,899 4,508 96 1,494,324 15,329 221 2,065,223 19,837 Non-Agency MBS: Expected to Recover Par (1) 1,841,079 15,689 55 181,507 3,324 10 2,022,586 19,013 Expected to Recover Less than Par (1) 276,920 7,233 43 67,129 4,790 15 344,049 12,023 Total Non-Agency MBS 2,117,999 22,922 98 248,636 8,114 25 2,366,635 31,036 Total MBS 2,688,898 27,430 194 1,742,960 23,443 246 4,431,858 50,873 CRT securities (2) 95,402 1,071 23 4,588 413 1 99,990 1,484 Total MBS and CRT securities $ 2,784,300 $ 28,501 217 $ 1,747,548 $ 23,856 247 $ 4,531,848 $ 52,357 (1) Based on management’s current estimates of future principal cash flows expected to be received. (2) Amounts disclosed at March 31, 2016 includes CRT securities with a fair value of $24.7 million for which the fair value option has been elected. Such securities have unrealized losses of $132,000 at March 31, 2016 . |
Schedule of composition of OTTI charges recorded | The following table presents the composition of OTTI charges recorded by the Company for the three months ended March 31, 2016 and 2015 : Three Months Ended (In Thousands) 2016 2015 Total OTTI losses $ — $ (395 ) OTTI reclassified from OCI — (12 ) OTTI recognized in earnings $ — $ (407 ) |
Schedule of changes in credit loss component of OTTI | The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI. Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded. Three Months Ended (In Thousands) 2016 2015 Credit loss component of OTTI at beginning of period $ 36,820 $ 36,115 Additions for credit related OTTI not previously recognized — 395 Subsequent additional credit related OTTI recorded — 12 Credit loss component of OTTI at end of period $ 36,820 $ 36,522 |
Schedule of changes in the components of the purchase discount on Non-Agency MBS | The following tables present the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the three months ended March 31, 2016 and 2015 : Three Months Ended Three Months Ended (In Thousands) Discount Designated as Credit Reserve and OTTI Accretable Discount (1) Discount Designated as Credit Reserve and OTTI Accretable Discount (1) Balance at beginning of period $ (787,541 ) $ (312,182 ) $ (900,557 ) $ (399,564 ) Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing — — (15,543 ) 1,832 Accretion of discount — 21,406 — 24,800 Realized credit losses 18,050 — 19,624 — Purchases (4,294 ) 1,606 (34 ) (3,410 ) Sales 12,020 12,040 1,049 9,969 Net impairment losses recognized in earnings — — (407 ) — Transfers/release of credit reserve 4,201 (4,201 ) 22,335 (22,335 ) Balance at end of period $ (757,564 ) $ (281,331 ) $ (873,533 ) $ (388,708 ) (1) Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security. |
Schedule of impact of AFS on AOCI | The following table presents the impact of the Company’s AFS securities on its AOCI for the three months ended March 31, 2016 and 2015 : Three Months Ended March 31, (In Thousands) 2016 2015 AOCI from AFS securities: Unrealized gain on AFS securities at beginning of period $ 585,250 $ 813,515 Unrealized gain on Agency MBS, net 13,226 12,885 Unrealized (loss)/gain on Non-Agency MBS, net (58,840 ) 26,150 Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing — 4,537 Reclassification adjustment for MBS sales included in net income (10,485 ) (6,423 ) Reclassification adjustment for OTTI included in net income — (407 ) Change in AOCI from AFS securities (56,099 ) 36,742 Balance at end of period $ 529,151 $ 850,257 |
Schedule of interest income on MBS and CRT Securities | The following table presents the components of interest income on the Company’s MBS and CRT securities for the three months ended March 31, 2016 and 2015 : Three Months Ended March 31, (In Thousands) 2016 2015 Agency MBS Coupon interest $ 32,132 $ 40,743 Effective yield adjustment (1) (8,135 ) (9,070 ) Interest income $ 23,997 $ 31,673 Legacy Non-Agency MBS Coupon interest $ 40,309 $ 49,356 Effective yield adjustment (2) 19,913 24,406 Interest income $ 60,222 $ 73,762 RPL/NPL MBS Coupon interest $ 24,370 $ 19,185 Effective yield adjustment (2) 1,560 344 Interest income $ 25,930 $ 19,529 CRT securities Coupon interest $ 2,356 $ 1,202 Effective yield adjustment (2) 336 158 Interest income $ 2,692 $ 1,360 (1) Includes amortization of premium paid net of accretion of purchase discount. For Agency MBS, interest income is recorded at an effective yield, which reflects net premium amortization based on actual prepayment activity. (2) The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield. |
Residential Whole Loans (Tables
Residential Whole Loans (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of Activity in Allowance for Loan Losses, Residential Whole Loans | The following table presents the activity in the Company’s allowance for loan losses on its residential whole loan pools at carrying value for the three months ended March 31, 2016 and 2015 : (In Thousands) Three Months Ended March 31, 2016 March 31, 2015 Balance at the beginning of period $ 1,165 $ 137 (Reversal of)/Provisions for loan losses (37 ) 327 Balance at the end of period $ 1,128 $ 464 |
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities Acquired During Period | The following table presents information regarding estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the residential whole loans held at carrying value acquired by the Company for the three months ended March 31, 2016 and 2015 : (In Thousands) Three Months Ended March 31, 2016 March 31, 2015 Contractually required principal and interest $ 199,092 $ 78,799 Contractual cash flows not expected to be collected (non-accretable yield) (28,663 ) (13,357 ) Expected cash flows to be collected 170,429 65,442 Interest component of expected cash flows (accretable yield) (58,509 ) (26,840 ) Fair value at the date of acquisition $ 111,920 $ 38,602 |
Certain Loans Acquired in Transfer Accounted for as Debt Securities, Accretable Yield Movement | The following table presents accretable yield activity for the Company’s residential whole loans held at carrying value for the three months ended March 31, 2016 and 2015 : (In Thousands) Three Months Ended March 31, 2016 March 31, 2015 Balance at beginning of period $ 175,271 $ 133,012 Additions 58,509 26,840 Accretion (4,436 ) (3,468 ) Reclassifications to non-accretable difference, net 64 (1,433 ) Balance at end of period $ 229,408 $ 154,951 |
Residential Whole Loans, Fair Value | The following table presents information regarding the Company’s residential whole loans at fair value at March 31, 2016 and December 31, 2015 : (Dollars in Thousands) March 31, 2016 December 31, 2015 Outstanding principal balance $ 810,263 $ 786,330 Aggregate fair value $ 647,360 $ 623,276 Number of loans 3,086 3,143 |
Residential Whole Loans, Fair Value, Component of Net gain on residential whole loans | The following table presents the components of Net gain on residential whole loans held at fair value for the three months ended March 31, 2016 and 2015 : (In Thousands) Three Months Ended March 31, 2016 March 31, 2015 Coupon payments and other income received $ 4,401 $ 1,321 Net unrealized gains 6,226 345 Net gain on payoff/liquidation of loans 1,254 368 Total $ 11,881 $ 2,034 |
Interest Receivable (Tables)
Interest Receivable (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Receivables [Abstract] | |
Schedule of company's interest receivable by investment category | The following table presents the Company’s interest receivable by investment category at March 31, 2016 and December 31, 2015 : (In Thousands) March 31, 2016 December 31, 2015 MBS interest receivable: Fannie Mae $ 8,640 $ 8,999 Freddie Mac 2,091 2,177 Ginnie Mae 15 15 Non-Agency MBS 14,853 15,438 Total MBS interest receivable 25,599 26,629 Residential whole loans 3,298 2,259 CRT securities 196 92 Money market and other investments 33 22 Total interest receivable $ 29,126 $ 29,002 |
Derivative Instruments (Tables)
Derivative Instruments (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of derivative instruments and balance sheet location | The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 Derivative Instrument Designation Balance Sheet Location Notional Amount Fair Value Notional Amount Fair Value (In Thousands) Non-cleared legacy Swaps (1) Hedging Assets $ 300,000 $ 152 $ 450,000 $ 1,127 Non-cleared legacy Swaps (1) Hedging Liabilities $ 150,000 $ (117 ) $ 50,000 $ (59 ) Cleared Swaps (2) Hedging Liabilities $ 2,550,000 $ (118,776 ) $ 2,550,000 $ (70,467 ) (1) Non-cleared legacy Swaps include Swaps executed and settled bilaterally with counterparties without the use of an organized exchange or central clearing house. (2) Cleared Swaps include Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties. |
Schedule of assets pledged as collateral against derivative contracts | The following table presents the assets pledged as collateral against the Company’s Swap contracts at March 31, 2016 and December 31, 2015 : (In Thousands) March 31, 2016 December 31, 2015 Agency MBS, at fair value $ 36,927 $ 38,569 Restricted cash 118,264 70,573 Total assets pledged against Swaps $ 155,191 $ 109,142 |
Schedule of information about Swap activity | The following table presents certain information with respect to the Company’s Swap activity during the three months ended March 31, 2016 : (Dollars in Thousands) Three Months Ended New Swaps: Aggregate notional amount $ — Weighted average fixed-pay rate — % Initial maturity date N/A Number of new Swaps — Swaps amortized/expired: Aggregate notional amount $ 50,000 Weighted average fixed-pay rate 2.13 % |
Schedule of information about swaps | The following table presents information about the Company’s Swaps at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 Notional Amount Weighted Average Fixed-Pay Interest Rate Weighted Average Variable Interest Rate (2) Notional Amount Weighted Average Fixed-Pay Interest Rate Weighted Average Variable Interest Rate (2) Maturity (1) (Dollars in Thousands) Within 30 days $ — — % — % $ 50,000 2.13 % 0.42 % Over 6 months to 12 months 150,000 0.54 0.44 100,000 0.48 0.32 Over 12 months to 24 months 300,000 0.57 0.44 350,000 0.58 0.27 Over 24 months to 36 months 650,000 1.53 0.44 550,000 1.49 0.32 Over 36 months to 48 months 100,000 1.71 0.43 200,000 1.71 0.42 Over 48 months to 60 months 1,600,000 2.22 0.44 1,500,000 2.22 0.36 Over 60 months to 72 months 100,000 2.21 0.44 200,000 2.20 0.30 Over 84 months (3) 100,000 2.75 0.43 100,000 2.75 0.40 Total Swaps $ 3,000,000 1.82 % 0.44 % $ 3,050,000 1.82 % 0.34 % (1) Each maturity category reflects contractual amortization and/or maturity of notional amounts. (2) Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one -month or three -month LIBOR, respectively. (3) Reflects one Swap with a maturity date of July 2023. |
Schedule of interest expense and the weighted average interest rate paid and received on swaps | The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the three months ended March 31, 2016 and 2015 : Three Months Ended (Dollars in Thousands) 2016 2015 Interest expense attributable to Swaps $ 10,650 $ 15,382 Weighted average Swap rate paid 1.82 % 1.84 % Weighted average Swap rate received 0.42 % 0.17 % |
Schedule of impact of hedging instruments on AOCI | The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the three months ended March 31, 2016 and 2015 : Three Months Ended (In Thousands) 2016 2015 AOCI from derivative hedging instruments: Balance at beginning of period $ (69,399 ) $ (59,062 ) Unrealized loss on Swaps, net (49,342 ) (32,367 ) Balance at end of period $ (118,741 ) $ (91,429 ) |
Real Estate Owned (Tables)
Real Estate Owned (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Real Estate [Abstract] | |
Schedule of Activity for Real Estate Owned | The following table presents the activity in the Company’s REO for the three months ended March 31, 2016 and 2015 : (In Thousands) Three Months Ended March 31, 2016 March 31, 2015 Balance at beginning of period $ 28,026 $ 5,492 Adjustments to record at lower of cost or fair value (1,777 ) — Transfer from residential whole loans (1) 22,280 3,448 Purchases and capital improvements 410 — Disposals (5,648 ) (607 ) Balance at end of period $ 43,291 $ 8,333 (1) Includes net gain recorded on transfer of approximately $441,000 and $285,000 , respectively, for the three months ended March 31, 2016 and 2015 . |
Other Assets (Tables)
Other Assets (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Other Assets [Abstract] | |
Schedule of Other Assets | The following table presents the components of the Company’s Other assets at March 31, 2016 and December 31, 2015 : (In Thousands) March 31, 2016 December 31, 2015 REO $ 43,291 $ 28,026 Interest receivable 29,126 29,002 Swaps, at fair value 152 1,127 Goodwill 7,189 7,189 Prepaid and other assets 96,324 101,455 Total Other Assets $ 176,082 $ 166,799 |
Repurchase Agreements and Oth35
Repurchase Agreements and Other Advances (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Disclosure of Repurchase Agreements [Abstract] | |
Schedule of Company's borrowings under repurchase agreements and associated assets pledged as collateral | The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at March 31, 2016 and December 31, 2015 : (Dollars in Thousands) March 31, December 31, Repurchase agreement borrowings secured by Agency MBS $ 2,851,997 $ 2,727,542 Fair value of Agency MBS pledged as collateral under repurchase agreements $ 2,994,028 $ 2,881,049 Weighted average haircut on Agency MBS (1) 4.69 % 4.67 % Repurchase agreement borrowings secured by Legacy Non-Agency MBS $ 1,954,499 $ 1,960,222 Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase agreements (2) $ 2,692,830 $ 2,818,968 Weighted average haircut on Legacy Non-Agency MBS (1) 24.27 % 25.42 % Repurchase agreement borrowings secured by RPL/NPL MBS $ 1,911,483 $ 2,080,163 Fair value of RPL/NPL MBS pledged as collateral under repurchase agreements $ 2,496,165 $ 2,625,866 Weighted average haircut on RPL/NPL MBS (1) 23.49 % 21.37 % Repurchase agreements secured by U.S. Treasuries $ 504,999 $ 504,760 Fair value of U.S. Treasuries pledged as collateral under repurchase agreements $ 513,409 $ 507,443 Weighted average haircut on U.S. Treasuries (1) 1.59 % 1.60 % Repurchase agreements secured by CRT securities $ 139,409 $ 128,465 Fair value of CRT securities pledged as collateral under repurchase agreements $ 196,350 $ 170,352 Weighted average haircut on CRT securities (1) 24.91 % 25.04 % Repurchase agreements secured by residential whole loans (3) $ 589,136 $ 487,750 Fair value of residential whole loans pledged as collateral under repurchase agreements $ 815,745 $ 684,136 Weighted average haircut on residential whole loans (1) 26.05 % 27.69 % (1) Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount. (2) Includes $185.9 million and $570.5 million of Legacy Non-Agency MBS acquired from consolidated VIEs at March 31, 2016 and December 31, 2015 , respectively, that are eliminated from the Company’s consolidated balance sheets. (3) Excludes $878,000 and $1.3 million of unamortized debt issuance costs at March 31, 2016 and December 31, 2015 , respectively. |
Schedule of repricing information about borrowings under repurchase agreements | The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 Balance Weighted Average Interest Rate Balance Weighted Average Interest Rate Time Until Interest Rate Reset (Dollars in Thousands) Within 30 days $ 7,079,968 1.44 % $ 7,054,483 1.44 % Over 30 days to 3 months 772,091 2.00 734,955 1.79 Over 3 months to 12 months 99,464 2.36 99,464 2.36 Total repurchase agreements 7,951,523 1.51 % 7,888,902 1.48 % Less debt issuance costs 878 1,280 Total repurchase agreements less debt issuance costs $ 7,950,645 $ 7,887,622 |
Schedule of contractual maturity information about repurchase agreements | The following table presents contractual maturity information about the Company’s borrowings under repurchase agreements, all of which are accounted for as secured borrowings, at March 31, 2016 and does not reflect the impact of derivative contracts that hedge such repurchase agreements: March 31, 2016 Contractual Maturity Agency MBS Legacy Non-Agency MBS RPL/NPL MBS U.S. Treasuries CRT Securities Residential Whole Loans Total (1) Weighted Average Interest Rate (Dollars in Thousands) Overnight $ — $ — $ — $ — $ — $ — $ — — % Within 30 days 2,851,997 933,113 1,429,721 504,999 122,861 — 5,842,691 1.23 Over 30 days to 3 months — 581,487 73,376 — 16,548 — 671,411 2.02 Over 3 months to 12 months — 439,899 408,386 — — 410,578 1,258,863 2.29 Over 12 months — — — — — 178,558 178,558 3.13 Total $ 2,851,997 $ 1,954,499 $ 1,911,483 $ 504,999 $ 139,409 $ 589,136 $ 7,951,523 1.51 % Gross amount of recognized liabilities for repurchase agreements in Note 11 $ 7,951,523 Amounts related to repurchase agreements not included in offsetting disclosure in Note 11 $ — (1) Excludes $878,000 of unamortized debt issuance costs at March 31, 2016 . |
Schedule of information about counterparty for repurchase agreements for which the entity had greater than 5% of stockholders' equity at risk | The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at March 31, 2016 : March 31, 2016 Counterparty Rating (1) Amount at Risk (2) Weighted Average Months to Maturity for Repurchase Agreements Percent of Stockholders’ Equity Counterparty (Dollars in Thousands) Wells Fargo (3) AA-/Aa2/AA $ 350,432 6 12.3 % Credit Suisse BBB+/Aa2/A 343,366 1 12.0 RBC (4) AA-/Aa3/AA 269,663 2 9.4 Goldman Sachs BBB+/A3/A 183,706 5 6.4 UBS (5) A/A1/A 166,961 16 5.8 (1) As rated at March 31, 2016 by S&P, Moody’s and Fitch, Inc., respectively. The counterparty rating presented is the lowest published for these entities. (2) The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities. (3) Includes $284.9 million at risk with Wells Fargo Bank, NA and $65.5 million at risk with Wells Fargo Securities LLC. (4) Includes $225.3 million at risk with RBC Barbados, $37.7 million at risk with Royal Bank of Canada and $6.7 million at risk with RBC Capital Markets LLC. Counterparty ratings are not published for RBC Barbados and RBC Capital Markets LLC. (5) Includes Non-Agency MBS pledged as collateral with contemporaneous repurchase and reverse repurchase agreements. |
Collateral Positions (Tables)
Collateral Positions (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Collateral Positions | |
Schedule of fair value of collateral pledged and collateral held | The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements, derivative hedging instruments and FHLB advances at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 (In Thousands) Assets Pledged Collateral Held Assets Pledged Collateral Held Derivative Hedging Instruments: Agency MBS $ 36,927 $ — $ 38,569 $ — Cash (1) 118,264 — 70,573 — 155,191 — 109,142 — Repurchase Agreement Borrowings: Agency MBS 2,994,028 — 2,881,049 — Legacy Non-Agency MBS (2)(3) 2,692,830 — 2,818,968 — RPL/NPL MBS 2,496,165 — 2,625,866 — U.S. Treasury securities 513,409 — 507,443 — CRT securities 196,350 — 170,352 — Residential whole loans 815,745 — 684,136 — Cash (1) 5,412 — 965 — 9,713,939 — 9,688,779 — FHLB Advances: Agency MBS 1,286,203 — 1,612,476 — 1,286,203 — 1,612,476 — Reverse Repurchase Agreements: U.S. Treasury securities — 513,409 — 507,443 — 513,409 — 507,443 Total $ 11,155,333 $ 513,409 $ 11,410,397 $ 507,443 (1) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets. (2) Includes $185.9 million and $570.5 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at March 31, 2016 and December 31, 2015 , respectively, that are eliminated from the Company’s consolidated balance sheets. (3) In addition, at March 31, 2016 and December 31, 2015 , $675.5 million and $726.7 million of Legacy Non-Agency MBS, respectively, are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty. |
Schedule of additional information about assets Pledged as collateral pursuant to borrowings under repurchase agreements and Derivative Hedging Contracts | The following table presents detailed information about the Company’s assets pledged as collateral pursuant to its borrowings under repurchase agreements and other advances, and derivative hedging instruments at March 31, 2016 : March 31, 2016 Assets Pledged Under Repurchase Agreements and Other Advances Assets Pledged Against Derivative Hedging Instruments Total Fair Value of Assets Pledged and Accrued Interest (In Thousands) Fair Value Amortized Cost Accrued Interest on Pledged Assets Fair Value/ Carrying Value Amortized Cost Accrued Interest on Pledged Assets Agency MBS (1) $ 4,280,231 $ 4,241,609 $ 10,111 $ 36,927 $ 37,174 $ 75 $ 4,327,344 Legacy Non-Agency MBS (2)(3) 2,692,830 2,272,910 9,961 — — — 2,702,791 RPL/NPL MBS 2,496,165 2,513,829 1,393 — — — 2,497,558 U.S. Treasuries 513,409 513,409 — — — — 513,409 CRT securities 196,350 196,695 176 — — — 196,526 Residential whole loans 815,745 798,377 1,609 — — — 817,354 Cash (4) 5,412 5,412 — 118,264 118,264 — 123,676 Total $ 11,000,142 $ 10,542,241 $ 23,250 $ 155,191 $ 155,438 $ 75 $ 11,178,658 (1) Includes Agency MBS pledged under FHLB advances with an aggregate fair value of $1.286 billion , aggregate amortized cost of $1.275 billion and aggregate accrued interest of approximately $3.1 million at March 31, 2016 . (2) Includes $185.9 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at March 31, 2016 , that are eliminated from the Company’s consolidated balance sheets. (3) In addition, at March 31, 2016 , $675.5 million of Legacy Non-Agency MBS are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty. (4) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets. |
Offsetting Assets and Liabili37
Offsetting Assets and Liabilities (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Offsetting [Abstract] | |
Schedule of information about certain assets that are subject to master netting arrangements (or similar agreements) | The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at March 31, 2016 and December 31, 2015 : Offsetting of Financial Assets and Derivative Assets Gross Amounts of Recognized Assets Gross Amounts Offset in the Consolidated Balance Sheets Net Amounts of Assets Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount (In Thousands) Financial Instruments Cash Collateral Received March 31, 2016 Swaps, at fair value $ 152 $ — $ 152 $ (152 ) $ — $ — Total $ 152 $ — $ 152 $ (152 ) $ — $ — December 31, 2015 Swaps, at fair value $ 1,127 $ — $ 1,127 $ (1,127 ) $ — $ — Total $ 1,127 $ — $ 1,127 $ (1,127 ) $ — $ — |
Schedule of information about certain liabilities that are subject to master netting arrangements (or similar agreements) | Offsetting of Financial Liabilities and Derivative Liabilities Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Consolidated Balance Sheets Net Amounts of Liabilities Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount (In Thousands) Financial Instruments (1) Cash Collateral Pledged (1) March 31, 2016 Swaps, at fair value (2) $ 118,893 $ — $ 118,893 $ (629 ) $ (118,264 ) $ — Repurchase agreements and other advances (3) (4) 9,144,523 — 9,144,523 (9,139,111 ) (5,412 ) — Total $ 9,263,416 $ — $ 9,263,416 $ (9,139,740 ) $ (123,676 ) $ — December 31, 2015 Swaps, at fair value (2) $ 70,526 $ — $ 70,526 $ — $ (70,526 ) $ — Repurchase agreements and other advances (3) (4) 9,388,902 — 9,388,902 (9,387,937 ) (965 ) — Total $ 9,459,428 $ — $ 9,459,428 $ (9,387,937 ) $ (71,491 ) $ — (1) Amounts disclosed in the Financial Instruments column of the table above represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements and other advances, and derivative transactions. Amounts disclosed in the Cash Collateral Pledged column of the table above represent amounts pledged as collateral against derivative transactions and repurchase agreements, and exclude excess collateral of $47,000 at December 31, 2015 . (2) The fair value of securities pledged against the Company’s Swaps was $36.9 million and $38.6 million at March 31, 2016 and December 31, 2015 , respectively. (3) The fair value of financial instruments pledged against the Company’s repurchase agreements and other advances was $10.995 billion and $11.300 billion at March 31, 2016 and December 31, 2015 , respectively. (4) Excludes $878,000 and $1.3 million of unamortized debt issuance costs at March 31, 2016 and December 31, 2015 , respectively. |
Other Liabilities (Tables)
Other Liabilities (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Other Liabilities [Abstract] | |
Other Liabilities | The following table presents the components of the Company’s Other liabilities at March 31, 2016 and December 31, 2015 : (In Thousands) March 31, 2016 December 31, 2015 Accrued interest payable $ 13,402 $ 16,949 Swaps, at fair value 118,893 70,526 Dividends and dividend equivalents payable 74,583 74,575 Accrued expenses and other liabilities 10,336 19,610 Total Other Liabilities $ 217,214 $ 181,660 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Stockholders' Equity Note [Abstract] | |
Schedule of preferred stock dividend declaration and payment | The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2016 through March 31, 2016 : Declaration Date Record Date Payment Date Dividend Per Share February 12, 2016 February 29, 2016 March 31, 2016 $ 0.46875 |
Schedule of cash dividends declared on common stock | The following table presents cash dividends declared by the Company on its common stock from January 1, 2016 through March 31, 2016 : Declaration Date (1) Record Date Payment Date Dividend Per Share March 11, 2016 March 28, 2016 April 29, 2016 $ 0.20 (1) (1) At March 31, 2016 , the Company had accrued dividends and dividend equivalents payable of $74.6 million related to the common stock dividend declared on March 11, 2016 . |
Schedule of changes in balances of each component of the entity's AOCI | The following table presents changes in the balances of each component of the Company’s AOCI for the three months ended March 31, 2016 : Three Months Ended (In Thousands) Net Unrealized Gain/(Loss) on AFS Securities Net Unrealized Loss on Swaps Total AOCI Balance at beginning of period $ 585,250 $ (69,399 ) $ 515,851 OCI before reclassifications (45,614 ) (49,342 ) (94,956 ) Amounts reclassified from AOCI (1) (10,485 ) — (10,485 ) Net OCI during the period (2) (56,099 ) (49,342 ) (105,441 ) Balance at end of period $ 529,151 $ (118,741 ) $ 410,410 (1) See separate table below for details about these reclassifications. (2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss). The following table presents changes in the balances of each component of the Company’s AOCI for the three months ended March 31, 2015 : Three Months Ended (In Thousands) Net Unrealized Net Total AOCI Balance at beginning of period $ 813,515 $ (59,062 ) $ 754,453 OCI before reclassifications 39,035 (32,367 ) 6,668 Amounts reclassified from AOCI (1) (6,830 ) — (6,830 ) Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing 4,537 — 4,537 Net OCI during the period (2) 36,742 (32,367 ) 4,375 Balance at end of period $ 850,257 $ (91,429 ) $ 758,828 (1) See separate table below for details about these reclassifications. (2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss). |
Information about the significant amounts reclassified out of the entity's AOCI | The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three months ended March 31, 2016 : Three Months Ended Details about AOCI Components Amounts Reclassified from AOCI Affected Line Item in the Statement Where Net Income Is Presented (In Thousands) AFS Securities: Realized gain on sale of securities $ (10,485 ) Gain on sales of MBS Total AFS Securities $ (10,485 ) Total reclassifications for period $ (10,485 ) The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three months ended March 31, 2015 : Three Months Ended Details about AOCI Components Amounts Affected Line Item in the Statement (In Thousands) AFS Securities: Realized gain on sale of securities $ (6,423 ) Gain on sales of MBS OTTI recognized in earnings (407 ) Net impairment losses recognized in earnings Total AFS Securities $ (6,830 ) Total reclassifications for period $ (6,830 ) |
EPS Calculation (Tables)
EPS Calculation (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Earnings Per Share [Abstract] | |
Schedule of reconciliation of the earnings and shares used in calculating basic and diluted EPS | The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the three months ended March 31, 2016 and 2015 : Three Months Ended (In Thousands, Except Per Share Amounts) 2016 2015 Numerator: Net income $ 78,070 $ 82,173 Dividends declared on preferred stock (3,750 ) (3,750 ) Dividends, dividend equivalents and undistributed earnings allocated to participating securities (395 ) (395 ) Net income to common stockholders - basic and diluted $ 73,925 $ 78,028 Denominator: Weighted average common shares for basic and diluted earnings per share (1) 370,942 371,910 Basic and diluted earnings per share $ 0.20 $ 0.21 (1) At March 31, 2016 , the Company had an aggregate of 2.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the three months ended March 31, 2016 , as their inclusion would have been anti-dilutive. These equity instruments were comprised of approximately 96,000 shares of restricted common stock with a weighted average grant date fair value of $7.37 and approximately 2.0 million RSUs with a weighted average grant date fair value of $6.82 . These equity instruments may have a dilutive impact on future EPS. |
Equity Compensation, Employme41
Equity Compensation, Employment Agreements and Other Benefit Plans (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Compensation Related Costs [Abstract] | |
Schedule of expenses related to equity-based compensation | The following table presents the Company’s expenses related to its equity-based compensation instruments for the three months ended March 31, 2016 and 2015 : Three Months Ended (In Thousands) 2016 2015 Restricted shares of common stock $ 152 $ 246 RSUs 960 646 Dividend equivalent rights 22 20 Total $ 1,134 $ 912 |
Schedule of expenses related to deferred compensation plans | The following table presents the Company’s expenses related to its Deferred Plans for its non-employee directors and senior officers for the three months ended March 31, 2016 and 2015 : Three Months Ended (In Thousands) 2016 2015 Non-employee directors $ 49 $ (8 ) Total $ 49 $ (8 ) |
Schedule of aggregate income deferred by participants and associated liability under deferred compensation plans | The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through March 31, 2016 and December 31, 2015 that had not been distributed and the Company’s associated liability for such deferrals at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 (In Thousands) Undistributed Income Deferred (1) Liability Under Deferred Plans Undistributed Income Deferred (1) Liability Under Deferred Plans Non-employee directors $ 638 $ 654 $ 601 $ 614 Total $ 638 $ 654 $ 601 $ 614 (1) Represents the cumulative amounts that were deferred by participants through March 31, 2016 and December 31, 2015 , which had not been distributed through such respective date. |
Fair Value of Financial Instr42
Fair Value of Financial Instruments (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Fair Value Disclosures [Abstract] | |
Schedule of financial instruments carried at fair value by valuation hierarchy | The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of March 31, 2016 and December 31, 2015 , on the consolidated balance sheets by the valuation hierarchy, as previously described: Fair Value at March 31, 2016 (In Thousands) Level 1 Level 2 Level 3 Total Assets: Agency MBS $ — $ 4,544,883 $ — $ 4,544,883 Non-Agency MBS, including MBS transferred to consolidated VIEs — 6,100,757 — 6,100,757 CRT securities — 215,803 — 215,803 Securities obtained and pledged as collateral 513,409 — — 513,409 Residential whole loans, at fair value — — 647,360 647,360 Swaps — 152 — 152 Total assets carried at fair value $ 513,409 $ 10,861,595 $ 647,360 $ 12,022,364 Liabilities: Swaps $ — $ 118,893 $ — $ 118,893 Obligation to return securities obtained as collateral 513,409 — — 513,409 Total liabilities carried at fair value $ 513,409 $ 118,893 $ — $ 632,302 Fair Value at December 31, 2015 (In Thousands) Level 1 Level 2 Level 3 Total Assets: Agency MBS $ — $ 4,752,244 $ — $ 4,752,244 Non-Agency MBS, including MBS transferred to consolidated VIEs — 6,420,817 — 6,420,817 CRT securities — 183,582 — 183,582 Securities obtained and pledged as collateral 507,443 — — 507,443 Residential whole loans, at fair value — — 623,276 623,276 Swaps — 1,127 — 1,127 Total assets carried at fair value $ 507,443 $ 11,357,770 $ 623,276 $ 12,488,489 Liabilities: Swaps $ — $ 70,526 $ — $ 70,526 Obligation to return securities obtained as collateral 507,443 — — 507,443 Total liabilities carried at fair value $ 507,443 $ 70,526 $ — $ 577,969 |
Schedule of significant unobservable inputs used in fair value measurement of residential whole loans | The following table presents additional information for the three months ended March 31, 2016 and 2015 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis. Changes in Level 3 Assets Measured at Fair Value on a Recurring Basis Residential Whole Loans, at Fair Value Three Months Ended (In Thousands) 2016 2015 Balance at beginning of period $ 623,276 $ 143,472 Purchases and capitalized advances 53,590 4,725 Changes in fair value recorded in Net gain on residential whole loans held at fair value 6,226 602 Collection of principal, net of liquidation gains/losses (14,602 ) (2,176 ) Transfer to REO (21,130 ) (3,163 ) Balance at end of period $ 647,360 $ 143,460 |
Schedule of quantitative information about significant unobservable inputs | The following table presents a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of March 31, 2016 and December 31, 2015 : Fair Value Methodology for Level 3 Financial Instruments March 31, 2016 (Dollars in Thousands) Fair Value (1) Valuation Technique Unobservable Input Weighted Average (2) Range Residential whole loans, at fair value $ 165,177 Discounted cash flow Discount rate 6.5 % 5.0-7.7% Prepayment rate 7.1 % 0.3-11.5% Default rate 2.7 % 0.0-8.3% Loss severity 13.8 % 0.0-79.1% $ 435,971 Liquidation model Discount rate 7.8 % 6.8-42.0% Annual change in home prices 1.1 % (6.1)-5.8% Liquidation timeline (in years) 1.6 0.7-4.4 Current value of underlying properties $ 623 $14-$4,200 Total $ 601,148 December 31, 2015 (Dollars in Thousands) Fair Value (1) Valuation Technique Unobservable Input Weighted Average (2) Range Residential whole loans, at fair value $ 113,166 Discounted cash flow Discount rate 7.0 % 6.0-8.7% Prepayment rate 6.6 % 0.3-11.1% Default rate 3.1 % 0.0-9.1% Loss severity 17.0 % 10.0-79.4% $ 392,557 Liquidation model Discount rate 6.9 % 6.8-10.0% Annual change in home prices 1.3 % (5.5)-6.1% Liquidation timeline (in years) 1.6 0.7-4.4 Current value of underlying properties $ 626 $14-$3,500 Total $ 505,723 (1) Excludes approximately $46.2 million and $117.6 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at March 31, 2016 and December 31, 2015 , respectively. (2) Amounts are weighted based on the fair value of the underlying loan. |
Schedule of residential whole loans, fair value and aggregate unpaid principal, fair value option elected | The following table presents the difference between the fair value and the aggregate unpaid principal balance of the Company’s residential whole loans for which the fair value option was elected, at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 (In Thousands) Fair Value Unpaid Principal Balance Difference Fair Value Unpaid Principal Balance Difference Residential whole loans, at fair value Total loans $ 647,360 $ 810,263 $ (162,903 ) $ 623,276 $ 786,330 $ (163,054 ) Loans 90 days or more past due $ 498,989 $ 639,747 $ (140,758 ) $ 493,640 $ 637,459 $ (143,819 ) |
Schedule of carrying value and fair value of financial instruments | The following table presents the carrying values and estimated fair values of the Company’s financial instruments at March 31, 2016 and December 31, 2015 : March 31, 2016 December 31, 2015 Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value (In Thousands) Financial Assets: Agency MBS $ 4,544,883 $ 4,544,883 $ 4,752,244 $ 4,752,244 Non-Agency MBS, including MBS transferred to consolidated VIEs 6,100,757 6,100,757 6,420,817 6,420,817 CRT securities 215,803 215,803 183,582 183,582 Securities obtained and pledged as collateral 513,409 513,409 507,443 507,443 Residential whole loans, at carrying value 376,235 392,924 271,845 289,696 Residential whole loans, at fair value 647,360 647,360 623,276 623,276 Cash and cash equivalents 146,236 146,236 165,007 165,007 Restricted cash 123,676 123,676 71,538 71,538 Swaps 152 152 1,127 1,127 Financial Liabilities (1) : Repurchase agreements 7,950,645 7,952,474 7,887,622 7,828,115 FHLB advances 1,193,000 1,193,000 1,500,000 1,500,000 Securitized debt 11,821 11,924 21,868 22,057 Obligation to return securities obtained as collateral 513,409 513,409 507,443 507,443 Senior Notes 96,706 100,351 96,697 99,391 Swaps 118,893 118,893 70,526 70,526 (1) Carrying value of Senior Notes, Securitized debt and certain Repurchase agreements is net of associated debt issuance costs. |
Use of Special Purpose Entiti43
Use of Special Purpose Entities and Variable Interest Entities (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Use of Special Purpose Entities and Variable Interest Entities | |
Summary of key details related to resecuritization transactions | The following table summarizes the key details of the resecuritization transactions in which the Company participated as of March 31, 2016 : (Dollars in Thousands) February 2012 Name of Trust (Consolidated as a VIE) WFMLT Series Principal value of Non-Agency MBS sold $ 433,347 Face amount of Bonds issued by the VIE and purchased by 3rd party investors $ 186,691 Outstanding amount of Senior Bonds at March 31, 2016 $ 11,924 Pass-through rate for Senior Bonds issued 2.85 % Face amount of Senior Support Certificates received by the Company (1) $ 216,603 Cash received $ 186,691 Notional amount acquired of non-rated, interest only senior certificates $ 186,691 Unamortized deferred costs $ 103 (1) Provides credit support for the sequential Senior Non-Agency MBS sold to third-party investors in resecuritization transactions (“Senior Bonds”). |
Summary of Significant Accoun44
Summary of Significant Accounting Policies (Details) | 3 Months Ended |
Mar. 31, 2016segment | |
Accounting Policies [Abstract] | |
Number of Reportable Segments | 1 |
Summary of Significant Accoun45
Summary of Significant Accounting Policies - Residential Whole Loans (Details) | 3 Months Ended |
Mar. 31, 2016 | |
Accounting Policies [Abstract] | |
Number of days considered to classify loans delinquent | 60 days |
LTV ratio percentage (or less than) | 80.00% |
Summary of Significant Accoun46
Summary of Significant Accounting Policies - Cash (Details) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 |
Accounting Policies [Abstract] | ||
Overnight money market funds | $ 129,300 | $ 120,400 |
Restricted cash | $ 123,676 | $ 71,538 |
Summary of Significant Accoun47
Summary of Significant Accounting Policies - Goodwill (Details) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 |
Accounting Policies [Abstract] | ||
Goodwill | $ 7,189 | $ 7,189 |
Summary of Significant Accoun48
Summary of Significant Accounting Policies - Depreciation (Details) - Furniture, fixtures, computers and related hardwares | 3 Months Ended |
Mar. 31, 2016 | |
Low end of range | |
Estimated useful life of long-lived assets | |
Estimated useful life | 5 years |
High end of range | |
Estimated useful life of long-lived assets | |
Estimated useful life | 8 years |
Summary of Significant Accoun49
Summary of Significant Accounting Policies - Repurchase Agreements (Details) | 3 Months Ended |
Mar. 31, 2016 | |
Accounting Policies [Abstract] | |
Repurchase financing period, low end of range | 1 month |
Repurchase financing period, high end of range | 6 months |
Summary of Significant Accoun50
Summary of Significant Accounting Policies - Equity Based Compensation (Details) | 3 Months Ended | 12 Months Ended | 27 Months Ended | 36 Months Ended |
Mar. 31, 2016 | Dec. 31, 2010 | Mar. 31, 2016 | Dec. 31, 2013 | |
Share based compensation | ||||
Forfeiture rate assumption for equity based awards granted in 2009 and prior years (as a percent) | 0.00% | |||
RSUs | ||||
Share based compensation | ||||
Vesting period of restricted share units (RSUs) | 3 years | |||
Period for measuring market condition of award | 3 years | 3 years | ||
RSUs | Minimum | ||||
Share based compensation | ||||
Vesting period of restricted share units (RSUs) | 2 years | 1 year | ||
Period for measuring market condition of award | 2 years | |||
RSUs | Maximum | ||||
Share based compensation | ||||
Vesting period of restricted share units (RSUs) | 4 years | 3 years | ||
Period for measuring market condition of award | 4 years |
Summary of Significant Accoun51
Summary of Significant Accounting Policies - Income Tax (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Accounting Policies [Abstract] | ||
Percentage Of Annual REIT Taxable Income Distributed to Stockholders, percentage | 100.00% | |
REIT income tax expense | $ 0 | |
Deferred income tax expense (benefit) | $ 0 | $ 0 |
Summary of Significant Accoun52
Summary of Significant Accounting Policies - Linked Transactions (Details) | 3 Months Ended |
Mar. 31, 2016Component | |
Accounting Policies [Abstract] | |
Number of components in a linked transaction | 2 |
Summary of Significant Accoun53
Summary of Significant Accounting Policies - New Accounting Standards Adopted in 2016 (Details) - Accounting Standards Update 2015-03 | Mar. 31, 2016USD ($) |
Senior Notes | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Debt Issuance Cost | $ (3,300,000) |
Repurchase Agreements | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Debt Issuance Cost | (1,300,000) |
Securitized Debt | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Debt Issuance Cost | $ (189,000) |
MBS and CRT Securities (Details
MBS and CRT Securities (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2016 | Mar. 31, 2015 | Dec. 31, 2015 | |
Schedule of MBS and CRT Securities [Line Items] | |||
Minimum term of fixed rate mortgages underlying MBS, years | 15 years | ||
Principal/ Current Face | $ 11,211,339 | $ 11,703,896 | |
Purchase Premiums | 164,016 | 172,160 | |
Accretable Purchase Discounts | (287,854) | (317,930) | |
Discount Designated as Credit Reserve and OTTI | (757,564) | (787,541) | |
Amortized Cost | 10,331,055 | 10,771,616 | |
Fair Value | 10,861,443 | 11,356,643 | |
Gross Unrealized Gains | 582,745 | 656,956 | |
Gross Unrealized Losses | (52,357) | (71,929) | |
Net Unrealized Gain/(Loss) | 530,388 | 585,027 | |
Principal payments receivable | 1,100 | 1,000 | |
Total MBS | |||
Schedule of MBS and CRT Securities [Line Items] | |||
Principal/ Current Face | 10,989,254 | 11,511,896 | |
Purchase Premiums | 164,016 | 172,160 | |
Accretable Purchase Discounts | (281,388) | (312,241) | |
Discount Designated as Credit Reserve and OTTI | (757,564) | (787,541) | |
Amortized Cost | 10,115,436 | 10,585,305 | |
Fair Value | 10,645,640 | 11,173,061 | |
Gross Unrealized Gains | 581,077 | 656,538 | |
Gross Unrealized Losses | (50,873) | (68,782) | |
Net Unrealized Gain/(Loss) | 530,204 | 587,756 | |
Agency Mortgage Backed Securities | |||
Schedule of MBS and CRT Securities [Line Items] | |||
Principal/ Current Face | 4,337,864 | 4,550,403 | |
Purchase Premiums | 163,950 | 172,087 | |
Accretable Purchase Discounts | (57) | (59) | |
Discount Designated as Credit Reserve and OTTI | 0 | 0 | |
Amortized Cost | 4,502,875 | 4,723,462 | |
Fair Value | 4,544,883 | 4,752,244 | |
Gross Unrealized Gains | 61,845 | 69,207 | |
Gross Unrealized Losses | (19,837) | (40,425) | |
Net Unrealized Gain/(Loss) | 42,008 | 28,782 | |
Agency Mortgage Backed Securities | Fannie Mae | |||
Schedule of MBS and CRT Securities [Line Items] | |||
Principal/ Current Face | 3,512,731 | 3,690,020 | |
Purchase Premiums | 132,452 | 139,243 | |
Accretable Purchase Discounts | (57) | (59) | |
Discount Designated as Credit Reserve and OTTI | 0 | 0 | |
Amortized Cost | 3,645,126 | 3,829,204 | |
Fair Value | 3,684,575 | 3,865,485 | |
Gross Unrealized Gains | 54,304 | 62,111 | |
Gross Unrealized Losses | (14,855) | (25,830) | |
Net Unrealized Gain/(Loss) | 39,449 | 36,281 | |
Agency Mortgage Backed Securities | Freddie Mac | |||
Schedule of MBS and CRT Securities [Line Items] | |||
Principal/ Current Face | 816,393 | 851,087 | |
Purchase Premiums | 31,343 | 32,680 | |
Accretable Purchase Discounts | 0 | 0 | |
Discount Designated as Credit Reserve and OTTI | 0 | 0 | |
Amortized Cost | 848,854 | 884,798 | |
Fair Value | 851,230 | 877,109 | |
Gross Unrealized Gains | 7,358 | 6,906 | |
Gross Unrealized Losses | (4,982) | (14,595) | |
Net Unrealized Gain/(Loss) | 2,376 | (7,689) | |
Agency Mortgage Backed Securities | Ginnie Mae | |||
Schedule of MBS and CRT Securities [Line Items] | |||
Principal/ Current Face | 8,740 | 9,296 | |
Purchase Premiums | 155 | 164 | |
Accretable Purchase Discounts | 0 | 0 | |
Discount Designated as Credit Reserve and OTTI | 0 | 0 | |
Amortized Cost | 8,895 | 9,460 | |
Fair Value | 9,078 | 9,650 | |
Gross Unrealized Gains | 183 | 190 | |
Gross Unrealized Losses | 0 | 0 | |
Net Unrealized Gain/(Loss) | 183 | 190 | |
Non-Agency MBS | |||
Schedule of MBS and CRT Securities [Line Items] | |||
Principal/ Current Face | 6,651,390 | 6,961,493 | |
Purchase Premiums | 66 | 73 | |
Accretable Purchase Discounts | (281,331) | (312,182) | |
Discount Designated as Credit Reserve and OTTI | (757,564) | (787,541) | |
Amortized Cost | 5,612,561 | 5,861,843 | |
Fair Value | 6,100,757 | 6,420,817 | |
Gross Unrealized Gains | 519,232 | 587,331 | |
Gross Unrealized Losses | (31,036) | (28,357) | |
Net Unrealized Gain/(Loss) | 488,196 | 558,974 | |
Credit Reserve | 736,400 | $ 766,000 | |
OTTI | 21,200 | 21,500 | |
Non-Agency MBS | Expected to Recover Par | |||
Schedule of MBS and CRT Securities [Line Items] | |||
Principal/ Current Face | 2,774,846 | 2,906,878 | |
Purchase Premiums | 66 | 73 | |
Accretable Purchase Discounts | (28,004) | (31,576) | |
Discount Designated as Credit Reserve and OTTI | 0 | 0 | |
Amortized Cost | 2,746,908 | 2,875,375 | |
Fair Value | 2,747,272 | 2,878,532 | |
Gross Unrealized Gains | 19,377 | 23,300 | |
Gross Unrealized Losses | (19,013) | (20,143) | |
Net Unrealized Gain/(Loss) | 364 | 3,157 | |
Non-Agency MBS | Expected to Recover Less Than Par | |||
Schedule of MBS and CRT Securities [Line Items] | |||
Principal/ Current Face | 3,876,544 | 4,054,615 | |
Purchase Premiums | 0 | 0 | |
Accretable Purchase Discounts | (253,327) | (280,606) | |
Discount Designated as Credit Reserve and OTTI | (757,564) | (787,541) | |
Amortized Cost | 2,865,653 | 2,986,468 | |
Fair Value | 3,353,485 | 3,542,285 | |
Gross Unrealized Gains | 499,855 | 564,031 | |
Gross Unrealized Losses | (12,023) | (8,214) | |
Net Unrealized Gain/(Loss) | $ 487,832 | $ 555,817 | |
Percentage of current face amount of Non-Agency MBS to be recovered | 89.00% | 89.00% | |
CRT securities | |||
Schedule of MBS and CRT Securities [Line Items] | |||
Principal/ Current Face | $ 222,085 | $ 192,000 | |
Purchase Premiums | 0 | 0 | |
Accretable Purchase Discounts | (6,466) | (5,689) | |
Discount Designated as Credit Reserve and OTTI | 0 | 0 | |
Amortized Cost | 215,619 | 186,311 | |
Fair Value | 215,803 | 183,582 | |
Gross Unrealized Gains | 1,668 | 418 | |
Gross Unrealized Losses | (1,484) | (3,147) | |
Net Unrealized Gain/(Loss) | 184 | (2,729) | |
CRT securities | Fair value option elected, debt securities | |||
Schedule of MBS and CRT Securities [Line Items] | |||
Fair Value | 92,900 | 62,200 | |
Gross Unrealized Gains | 1,400 | 332 | |
Gross Unrealized Losses | (132) | (555) | |
Net Unrealized Gain/(Loss) | $ 1,200 | (223) | |
RPL/NPL MBS | |||
Schedule of MBS and CRT Securities [Line Items] | |||
Debt Instrument, Basis Spread on Variable Rate, percentage | 3.00% | ||
Debt Instrument, Coupon Step-Up Period | 36 months | ||
Principal/ Current Face | $ 2,515,000 | 2,648,000 | |
Amortized Cost | 2,514,000 | 2,645,000 | |
Fair Value | 2,496,000 | $ 2,626,000 | |
Gross Unrealized Losses | $ (17,800) |
MBS and CRT Securities (Detai55
MBS and CRT Securities (Details 2) | Dec. 31, 2014USD ($) | Mar. 31, 2016USD ($)Security | Mar. 31, 2015USD ($) | Dec. 31, 2015USD ($) |
Fair Value | ||||
Less than 12 Months | $ 2,784,300,000 | |||
12 Months or more | 1,747,548,000 | |||
Total | 4,531,848,000 | |||
Unrealized Losses | ||||
Less than 12 Months | 28,501,000 | |||
12 Months or more | 23,856,000 | |||
Total | $ 52,357,000 | |||
Number of Securities | ||||
Less than 12 months (in security) | Security | 217 | |||
12 months or more (in security) | Security | 247 | |||
Unrealized loss on investment securities | $ (52,357,000) | $ (71,929,000) | ||
Total OTTI losses | 0 | $ (395,000) | ||
OTTI reclassified from OCI | 0 | (12,000) | ||
Net Impairment Losses Recognized in Earnings | 0 | (407,000) | ||
Roll-forward of the credit loss component of OTTI | ||||
Credit loss component of OTTI at beginning of period | 36,820,000 | 36,115,000 | ||
Additions for credit related OTTI not previously recognized | 0 | 395,000 | ||
Subsequent additional credit related OTTI recorded | 0 | 12,000 | ||
Credit loss component of OTTI at end of period | $ 36,115,000 | 36,820,000 | 36,522,000 | |
Changes in the components of the purchase discount on Non-Agency MBS | ||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 4,500,000 | 0 | 4,537,000 | |
AOCI from AFS Securities: | ||||
Unrealized gain on AFS securities at beginning of period | 585,250,000 | 813,515,000 | ||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 4,500,000 | 0 | 4,537,000 | |
Reclassification adjustment for MBS sales included in net income | (10,485,000) | (6,423,000) | ||
Reclassification adjustment for OTTI included in net income | 0 | (407,000) | ||
Change in AOCI from AFS securities | (56,099,000) | 36,742,000 | ||
Balance at end of period | 813,515,000 | 529,151,000 | 850,257,000 | |
Total MBS | ||||
Fair Value | ||||
Less than 12 Months | 2,688,898,000 | |||
12 Months or more | 1,742,960,000 | |||
Total | 4,431,858,000 | |||
Unrealized Losses | ||||
Less than 12 Months | 27,430,000 | |||
12 Months or more | 23,443,000 | |||
Total | $ 50,873,000 | |||
Number of Securities | ||||
Less than 12 months (in security) | Security | 194 | |||
12 months or more (in security) | Security | 246 | |||
Unrealized loss on investment securities | $ (50,873,000) | (68,782,000) | ||
Agency Mortgage Backed Securities | ||||
Fair Value | ||||
Less than 12 Months | 570,899,000 | |||
12 Months or more | 1,494,324,000 | |||
Total | 2,065,223,000 | |||
Unrealized Losses | ||||
Less than 12 Months | 4,508,000 | |||
12 Months or more | 15,329,000 | |||
Total | $ 19,837,000 | |||
Number of Securities | ||||
Less than 12 months (in security) | Security | 96 | |||
12 months or more (in security) | Security | 221 | |||
Unrealized loss on investment securities | $ (19,837,000) | (40,425,000) | ||
AOCI from AFS Securities: | ||||
Unrealized (loss)/gain on AFS securities, net | 13,226,000 | 12,885,000 | ||
MBS and CRT Securities Interest Income | ||||
Coupon interest | 32,132,000 | 40,743,000 | ||
Effective yield adjustment | (8,135,000) | (9,070,000) | ||
Interest income | 23,997,000 | 31,673,000 | ||
Agency Mortgage Backed Securities | Fannie Mae | ||||
Fair Value | ||||
Less than 12 Months | 566,376,000 | |||
12 Months or more | 976,991,000 | |||
Total | 1,543,367,000 | |||
Unrealized Losses | ||||
Less than 12 Months | 4,507,000 | |||
12 Months or more | 10,348,000 | |||
Total | $ 14,855,000 | |||
Number of Securities | ||||
Less than 12 months (in security) | Security | 95 | |||
12 months or more (in security) | Security | 129 | |||
Unrealized loss on investment securities | $ (14,855,000) | (25,830,000) | ||
Agency Mortgage Backed Securities | Freddie Mac | ||||
Fair Value | ||||
Less than 12 Months | 4,523,000 | |||
12 Months or more | 517,333,000 | |||
Total | 521,856,000 | |||
Unrealized Losses | ||||
Less than 12 Months | 1,000 | |||
12 Months or more | 4,981,000 | |||
Total | $ 4,982,000 | |||
Number of Securities | ||||
Less than 12 months (in security) | Security | 1 | |||
12 months or more (in security) | Security | 92 | |||
Unrealized loss on investment securities | $ (4,982,000) | (14,595,000) | ||
Non-Agency MBS | ||||
Fair Value | ||||
Less than 12 Months | 2,117,999,000 | |||
12 Months or more | 248,636,000 | |||
Total | 2,366,635,000 | |||
Unrealized Losses | ||||
Less than 12 Months | 22,922,000 | |||
12 Months or more | 8,114,000 | |||
Total | $ 31,036,000 | |||
Number of Securities | ||||
Less than 12 months (in security) | Security | 98 | |||
12 months or more (in security) | Security | 25 | |||
Unrealized loss on investment securities | $ (31,036,000) | (28,357,000) | ||
Credit-related OTTI losses | 0 | |||
AOCI from AFS Securities: | ||||
Unrealized (loss)/gain on AFS securities, net | (58,840,000) | 26,150,000 | ||
Sales of MBS | ||||
Proceeds from sale of MBS categorized as available-for-sale | 32,000,000 | 10,800,000 | ||
Gains on sales of MBS | 9,700,000 | 6,400,000 | ||
Non-Agency MBS | Discount Designated as Credit Reserve and OTTI | ||||
Changes in the components of the purchase discount on Non-Agency MBS | ||||
Balance at beginning of period | (787,541,000) | (900,557,000) | ||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | (15,543,000) | ||
Accretion of discount | 0 | 0 | ||
Realized credit losses | 18,050,000 | 19,624,000 | ||
Purchases | (4,294,000) | (34,000) | ||
Sales | 12,020,000 | 1,049,000 | ||
Net impairment losses recognized in earnings | 0 | (407,000) | ||
Transfers/release of credit reserve | 4,201,000 | 22,335,000 | ||
Balance at end of period | (900,557,000) | (757,564,000) | (873,533,000) | |
AOCI from AFS Securities: | ||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | (15,543,000) | ||
Non-Agency MBS | Accretable Discount | ||||
Changes in the components of the purchase discount on Non-Agency MBS | ||||
Balance at beginning of period | (312,182,000) | (399,564,000) | ||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | 1,832,000 | ||
Accretion of discount | 21,406,000 | 24,800,000 | ||
Realized credit losses | 0 | 0 | ||
Purchases | 1,606,000 | (3,410,000) | ||
Sales | 12,040,000 | 9,969,000 | ||
Net impairment losses recognized in earnings | 0 | 0 | ||
Transfers/release of credit reserve | (4,201,000) | (22,335,000) | ||
Balance at end of period | $ (399,564,000) | (281,331,000) | (388,708,000) | |
AOCI from AFS Securities: | ||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | 1,832,000 | ||
Non-Agency MBS | Expected to Recover Par | ||||
Fair Value | ||||
Less than 12 Months | 1,841,079,000 | |||
12 Months or more | 181,507,000 | |||
Total | 2,022,586,000 | |||
Unrealized Losses | ||||
Less than 12 Months | 15,689,000 | |||
12 Months or more | 3,324,000 | |||
Total | $ 19,013,000 | |||
Number of Securities | ||||
Less than 12 months (in security) | Security | 55 | |||
12 months or more (in security) | Security | 10 | |||
Unrealized loss on investment securities | $ (19,013,000) | (20,143,000) | ||
Non-Agency MBS | Expected to Recover Less Than Par | ||||
Fair Value | ||||
Less than 12 Months | 276,920,000 | |||
12 Months or more | 67,129,000 | |||
Total | 344,049,000 | |||
Unrealized Losses | ||||
Less than 12 Months | 7,233,000 | |||
12 Months or more | 4,790,000 | |||
Total | $ 12,023,000 | |||
Number of Securities | ||||
Less than 12 months (in security) | Security | 43 | |||
12 months or more (in security) | Security | 15 | |||
Unrealized loss on investment securities | $ (12,023,000) | (8,214,000) | ||
Legacy Non-Agency MBS | ||||
Number of Securities | ||||
Unrealized loss on investment securities | (13,200,000) | |||
MBS and CRT Securities Interest Income | ||||
Coupon interest | 40,309,000 | 49,356,000 | ||
Effective yield adjustment | 19,913,000 | 24,406,000 | ||
Interest income | 60,222,000 | 73,762,000 | ||
RPL/NPL MBS | ||||
Number of Securities | ||||
Unrealized loss on investment securities | (17,800,000) | |||
MBS and CRT Securities Interest Income | ||||
Coupon interest | 24,370,000 | 19,185,000 | ||
Effective yield adjustment | 1,560,000 | 344,000 | ||
Interest income | 25,930,000 | 19,529,000 | ||
CRT securities | ||||
Fair Value | ||||
Less than 12 Months | 95,402,000 | |||
12 Months or more | 4,588,000 | |||
Total | 99,990,000 | |||
Unrealized Losses | ||||
Less than 12 Months | 1,071,000 | |||
12 Months or more | 413,000 | |||
Total | $ 1,484,000 | |||
Number of Securities | ||||
Less than 12 months (in security) | Security | 23 | |||
12 months or more (in security) | Security | 1 | |||
Unrealized loss on investment securities | $ (1,484,000) | (3,147,000) | ||
MBS and CRT Securities Interest Income | ||||
Coupon interest | 2,356,000 | 1,202,000 | ||
Effective yield adjustment | 336,000 | 158,000 | ||
Interest income | 2,692,000 | $ 1,360,000 | ||
CRT securities | Fair value option elected, debt securities | ||||
Fair Value | ||||
Total | 24,700,000 | |||
Number of Securities | ||||
Unrealized loss on investment securities | $ (132,000) | $ (555,000) |
Residential Whole Loans - Narra
Residential Whole Loans - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | |||
Mar. 31, 2016 | Mar. 31, 2015 | Dec. 31, 2015 | Dec. 31, 2014 | |
Investments, Debt and Equity Securities [Abstract] | ||||
Residential whole loans | $ 1,024,000 | $ 895,100 | ||
Equity interest in certificates (percent) | 100.00% | |||
Residential whole loans at carrying value | $ 376,235 | 271,845 | ||
Allowance for loan losses, residential whole loan at carrying value | 1,128 | $ 464 | $ 1,165 | $ 137 |
(Reversal of)/Provision for loan losses, residential whole loan at carrying value | $ (37) | $ 327 |
Residential Whole Loans - Provi
Residential Whole Loans - Provision for Loan Losses (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Allowance for Loan and Lease Losses [Roll Forward] | ||
Balance at the beginning of period | $ 1,165 | $ 137 |
(Reversal of)/Provisions for loan losses | (37) | 327 |
Balance at the end of period | $ 1,128 | $ 464 |
Residential Whole Loans - Carry
Residential Whole Loans - Carrying Value (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Investments, Debt and Equity Securities [Abstract] | ||
Contractually required principal and interest | $ 199,092 | $ 78,799 |
Contractual cash flows not expected to be collected (non-accretable yield) | (28,663) | (13,357) |
Expected cash flows to be collected | 170,429 | 65,442 |
Interest component of expected cash flows (accretable yield) | (58,509) | (26,840) |
Fair value at the date of acquisition | $ 111,920 | $ 38,602 |
Residential Whole Loans - Car59
Residential Whole Loans - Carrying Value Accretable Yield Rollforward (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Residential Whole Loans Accretable Yield [Roll Forward] | ||
Balance at beginning of period | $ 175,271 | $ 133,012 |
Additions | 58,509 | 26,840 |
Accretion | (4,436) | (3,468) |
Reclassifications to non-accretable difference, net | 64 | (1,433) |
Balance at end of period | $ 229,408 | $ 154,951 |
Residential Whole Loans - Fair
Residential Whole Loans - Fair Value (Details) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2016USD ($)loan | Dec. 31, 2015USD ($)loan | |
Investments, Debt and Equity Securities [Abstract] | ||
Outstanding principal balance | $ 810,263 | $ 786,330 |
Aggregate fair value | $ 647,360 | $ 623,276 |
Number of loans | loan | 3,086 | 3,143 |
Residential Whole Loans - Fai61
Residential Whole Loans - Fair Value Components of Net Income (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Investments, Debt and Equity Securities [Abstract] | ||
Coupon payments and other income received | $ 4,401 | $ 1,321 |
Net unrealized gains | 6,226 | 345 |
Net gain on payoff/liquidation of loans | 1,254 | 368 |
Total | $ 11,881 | $ 2,034 |
Interest Receivable (Details)
Interest Receivable (Details) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 |
Interest receivable by investment category | ||
Total interest receivable | $ 29,126 | $ 29,002 |
Total MBS interest receivable | ||
Interest receivable by investment category | ||
Total interest receivable | 25,599 | 26,629 |
Fannie Mae | ||
Interest receivable by investment category | ||
Total interest receivable | 8,640 | 8,999 |
Freddie Mac | ||
Interest receivable by investment category | ||
Total interest receivable | 2,091 | 2,177 |
Ginnie Mae | ||
Interest receivable by investment category | ||
Total interest receivable | 15 | 15 |
Non-Agency MBS | ||
Interest receivable by investment category | ||
Total interest receivable | 14,853 | 15,438 |
Residential whole loans | ||
Interest receivable by investment category | ||
Total interest receivable | 3,298 | 2,259 |
CRT securities | ||
Interest receivable by investment category | ||
Total interest receivable | 196 | 92 |
Money market and other investments | ||
Interest receivable by investment category | ||
Total interest receivable | $ 33 | $ 22 |
Derivative Instruments (Details
Derivative Instruments (Details) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 |
Derivative Instruments | ||
Derivative assets, fair value | $ 152 | $ 1,127 |
Swaps, at fair value | Hedging | Assets | Non-cleared legacy Swaps | ||
Derivative Instruments | ||
Notional amount of derivative assets | 300,000 | 450,000 |
Derivative assets, fair value | 152 | 1,127 |
Swaps, at fair value | Hedging | Liabilities | Non-cleared legacy Swaps | ||
Derivative Instruments | ||
Notional amount of derivative liabilities | 150,000 | 50,000 |
Derivative liabilities, at fair value | (117) | (59) |
Swaps, at fair value | Hedging | Liabilities | Cleared Swaps | ||
Derivative Instruments | ||
Notional amount of derivative liabilities | 2,550,000 | 2,550,000 |
Derivative liabilities, at fair value | $ (118,776) | $ (70,467) |
Derivative Instruments (Detai64
Derivative Instruments (Details 2) $ in Thousands | 3 Months Ended | |||
Mar. 31, 2016USD ($)derivative | Mar. 31, 2015USD ($) | Mar. 31, 2016USD ($) | Dec. 31, 2015USD ($) | |
Derivative [Line Items] | ||||
Assets pledged | $ 11,155,333 | $ 11,410,397 | ||
Net unrealized gains (losses) | $ (69,399) | $ (59,062) | (118,741) | (69,399) |
Interest expense attributable to Swaps | 47,600 | 43,940 | ||
AOCI from derivative hedging instruments: | ||||
Balance at beginning of period | (69,399) | (59,062) | ||
Unrealized loss on Swaps, net | (49,342) | (32,367) | ||
Balance at end of period | (118,741) | (91,429) | ||
Interest Rate Contract | ||||
Derivative [Line Items] | ||||
Aggregate fair value of assets needed to immediately settle | 120,200 | |||
Associated accrued interest payable | 1,300 | |||
Assets pledged | 155,191 | 109,142 | ||
Interest Rate Contract | Agency MBS, at fair value | ||||
Derivative [Line Items] | ||||
Assets pledged | 36,927 | 38,569 | ||
Interest Rate Contract | Restricted cash | ||||
Derivative [Line Items] | ||||
Assets pledged | 118,264 | 70,573 | ||
Swaps, at fair value | ||||
Derivative [Line Items] | ||||
Aggregate notional amount of derivatives | $ 3,000,000 | $ 3,050,000 | ||
Weighted Average Fixed-Pay Interest Rate (as a percent) | 1.82% | 1.82% | ||
Weighted Average Variable Interest Rate (as a percent) | 0.44% | 0.34% | ||
Interest expense attributable to Swaps | $ 10,650 | $ 15,382 | ||
Weighted average Swap rate paid (as a percent) | 1.82% | 1.84% | ||
Weighted average Swap rate received (as a percent) | 0.42% | 0.17% | ||
Swaps, at fair value | Within 30 days | ||||
Derivative [Line Items] | ||||
Aggregate notional amount of derivatives | $ 0 | $ 50,000 | ||
Weighted Average Fixed-Pay Interest Rate (as a percent) | 0.00% | 2.13% | ||
Weighted Average Variable Interest Rate (as a percent) | 0.00% | 0.42% | ||
Swaps, at fair value | Over 6 months to 12 months | ||||
Derivative [Line Items] | ||||
Aggregate notional amount of derivatives | $ 150,000 | $ 100,000 | ||
Weighted Average Fixed-Pay Interest Rate (as a percent) | 0.54% | 0.48% | ||
Weighted Average Variable Interest Rate (as a percent) | 0.44% | 0.32% | ||
Swaps, at fair value | Over 12 months to 24 months | ||||
Derivative [Line Items] | ||||
Aggregate notional amount of derivatives | $ 300,000 | $ 350,000 | ||
Weighted Average Fixed-Pay Interest Rate (as a percent) | 0.57% | 0.58% | ||
Weighted Average Variable Interest Rate (as a percent) | 0.44% | 0.27% | ||
Swaps, at fair value | Over 24 months to 36 months | ||||
Derivative [Line Items] | ||||
Aggregate notional amount of derivatives | $ 650,000 | $ 550,000 | ||
Weighted Average Fixed-Pay Interest Rate (as a percent) | 1.53% | 1.49% | ||
Weighted Average Variable Interest Rate (as a percent) | 0.44% | 0.32% | ||
Swaps, at fair value | Over 36 months to 48 months | ||||
Derivative [Line Items] | ||||
Aggregate notional amount of derivatives | $ 100,000 | $ 200,000 | ||
Weighted Average Fixed-Pay Interest Rate (as a percent) | 1.71% | 1.71% | ||
Weighted Average Variable Interest Rate (as a percent) | 0.43% | 0.42% | ||
Swaps, at fair value | Over 48 months to 60 months | ||||
Derivative [Line Items] | ||||
Aggregate notional amount of derivatives | $ 1,600,000 | $ 1,500,000 | ||
Weighted Average Fixed-Pay Interest Rate (as a percent) | 2.22% | 2.22% | ||
Weighted Average Variable Interest Rate (as a percent) | 0.44% | 0.36% | ||
Swaps, at fair value | Over 60 months to 72 months | ||||
Derivative [Line Items] | ||||
Aggregate notional amount of derivatives | $ 100,000 | $ 200,000 | ||
Weighted Average Fixed-Pay Interest Rate (as a percent) | 2.21% | 2.20% | ||
Weighted Average Variable Interest Rate (as a percent) | 0.44% | 0.30% | ||
Swaps, at fair value | Over 84 Months | ||||
Derivative [Line Items] | ||||
Aggregate notional amount of derivatives | $ 100,000 | $ 100,000 | ||
Weighted Average Fixed-Pay Interest Rate (as a percent) | 2.75% | 2.75% | ||
Weighted Average Variable Interest Rate (as a percent) | 0.43% | 0.40% | ||
Swaps, at fair value | New Swaps | ||||
Derivative [Line Items] | ||||
Aggregate notional amount | $ 0 | |||
Weighted Average Fixed-Pay Interest Rate (as a percent) | 0.00% | |||
Number of new Swaps | derivative | 0 | |||
Swaps, at fair value | Swaps amortized expired | ||||
Derivative [Line Items] | ||||
Aggregate notional amount | $ 50,000 | |||
Swaps, at fair value | Swaps amortized expired | QTD | ||||
Derivative [Line Items] | ||||
Weighted Average Fixed-Pay Interest Rate (as a percent) | 2.13% | |||
Swaps, at fair value | Hedging | ||||
Derivative [Line Items] | ||||
Aggregate notional amount of derivatives | $ 3,000,000 | |||
Net unrealized gains (losses) | $ (118,700) | $ (118,700) | ||
Average maturity term of swaps | 43 months | |||
Maximum maturity term of swaps | 89 months | |||
AOCI from derivative hedging instruments: | ||||
Balance at end of period | $ (118,700) | |||
Swaps, at fair value | Minimum | LIBOR | ||||
Derivative [Line Items] | ||||
Derivative, variable interest rate, term | 1 month | |||
Swaps, at fair value | Maximum | LIBOR | ||||
Derivative [Line Items] | ||||
Derivative, variable interest rate, term | 3 months |
Derivative Instruments (Detai65
Derivative Instruments (Details 3) - USD ($) $ in Thousands | Dec. 31, 2014 | Mar. 31, 2016 | Mar. 31, 2015 | Dec. 31, 2015 |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||||
MBS securities recorded upon adoption of revised accounting standard | $ 1,913,000 | |||
CRT securities recorded upon adoption of revised accounting standard | 4,600 | |||
Repurchase agreements recorded upon adoption of revised accounting standard for repurchase agreement financing | $ 0 | $ 1,519,593 | $ 1,520,000 | |
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | $ 4,500 | $ 0 | $ 4,537 |
Real Estate Owned (Details)
Real Estate Owned (Details) $ in Thousands | 3 Months Ended | |||
Mar. 31, 2016USD ($)property | Mar. 31, 2015USD ($)property | Dec. 31, 2015USD ($)property | Dec. 31, 2014USD ($) | |
Real Estate Owned Properties [Line Items] | ||||
Number of real estate owned properties | property | 270 | 182 | ||
Real estate owned | $ 43,291 | $ 8,333 | $ 28,026 | $ 5,492 |
Number of real estate properties reclassified to REO during period | property | 138 | 25 | ||
Mortgage loans reclassified to REO | $ 22,280 | $ 3,448 | ||
Residential Whole Loans acquired through foreclosure ordered in lieu | $ 42,100 | |||
Number of REO properties sold during period | property | 50 | 5 | ||
Proceeds from sale of real estate owned | $ 6,200 | $ 581 | ||
Gains/(losses) on sales of real estate owned | 509 | (26) | ||
Adjustments to record at lower of cost or fair value | 1,777 | 0 | ||
Estimated Fair Value | ||||
Real Estate Owned Properties [Line Items] | ||||
Mortgage loans reclassified to REO | 22,300 | $ 4,000 | ||
Mortgage loans in process of foreclosure | 366,600 | |||
Carrying Value | ||||
Real Estate Owned Properties [Line Items] | ||||
Mortgage loans in process of foreclosure | $ 18,700 | |||
Residential properties | ||||
Real Estate Owned Properties [Line Items] | ||||
Number of residential properties acquired | property | 0 | 0 |
Real Estate Owned - Activity (D
Real Estate Owned - Activity (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Real Estate Owned [Roll Forward] | ||
Balance at beginning of period | $ 28,026 | $ 5,492 |
Adjustments to record at lower of cost or fair value | (1,777) | 0 |
Transfer from residential whole loans | 22,280 | 3,448 |
Purchases and capital improvements | 410 | 0 |
Disposals | (5,648) | (607) |
Balance at end of period | 43,291 | 8,333 |
Gain recorded on transfer from residential whole loans to real estate owned | $ 441 | $ 285 |
Other Assets (Details)
Other Assets (Details) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 | Mar. 31, 2015 | Dec. 31, 2014 |
Other Assets [Abstract] | ||||
REO | $ 43,291 | $ 28,026 | $ 8,333 | $ 5,492 |
Interest receivable | 29,126 | 29,002 | ||
Swaps, at fair value | 152 | 1,127 | ||
Goodwill | 7,189 | 7,189 | ||
Prepaid and other assets | 96,324 | 101,455 | ||
Total Other Assets | $ 176,082 | $ 166,799 |
Repurchase Agreements and Oth69
Repurchase Agreements and Other Advances (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2016 | Dec. 31, 2015 | |
Assets Sold under Agreements to Repurchase [Line Items] | ||
Balance of repurchase agreements | $ 7,951,523 | |
Unamortized debt issuance expense | $ 878 | $ 1,280 |
Securities Sold under Agreements to Repurchase | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Weighted average remaining term-to-interest rate reset of borrowings under repurchase agreements, days | 20 days | 21 days |
Effective repricing period, months | 16 months | 18 months |
Balance of repurchase agreements | $ 7,951,523 | $ 7,888,902 |
Agency Mortgage Backed Securities | Securities Sold under Agreements to Repurchase | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Balance of repurchase agreements | 2,851,997 | 2,727,542 |
Fair value of securities pledged as collateral under repurchase agreements | $ 2,994,028 | $ 2,881,049 |
Weighted average haircut (percent) | 4.69% | 4.67% |
Legacy Non-Agency MBS | Securities Sold under Agreements to Repurchase | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Balance of repurchase agreements | $ 1,954,499 | $ 1,960,222 |
Fair value of securities pledged as collateral under repurchase agreements | $ 2,692,830 | $ 2,818,968 |
Weighted average haircut (percent) | 24.27% | 25.42% |
Non-Agency MBS acquired from consolidated VIEs | $ 185,900 | $ 570,500 |
RPL/NPL MBS | Securities Sold under Agreements to Repurchase | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Balance of repurchase agreements | 1,911,483 | 2,080,163 |
Fair value of securities pledged as collateral under repurchase agreements | $ 2,496,165 | $ 2,625,866 |
Weighted average haircut (percent) | 23.49% | 21.37% |
U.S. Treasuries | Securities Sold under Agreements to Repurchase | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Balance of repurchase agreements | $ 504,999 | $ 504,760 |
Fair value of securities pledged as collateral under repurchase agreements | $ 513,409 | $ 507,443 |
Weighted average haircut (percent) | 1.59% | 1.60% |
CRT securities | Securities Sold under Agreements to Repurchase | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Balance of repurchase agreements | $ 139,409 | $ 128,465 |
Fair value of securities pledged as collateral under repurchase agreements | $ 196,350 | $ 170,352 |
Weighted average haircut (percent) | 24.91% | 25.04% |
Residential Whole Loans | Securities Sold under Agreements to Repurchase | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Balance of repurchase agreements | $ 589,136 | $ 487,750 |
Fair value of securities pledged as collateral under repurchase agreements | $ 815,745 | $ 684,136 |
Weighted average haircut (percent) | 26.05% | 27.69% |
Repurchase Agreements and Oth70
Repurchase Agreements and Other Advances (Details 2) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 |
Information about MBS [Line Items] | ||
Balance of repurchase agreements | $ 7,951,523 | |
Securities Sold under Agreements to Repurchase, Gross | 7,950,645 | $ 7,887,622 |
Less unamortized debt issuance costs | 878 | 1,280 |
Amounts related to repurchase agreements not included in offsetting disclosure in Note 11 | 0 | |
Repurchase Agreement Borrowings | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | $ 7,951,523 | $ 7,888,902 |
Weighted Average Interest Rate (as a percent) | 1.51% | 1.48% |
Repurchase Agreement Borrowings | Overnight | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | $ 0 | |
Weighted Average Interest Rate (as a percent) | 0.00% | |
Repurchase Agreement Borrowings | Within 30 days | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | $ 5,842,691 | |
Weighted Average Interest Rate (as a percent) | 1.23% | |
Repurchase Agreement Borrowings | Over 30 days to 3 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | $ 671,411 | |
Weighted Average Interest Rate (as a percent) | 2.02% | |
Repurchase Agreement Borrowings | Over 3 months to 12 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | $ 1,258,863 | |
Weighted Average Interest Rate (as a percent) | 2.29% | |
Repurchase Agreement Borrowings | Over 12 Months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | $ 178,558 | |
Weighted Average Interest Rate (as a percent) | 3.13% | |
Repurchase Agreement Borrowings | Agency MBS | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | $ 2,851,997 | $ 2,727,542 |
Repurchase Agreement Borrowings | Agency MBS | Overnight | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | Agency MBS | Within 30 days | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 2,851,997 | |
Repurchase Agreement Borrowings | Agency MBS | Over 30 days to 3 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | Agency MBS | Over 3 months to 12 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | Agency MBS | Over 12 Months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | Legacy Non-Agency MBS | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 1,954,499 | |
Repurchase Agreement Borrowings | Legacy Non-Agency MBS | Overnight | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | Legacy Non-Agency MBS | Within 30 days | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 933,113 | |
Repurchase Agreement Borrowings | Legacy Non-Agency MBS | Over 30 days to 3 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 581,487 | |
Repurchase Agreement Borrowings | Legacy Non-Agency MBS | Over 3 months to 12 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 439,899 | |
Repurchase Agreement Borrowings | Legacy Non-Agency MBS | Over 12 Months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | RPL/NPL MBS | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 1,911,483 | 2,080,163 |
Repurchase Agreement Borrowings | RPL/NPL MBS | Overnight | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | RPL/NPL MBS | Within 30 days | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 1,429,721 | |
Repurchase Agreement Borrowings | RPL/NPL MBS | Over 30 days to 3 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 73,376 | |
Repurchase Agreement Borrowings | RPL/NPL MBS | Over 3 months to 12 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 408,386 | |
Repurchase Agreement Borrowings | RPL/NPL MBS | Over 12 Months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | U.S. Treasuries | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 504,999 | 504,760 |
Repurchase Agreement Borrowings | U.S. Treasuries | Overnight | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | U.S. Treasuries | Within 30 days | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 504,999 | |
Repurchase Agreement Borrowings | U.S. Treasuries | Over 30 days to 3 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | U.S. Treasuries | Over 3 months to 12 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | U.S. Treasuries | Over 12 Months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | CRT securities | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 139,409 | 128,465 |
Repurchase Agreement Borrowings | CRT securities | Overnight | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | CRT securities | Within 30 days | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 122,861 | |
Repurchase Agreement Borrowings | CRT securities | Over 30 days to 3 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 16,548 | |
Repurchase Agreement Borrowings | CRT securities | Over 3 months to 12 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | CRT securities | Over 12 Months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | Residential Whole Loans | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 589,136 | 487,750 |
Repurchase Agreement Borrowings | Residential Whole Loans | Overnight | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | Residential Whole Loans | Within 30 days | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | Residential Whole Loans | Over 30 days to 3 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 0 | |
Repurchase Agreement Borrowings | Residential Whole Loans | Over 3 months to 12 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 410,578 | |
Repurchase Agreement Borrowings | Residential Whole Loans | Over 12 Months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | 178,558 | |
Repurchase Agreement Borrowings | Within 30 days | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | $ 7,079,968 | $ 7,054,483 |
Weighted Average Interest Rate (as a percent) | 1.44% | 1.44% |
Repurchase Agreement Borrowings | Over 30 days to 3 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | $ 772,091 | $ 734,955 |
Weighted Average Interest Rate (as a percent) | 2.00% | 1.79% |
Repurchase Agreement Borrowings | Over 3 months to 12 months | ||
Information about MBS [Line Items] | ||
Balance of repurchase agreements | $ 99,464 | $ 99,464 |
Weighted Average Interest Rate (as a percent) | 2.36% | 2.36% |
Repurchase Agreements and Oth71
Repurchase Agreements and Other Advances (Details 3) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016USD ($)counterparty | Dec. 31, 2015counterparty | |
Repurchase agreements counterparty risk | ||
Number of counterparties | counterparty | 27 | 27 |
Threshold of stockholders' equity at risk with single counterparty to repurchase agreements or linked transactions (greater than) (percent) | 5.00% | |
Wells Fargo | ||
Repurchase agreements counterparty risk | ||
Amount at Risk | $ 350,432 | |
Weighted Average Months to Maturity for Repurchase Agreements | 6 months | |
Percent of Stockholders’ Equity | 12.30% | |
Wells Fargo Bank | ||
Repurchase agreements counterparty risk | ||
Amount at Risk | $ 284,900 | |
Wells Fargo Securities LLC | ||
Repurchase agreements counterparty risk | ||
Amount at Risk | 65,500 | |
Credit Suisse | ||
Repurchase agreements counterparty risk | ||
Amount at Risk | $ 343,366 | |
Weighted Average Months to Maturity for Repurchase Agreements | 1 month | |
Percent of Stockholders’ Equity | 12.00% | |
RBC | ||
Repurchase agreements counterparty risk | ||
Amount at Risk | $ 269,663 | |
Weighted Average Months to Maturity for Repurchase Agreements | 2 months | |
Percent of Stockholders’ Equity | 9.40% | |
RBC Barbados | ||
Repurchase agreements counterparty risk | ||
Amount at Risk | $ 225,300 | |
Royal Bank of Canada | ||
Repurchase agreements counterparty risk | ||
Amount at Risk | 37,700 | |
RBC Capital Markets LLC | ||
Repurchase agreements counterparty risk | ||
Amount at Risk | 6,700 | |
Goldman Sachs | ||
Repurchase agreements counterparty risk | ||
Amount at Risk | $ 183,706 | |
Weighted Average Months to Maturity for Repurchase Agreements | 5 months | |
Percent of Stockholders’ Equity | 6.40% | |
UBS | ||
Repurchase agreements counterparty risk | ||
Amount at Risk | $ 166,961 | |
Weighted Average Months to Maturity for Repurchase Agreements | 16 months | |
Percent of Stockholders’ Equity | 5.80% |
Repurchase Agreements and Oth72
Repurchase Agreements and Other Advances - FHLB Advances (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Dec. 31, 2015 | |
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items] | ||
FHLB advances, long-term | $ 1,193,000 | |
FHLB advances, weighted average borrowing rate | 0.55% | |
FHLB advances, weighted average term to maturity | 4 years 6 months 18 days | |
Accrued interest payable | $ 13,402 | $ 16,949 |
Federal Home Loan Bank Advances | ||
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items] | ||
Accrued interest payable | $ 472 |
Collateral Positions (Details)
Collateral Positions (Details) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 |
Collateral Positions | ||
Assets Pledged | $ 11,155,333 | $ 11,410,397 |
Collateral Held | 513,409 | 507,443 |
Derivative Hedging Instruments | ||
Collateral Positions | ||
Assets Pledged | 155,191 | 109,142 |
Derivative Hedging Instruments | Agency MBS | ||
Collateral Positions | ||
Assets Pledged | 36,927 | 38,569 |
Derivative Hedging Instruments | Cash | ||
Collateral Positions | ||
Assets Pledged | 118,264 | 70,573 |
Repurchase Agreement Borrowings | ||
Collateral Positions | ||
Assets Pledged | 9,713,939 | 9,688,779 |
Repurchase Agreement Borrowings | Agency MBS | ||
Collateral Positions | ||
Assets Pledged | 2,994,028 | 2,881,049 |
Repurchase Agreement Borrowings | Legacy Non-Agency MBS | ||
Collateral Positions | ||
Assets Pledged | 2,692,830 | 2,818,968 |
Non-Agency MBS acquired from consolidated VIEs | 185,900 | 570,500 |
Non-Agency MBS pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty | 675,500 | 726,700 |
Repurchase Agreement Borrowings | RPL/NPL MBS | ||
Collateral Positions | ||
Assets Pledged | 2,496,165 | 2,625,866 |
Repurchase Agreement Borrowings | U.S. Treasury securities | ||
Collateral Positions | ||
Assets Pledged | 513,409 | 507,443 |
Repurchase Agreement Borrowings | CRT securities | ||
Collateral Positions | ||
Assets Pledged | 196,350 | 170,352 |
Repurchase Agreement Borrowings | Residential Whole Loans | ||
Collateral Positions | ||
Assets Pledged | 815,745 | 684,136 |
Repurchase Agreement Borrowings | Cash | ||
Collateral Positions | ||
Assets Pledged | 5,412 | 965 |
FHLB Advances | ||
Collateral Positions | ||
Assets Pledged | 1,286,203 | 1,612,476 |
FHLB Advances | Agency MBS | ||
Collateral Positions | ||
Assets Pledged | 1,286,203 | 1,612,476 |
Reverse Repurchase Agreements | ||
Collateral Positions | ||
Collateral Held | 513,409 | 507,443 |
Reverse Repurchase Agreements | U.S. Treasury securities | ||
Collateral Positions | ||
Collateral Held | $ 513,409 | $ 507,443 |
Collateral Positions (Details 2
Collateral Positions (Details 2) $ in Thousands | Mar. 31, 2016USD ($) |
Collateral Positions | |
Total Fair Value of Assets Pledged and Accrued Interest | $ 11,178,658 |
Agency MBS | |
Collateral Positions | |
Total Fair Value of Assets Pledged and Accrued Interest | 4,327,344 |
Legacy Non-Agency MBS | |
Collateral Positions | |
Total Fair Value of Assets Pledged and Accrued Interest | 2,702,791 |
RPL/NPL MBS | |
Collateral Positions | |
Total Fair Value of Assets Pledged and Accrued Interest | 2,497,558 |
U.S. Treasuries | |
Collateral Positions | |
Total Fair Value of Assets Pledged and Accrued Interest | 513,409 |
CRT securities | |
Collateral Positions | |
Total Fair Value of Assets Pledged and Accrued Interest | 196,526 |
Residential Whole Loans | |
Collateral Positions | |
Total Fair Value of Assets Pledged and Accrued Interest | 817,354 |
Cash | |
Collateral Positions | |
Total Fair Value of Assets Pledged and Accrued Interest | 123,676 |
Repurchase Agreements and Other Advances | |
Collateral Positions | |
Fair Value | 11,000,142 |
Amortized Cost | 10,542,241 |
Accrued Interest on Pledged Assets | 23,250 |
Repurchase Agreements and Other Advances | Agency MBS | |
Collateral Positions | |
Fair Value | 4,280,231 |
Amortized Cost | 4,241,609 |
Accrued Interest on Pledged Assets | 10,111 |
Repurchase Agreements and Other Advances | Agency MBS | FHLB Advances | |
Collateral Positions | |
Fair Value | 1,286,000 |
Amortized Cost | 1,275,000 |
Accrued Interest on Pledged Assets | 3,100 |
Repurchase Agreements and Other Advances | Legacy Non-Agency MBS | |
Collateral Positions | |
Fair Value | 2,692,830 |
Amortized Cost | 2,272,910 |
Accrued Interest on Pledged Assets | 9,961 |
Non-Agency MBS acquired from consolidated VIEs in connection with resecuritization transactions | 185,900 |
Non-Agency MBS pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty | 675,500 |
Repurchase Agreements and Other Advances | RPL/NPL MBS | |
Collateral Positions | |
Fair Value | 2,496,165 |
Amortized Cost | 2,513,829 |
Accrued Interest on Pledged Assets | 1,393 |
Repurchase Agreements and Other Advances | U.S. Treasuries | |
Collateral Positions | |
Fair Value | 513,409 |
Amortized Cost | 513,409 |
Accrued Interest on Pledged Assets | 0 |
Repurchase Agreements and Other Advances | CRT securities | |
Collateral Positions | |
Fair Value | 196,350 |
Amortized Cost | 196,695 |
Accrued Interest on Pledged Assets | 176 |
Repurchase Agreements and Other Advances | Residential Whole Loans | |
Collateral Positions | |
Fair Value | 815,745 |
Amortized Cost | 798,377 |
Accrued Interest on Pledged Assets | 1,609 |
Repurchase Agreements and Other Advances | Cash | |
Collateral Positions | |
Fair Value | 5,412 |
Amortized Cost | 5,412 |
Accrued Interest on Pledged Assets | 0 |
Derivative Hedging Instruments | |
Collateral Positions | |
Fair Value | 155,191 |
Amortized Cost | 155,438 |
Accrued Interest on Pledged Assets | 75 |
Derivative Hedging Instruments | Agency MBS | |
Collateral Positions | |
Fair Value | 36,927 |
Amortized Cost | 37,174 |
Accrued Interest on Pledged Assets | 75 |
Derivative Hedging Instruments | Legacy Non-Agency MBS | |
Collateral Positions | |
Fair Value | 0 |
Amortized Cost | 0 |
Accrued Interest on Pledged Assets | 0 |
Derivative Hedging Instruments | RPL/NPL MBS | |
Collateral Positions | |
Fair Value | 0 |
Amortized Cost | 0 |
Accrued Interest on Pledged Assets | 0 |
Derivative Hedging Instruments | U.S. Treasuries | |
Collateral Positions | |
Fair Value | 0 |
Amortized Cost | 0 |
Accrued Interest on Pledged Assets | 0 |
Derivative Hedging Instruments | CRT securities | |
Collateral Positions | |
Fair Value | 0 |
Amortized Cost | 0 |
Accrued Interest on Pledged Assets | 0 |
Derivative Hedging Instruments | Residential Whole Loans | |
Collateral Positions | |
Fair Value | 0 |
Amortized Cost | 0 |
Accrued Interest on Pledged Assets | 0 |
Derivative Hedging Instruments | Cash | |
Collateral Positions | |
Fair Value | 118,264 |
Amortized Cost | 118,264 |
Accrued Interest on Pledged Assets | $ 0 |
Offsetting Assets and Liabili75
Offsetting Assets and Liabilities (Details) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016USD ($)counterparty | Dec. 31, 2015USD ($) | |
Swaps, at fair value | ||
Gross Amounts of Recognized Assets | $ 152 | $ 1,127 |
Gross Amounts Offset in the Consolidated Balance Sheets | 0 | 0 |
Net Amounts of Assets Presented in the Consolidated Balance Sheets | 152 | 1,127 |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||
Financial Instruments | (152) | (1,127) |
Cash Collateral Received | 0 | 0 |
Net Amount | 0 | 0 |
Swaps, at fair value | ||
Gross Amounts of Recognized Liabilities | 118,893 | 70,526 |
Gross Amounts Offset in the Consolidated Balance Sheets | 0 | 0 |
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets | 118,893 | 70,526 |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||
Financial Instruments | (629) | 0 |
Cash Collateral Pledged | (118,264) | (70,526) |
Net Amount | 0 | 0 |
Repurchase agreements and other advances | ||
Gross Amounts of Recognized Liabilities | 9,144,523 | 9,388,902 |
Gross Amounts Offset in the Consolidated Balance Sheets | 0 | 0 |
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets | 9,144,523 | 9,388,902 |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||
Financial Instruments | (9,139,111) | (9,387,937) |
Cash Collateral Pledged | (5,412) | (965) |
Net Amount | 0 | 0 |
Total | ||
Gross Amounts of Recognized Liabilities | 9,263,416 | 9,459,428 |
Gross Amounts Offset in the Consolidated Balance Sheets | 0 | 0 |
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets | 9,263,416 | 9,459,428 |
Gross Amounts Not Offset in the Consolidated Balance Sheet | ||
Financial Instruments | (9,139,740) | (9,387,937) |
Cash Collateral Pledged | (123,676) | (71,491) |
Net Amount | 0 | 0 |
Additional disclosures | ||
Excess collateral | 47 | |
Fair value of securities pledged against the swaps | 36,900 | 38,600 |
Fair value of financial instruments pledged against the repurchase agreements and other advances | 10,995,000 | 11,300,000 |
Unamortized debt issuance expense | $ 878 | 1,280 |
Number of repurchase agreement counterparties with unconditional right of setoff | counterparty | 1 | |
Swaps, at fair value | ||
Swaps, at fair value | ||
Gross Amounts of Recognized Assets | $ 152 | 1,127 |
Gross Amounts Offset in the Consolidated Balance Sheets | 0 | 0 |
Net Amounts of Assets Presented in the Consolidated Balance Sheets | 152 | 1,127 |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||
Financial Instruments | (152) | (1,127) |
Cash Collateral Received | 0 | 0 |
Net Amount | $ 0 | $ 0 |
Senior Notes (Details)
Senior Notes (Details) - Senior Notes - USD ($) | Apr. 11, 2012 | Mar. 31, 2016 | Dec. 31, 2015 |
Debt Instrument [Line Items] | |||
Aggregate principal amount | $ 100,000,000 | ||
Proceed from senior notes net of offering expenses and underwriting discount | $ 96,600,000 | ||
Interest rate (as a percent) | 8.00% | 8.00% | |
Effective interest rate (as a percent) | 8.31% | ||
Redemption price as percentage of principal amount | 100.00% |
Other Liabilities (Details)
Other Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 | Mar. 31, 2015 |
Other Liabilities [Abstract] | |||
Accrued interest payable | $ 13,402 | $ 16,949 | |
Swaps, at fair value | 118,893 | 70,526 | |
Dividends and dividend equivalents declared and unpaid | 74,583 | 74,575 | $ 74,581 |
Accrued expenses and other liabilities | 10,336 | 19,610 | |
Total Other Liabilities | $ 217,214 | $ 181,660 |
Commitments and Contingencies (
Commitments and Contingencies (Details) | 3 Months Ended |
Mar. 31, 2016USD ($)lease | |
Lease Commitments | |
Number of operating leases | lease | 2 |
Corporate headquarters | |
Lease Commitments | |
Irrevocable standby letter of credit provided to landlord | $ 785,000 |
Corporate headquarters | High end of range | |
Lease Commitments | |
Aggregate annual lease payments | 2,500,000 |
Off-site back-up facility | High end of range | |
Lease Commitments | |
Aggregate annual lease payments | $ 30,000 |
Stockholders' Equity (Details)
Stockholders' Equity (Details) $ / shares in Units, $ in Thousands | Apr. 15, 2013$ / sharesshares | Mar. 31, 2016USD ($)directorquarter$ / sharesshares | Mar. 31, 2015USD ($)$ / shares | Mar. 31, 2016USD ($)$ / sharesshares | Dec. 31, 2015USD ($)$ / sharesshares | Dec. 31, 2013shares | Aug. 08, 2013shares | Aug. 31, 2005shares |
Stockholders' Equity | ||||||||
Preferred stock, shares issued | 8,000,000 | 8,000,000 | 8,000,000 | |||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.01 | $ 0.01 | $ 0.01 | |||||
Preferred stock, dividend rate | 7.50% | 7.50% | ||||||
Maximum quarters without dividends to get voting rights, in quarters | quarter | 6 | |||||||
Common stock, cash dividends declared (in dollars per share) | $ / shares | $ 0.20 | $ 0.20 | ||||||
Dividends and dividend equivalents declared and unpaid | $ | $ 74,583 | $ 74,581 | $ 74,583 | $ 74,575 | ||||
Aggregate number of shares of common stock authorized (in shares) | 886,950,000 | 886,950,000 | 886,950,000 | |||||
Number of shares authorized to be repurchased under the Repurchase Program | 10,000,000 | 4,000,000 | ||||||
Repurchase of shares of common stock (in shares) | 0 | |||||||
Number of remaining shares authorized to be repurchased under the Repurchase Program (in shares) | 6,616,355 | 6,616,355 | ||||||
DRSPP | ||||||||
Stockholders' Equity | ||||||||
Aggregate number of shares of common stock authorized (in shares) | 15,000,000 | |||||||
Shares of common stock authorized and available for issuance (in shares) | 6,800,000 | 6,800,000 | ||||||
Common shares issued through DRSPP (in shares) | 47,674 | 30,776,666 | ||||||
Net proceeds from shares issued through DRSPP | $ | $ 302 | $ 258,600 | ||||||
Series B | ||||||||
Stockholders' Equity | ||||||||
Dividend Declared Per Share, preferred stock (in dollars per share) | $ / shares | $ 0.46875 | |||||||
Preferred Stock | Series B | ||||||||
Stockholders' Equity | ||||||||
Preferred stock, shares issued | 8,000,000 | |||||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.01 | |||||||
Preferred stock, liquidation preference (in dollars per share) | $ / shares | $ 25 | $ 25 | $ 25 | $ 25 | ||||
Preferred stock, dividend rate | 7.50% | 7.50% | 7.50% | |||||
Preferred stock, redemption price (in dollars per share) | $ / shares | $ 25 | |||||||
Number of additional directors that can be elected by preferred stock holders | director | 2 | |||||||
Minimum percentage of preferred shareholders required for approval (percent) | 66.67% |
Stockholders' Equity (Details 2
Stockholders' Equity (Details 2) - USD ($) $ in Thousands | Dec. 31, 2014 | Mar. 31, 2016 | Mar. 31, 2015 |
Components of accumulated other comprehensive income/(loss) | |||
Balance at beginning of period | $ 515,851 | ||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | $ 4,500 | 0 | $ 4,537 |
Net OCI during the period | (105,441) | 4,375 | |
Balance at end of period | 410,410 | ||
Net Unrealized Gain/(Loss) on AFS Securities | |||
Components of accumulated other comprehensive income/(loss) | |||
Balance at beginning of period | 585,250 | 813,515 | |
OCI before reclassifications | (45,614) | 39,035 | |
Amounts reclassified from AOCI | (10,485) | (6,830) | |
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 4,537 | ||
Net OCI during the period | (56,099) | 36,742 | |
Balance at end of period | 813,515 | 529,151 | 850,257 |
Net Unrealized Loss on Swaps | |||
Components of accumulated other comprehensive income/(loss) | |||
Balance at beginning of period | (69,399) | (59,062) | |
OCI before reclassifications | (49,342) | (32,367) | |
Amounts reclassified from AOCI | 0 | 0 | |
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | ||
Net OCI during the period | (49,342) | (32,367) | |
Balance at end of period | (59,062) | (118,741) | (91,429) |
Total AOCI | |||
Components of accumulated other comprehensive income/(loss) | |||
Balance at beginning of period | 515,851 | 754,453 | |
OCI before reclassifications | (94,956) | 6,668 | |
Amounts reclassified from AOCI | (10,485) | (6,830) | |
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 4,537 | ||
Net OCI during the period | (105,441) | 4,375 | |
Balance at end of period | $ 754,453 | $ 410,410 | $ 758,828 |
Stockholders' Equity (Details 3
Stockholders' Equity (Details 3) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2016 | Mar. 31, 2015 | Dec. 31, 2015 | |
Amounts Reclassified from AOCI | |||
Realized gain on sale of securities | $ (10,485) | $ (6,423) | |
OTTI recognized in earnings | 0 | (407) | |
Accumulated Other Comprehensive Income/(Loss) | |||
Unrealized losses recorded in AOCI on securities for which Other-than-temporary impairments had been recognized in earnings in prior periods | 1,700 | $ 1,300 | |
Available-for-sale MBS | |||
Amounts Reclassified from AOCI | |||
Total reclassifications for period | (10,485) | (6,830) | |
Swaps Designated as Cash Flow Hedges | |||
Amounts Reclassified from AOCI | |||
Total reclassifications for period | 0 | 0 | |
Amounts Reclassified from AOCI | |||
Amounts Reclassified from AOCI | |||
Total AFS Securities | (10,485) | (6,830) | |
Total reclassifications for period | (10,485) | ||
Amounts Reclassified from AOCI | Available-for-sale MBS | |||
Amounts Reclassified from AOCI | |||
Realized gain on sale of securities | $ (10,485) | (6,423) | |
Total reclassifications for period | $ (6,830) |
EPS Calculation (Details)
EPS Calculation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Numerator: | ||
Net income | $ 78,070 | $ 82,173 |
Dividends declared on preferred stock | (3,750) | (3,750) |
Dividends, dividend equivalents and undistributed earnings allocated to participating securities | (395) | (395) |
Net income to common stockholders - basic and diluted | $ 73,925 | $ 78,028 |
Denominator: | ||
Weighted average common shares for basic and diluted earnings per share (in shares) | 370,942 | 371,910 |
Basic and diluted earnings per share (in dollars per share) | $ 0.20 | $ 0.21 |
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares) | 2,000 | |
Restricted shares of common stock | ||
Denominator: | ||
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares) | 96 | |
Weighted average grant date fair value (in dollars per share) | $ 7.37 | |
RSUs | ||
Denominator: | ||
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares) | 2,000 | |
Weighted average grant date fair value (in dollars per share) | $ 6.82 |
Equity Compensation, Employme83
Equity Compensation, Employment Agreements and Other Benefit Plans (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2016 | Mar. 31, 2015 | Dec. 31, 2015 | |
Share based compensation | |||
Maximum shares authorized for grant | 12,000,000 | ||
Shares available for grant (in shares) | 8,800,000 | ||
Accrued dividends payable | $ 74,583 | $ 74,581 | $ 74,575 |
Expense recognized for equity-based compensation instruments | 1,134 | 912 | |
Dividend Equivalents | |||
Share based compensation | |||
Payments attributable to dividend equivalent rights | $ 1,600 | 5,000 | |
Share-based awards outstanding (in shares) | 8,215 | ||
Average forfeiture rate on dividend equivalent rights outstanding | 0.00% | ||
Unrecognized compensation cost | $ 22,000 | ||
Weighted average period over which dividend equivalent rights are scheduled to elapse | 3 months | ||
Expense recognized for equity-based compensation instruments | $ 22 | $ 20 | |
Stock options | |||
Share based compensation | |||
Stock options, grants in period (in shares) | 0 | 0 | |
Stock options, outstanding (in shares) | 0 | ||
Restricted shares of common stock | |||
Share based compensation | |||
Unrecognized compensation cost | $ 654 | 807 | |
Awards granted (in shares) | 0 | 0 | |
Accrued dividends payable | $ 167 | 193 | |
Period for recognizing unrecognized compensation cost | 1 year 3 months 18 days | ||
Expense recognized for equity-based compensation instruments | $ 152 | $ 246 | |
RSUs | |||
Share based compensation | |||
Unrecognized compensation cost | $ 7,100 | $ 4,000 | |
Awards granted (in shares) | 615,000 | 590,000 | |
Period for recognizing unrecognized compensation cost | 2 years 1 month 6 days | ||
Forfeitures (in shares) | 10,000 | 0 | |
Forfeiture rate, percent | 0.00% | ||
Expense recognized for equity-based compensation instruments | $ 960 | $ 646 | |
Equity Compensation Plan | |||
Share based compensation | |||
Maximum number of common shares that can be granted to participant in any one year | 1,500,000 | ||
Period during which a participant can be awarded the maximum number of shares allowable under the Plan | 1 year | ||
Maximum percentage of common shares that can be owned or deemed to be owned by a participant (more than) | 9.80% |
Equity Compensation, Employme84
Equity Compensation, Employment Agreements and Other Benefit Plans (Details 2) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2016USD ($)officer | Mar. 31, 2015USD ($) | Dec. 31, 2015USD ($) | |
Deferred Compensation Activity | |||
Number of officers having employment agreements with the company | officer | 4 | ||
Deferred Compensation Plans | |||
Deferred Compensation Activity | |||
Deferrable compensation by the employee, maximum (as a percent) | 100.00% | ||
Non-employee directors | $ 49 | $ (8) | |
Undistributed Income Deferred | 638 | $ 601 | |
Liability Under Deferred Plans | 654 | 614 | |
Deferred Compensation Plans | Non-employee directors | |||
Deferred Compensation Activity | |||
Non-employee directors | 49 | (8) | |
Undistributed Income Deferred | 638 | 601 | |
Liability Under Deferred Plans | $ 654 | $ 614 | |
Savings Plan | |||
Deferred Compensation Activity | |||
Employer contribution percentage on first 3 percent of eligible compensation deferred by employees (percent) | 100.00% | ||
Percentage of eligible compensation deferred by employees qualifying for 100 percent matching contribution (percent) | 3.00% | ||
Employer contribution percentage on next 2 percent of eligible compensation deferred by employees (percent) | 50.00% | ||
Percentage of eligible compensation deferred by employees qualifying for 50 percent matching contribution (percent) | 2.00% | ||
Percentage of employer matching contributions that vest immediately (percent) | 100.00% | ||
Expenses for matching contributions | $ 86 | $ 75 |
Fair Value of Financial Instr85
Fair Value of Financial Instruments - Fair Value Hierarchy (Details) - USD ($) | Mar. 31, 2016 | Dec. 31, 2015 |
Assets: | ||
Available-for-sale securities | $ 10,861,443,000 | $ 11,356,643,000 |
Securities obtained and pledged as collateral | 513,409,000 | 507,443,000 |
Residential whole loans, at fair value | 647,360,000 | 623,276,000 |
Swaps | 152,000 | 1,127,000 |
Liabilities: | ||
Obligation to return securities obtained as collateral | 513,409,000 | 507,443,000 |
Agency MBS | ||
Assets: | ||
Available-for-sale securities | 4,544,883,000 | 4,752,244,000 |
Non-Agency MBS, including MBS transferred to consolidated VIEs | ||
Assets: | ||
Available-for-sale securities | 6,100,757,000 | 6,420,817,000 |
CRT securities | ||
Assets: | ||
Available-for-sale securities | 215,803,000 | 183,582,000 |
Recurring basis | ||
Assets: | ||
Securities obtained and pledged as collateral | 513,409,000 | 507,443,000 |
Swaps | 152,000 | 1,127,000 |
Total assets carried at fair value | 12,022,364,000 | 12,488,489,000 |
Liabilities: | ||
Swaps | 118,893,000 | 70,526,000 |
Obligation to return securities obtained as collateral | 513,409,000 | 507,443,000 |
Total liabilities carried at fair value | 632,302,000 | 577,969,000 |
Recurring basis | Agency MBS | ||
Assets: | ||
Available-for-sale securities | 4,544,883,000 | 4,752,244,000 |
Recurring basis | Non-Agency MBS, including MBS transferred to consolidated VIEs | ||
Assets: | ||
Available-for-sale securities | 6,100,757,000 | 6,420,817,000 |
Recurring basis | CRT securities | ||
Assets: | ||
Available-for-sale securities | 215,803,000 | 183,582,000 |
Recurring basis | Residential Whole Loans | ||
Assets: | ||
Residential whole loans, at fair value | 647,360,000 | 623,276,000 |
Level 1 | Recurring basis | ||
Assets: | ||
Securities obtained and pledged as collateral | 513,409,000 | 507,443,000 |
Swaps | 0 | 0 |
Total assets carried at fair value | 513,409,000 | 507,443,000 |
Liabilities: | ||
Swaps | 0 | 0 |
Obligation to return securities obtained as collateral | 513,409,000 | 507,443,000 |
Total liabilities carried at fair value | 513,409,000 | 507,443,000 |
Level 1 | Recurring basis | Agency MBS | ||
Assets: | ||
Available-for-sale securities | 0 | 0 |
Level 1 | Recurring basis | Non-Agency MBS, including MBS transferred to consolidated VIEs | ||
Assets: | ||
Available-for-sale securities | 0 | 0 |
Level 1 | Recurring basis | CRT securities | ||
Assets: | ||
Available-for-sale securities | 0 | 0 |
Level 1 | Recurring basis | Residential Whole Loans | ||
Assets: | ||
Residential whole loans, at fair value | 0 | 0 |
Level 2 | ||
Components of financial instruments carried at fair value | ||
Credit valuation adjustment to derivative liabilities | 0 | |
Credit valuation adjustment to derivative assets | 0 | |
Level 2 | Recurring basis | ||
Assets: | ||
Securities obtained and pledged as collateral | 0 | 0 |
Swaps | 152,000 | 1,127,000 |
Total assets carried at fair value | 10,861,595,000 | 11,357,770,000 |
Liabilities: | ||
Swaps | 118,893,000 | 70,526,000 |
Obligation to return securities obtained as collateral | 0 | 0 |
Total liabilities carried at fair value | 118,893,000 | 70,526,000 |
Level 2 | Recurring basis | Agency MBS | ||
Assets: | ||
Available-for-sale securities | 4,544,883,000 | 4,752,244,000 |
Level 2 | Recurring basis | Non-Agency MBS, including MBS transferred to consolidated VIEs | ||
Assets: | ||
Available-for-sale securities | 6,100,757,000 | 6,420,817,000 |
Level 2 | Recurring basis | CRT securities | ||
Assets: | ||
Available-for-sale securities | 215,803,000 | 183,582,000 |
Level 2 | Recurring basis | Residential Whole Loans | ||
Assets: | ||
Residential whole loans, at fair value | 0 | 0 |
Level 3 | Recurring basis | ||
Assets: | ||
Securities obtained and pledged as collateral | 0 | 0 |
Swaps | 0 | 0 |
Total assets carried at fair value | 647,360,000 | 623,276,000 |
Liabilities: | ||
Swaps | 0 | 0 |
Obligation to return securities obtained as collateral | 0 | 0 |
Total liabilities carried at fair value | 0 | 0 |
Level 3 | Recurring basis | Agency MBS | ||
Assets: | ||
Available-for-sale securities | 0 | 0 |
Level 3 | Recurring basis | Non-Agency MBS, including MBS transferred to consolidated VIEs | ||
Assets: | ||
Available-for-sale securities | 0 | 0 |
Level 3 | Recurring basis | CRT securities | ||
Assets: | ||
Available-for-sale securities | 0 | 0 |
Level 3 | Recurring basis | Residential Whole Loans | ||
Assets: | ||
Residential whole loans, at fair value | $ 647,360,000 | $ 623,276,000 |
Fair Value of Financial Instr86
Fair Value of Financial Instruments - Level 3 Assets (Details) - Recurring basis - Level 3 - Residential Whole Loans - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance at beginning of period | $ 623,276 | $ 143,472 |
Purchases and capitalized advances | 53,590 | 4,725 |
Changes in fair value recorded in Net gain on residential whole loans held at fair value | 6,226 | 602 |
Collection of principal, net of liquidation gains/losses | (14,602) | (2,176) |
Transfer to REO | (21,130) | (3,163) |
Balance at end of period | $ 647,360 | $ 143,460 |
Fair Value of Financial Instr87
Fair Value of Financial Instruments - Fair Value Methodology (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | Dec. 31, 2015 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Residential whole loans, at fair value, excluding unsettled loan purchases | $ 601,148 | $ 505,723 | |
Residential whole loans, at fair value, excluded from Level 3 Fair Value Methodology Disclosures | 46,200 | 117,600 | |
Discounted cash flow | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Residential whole loans, at fair value, excluding unsettled loan purchases | 165,177 | 113,166 | |
Liquidation model | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Residential whole loans, at fair value, excluding unsettled loan purchases | $ 435,971 | $ 392,557 | |
Residential Whole Loans | Level 3 | Discounted cash flow | Minimum | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Discount rate (percent) | 5.00% | 6.00% | |
Prepayment rate (percent) | 0.30% | 0.30% | |
Default rate (percent) | 0.00% | 0.00% | |
Loss severity (percent) | 0.00% | 10.00% | |
Residential Whole Loans | Level 3 | Discounted cash flow | Maximum | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Discount rate (percent) | 7.70% | 8.70% | |
Prepayment rate (percent) | 11.50% | 11.10% | |
Default rate (percent) | 8.30% | 9.10% | |
Loss severity (percent) | 79.10% | 79.40% | |
Residential Whole Loans | Level 3 | Discounted cash flow | Weighted Average | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Discount rate (percent) | 6.50% | 7.00% | |
Prepayment rate (percent) | 7.10% | 6.60% | |
Default rate (percent) | 2.70% | 3.10% | |
Loss severity (percent) | 13.80% | 17.00% | |
Residential Whole Loans | Level 3 | Liquidation model | Minimum | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Discount rate (percent) | 6.80% | 6.80% | |
Annual change in home prices (percent) | (6.10%) | (5.50%) | |
Liquidation timeline (in years) | 8 months 12 days | 8 months 12 days | |
Current value of underlying properties | $ 14 | $ 14 | |
Residential Whole Loans | Level 3 | Liquidation model | Maximum | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Discount rate (percent) | 42.00% | 10.00% | |
Annual change in home prices (percent) | 5.80% | 6.10% | |
Liquidation timeline (in years) | 4 years 4 months 24 days | 4 years 4 months 24 days | |
Current value of underlying properties | $ 4,200 | $ 3,500 | |
Residential Whole Loans | Level 3 | Liquidation model | Weighted Average | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Discount rate (percent) | 7.80% | 6.90% | |
Annual change in home prices (percent) | 1.10% | 1.30% | |
Liquidation timeline (in years) | 1 year 7 months 6 days | 1 year 7 months 6 days | |
Current value of underlying properties | $ 623 | $ 626 |
Fair Value of Financial Instr88
Fair Value of Financial Instruments - Fair Value vs Unpaid Principal Balance (Details) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total Residential Whole Loans, Fair Value | $ 647,360 | $ 623,276 |
Total Residential Whole Loans, Unpaid Principal Balance | 810,263 | 786,330 |
Residential Whole Loans | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total Residential Whole Loans, Fair Value | 647,360 | 623,276 |
Total Residential Whole Loans, Unpaid Principal Balance | 810,263 | 786,330 |
Total Residential Whole Loans, Difference | (162,903) | (163,054) |
Residential Whole Loans 90 days or more past due, Fair Value | 498,989 | 493,640 |
Residential Whole Loans 90 days or more past due, Unpaid Principal Balance | 639,747 | 637,459 |
Residential Whole Loans 90 days or more past due, Difference | $ (140,758) | $ (143,819) |
Fair Value of Financial Instr89
Fair Value of Financial Instruments - Carrying Value vs Fair Value (Details) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 | |
Financial Assets: | |||
Available-for-sale securities | $ 10,861,443 | $ 11,356,643 | |
Securities obtained and pledged as collateral | 513,409 | 507,443 | |
Residential whole loans, at carrying value | 376,235 | 271,845 | |
Residential whole loans, at fair value | 647,360 | 623,276 | |
Restricted cash | 123,676 | 71,538 | |
Swaps | 152 | 1,127 | |
Financial Liabilities (1): | |||
Repurchase agreements | 7,951,523 | ||
Securitized debt | [1] | 11,821 | 21,868 |
Obligation to return securities obtained as collateral | 513,409 | 507,443 | |
Senior Notes | 96,706 | 96,697 | |
Carrying Value | |||
Financial Assets: | |||
Securities obtained and pledged as collateral | 513,409 | 507,443 | |
Cash and cash equivalents | 146,236 | 165,007 | |
Restricted cash | 123,676 | 71,538 | |
Swaps | 152 | 1,127 | |
Financial Liabilities (1): | |||
Repurchase agreements | 7,950,645 | 7,887,622 | |
FHLB advances | 1,193,000 | 1,500,000 | |
Securitized debt | 11,821 | 21,868 | |
Obligation to return securities obtained as collateral | 513,409 | 507,443 | |
Senior Notes | 96,706 | 96,697 | |
Swaps | 118,893 | 70,526 | |
Estimated Fair Value | |||
Financial Assets: | |||
Securities obtained and pledged as collateral | 513,409 | 507,443 | |
Cash and cash equivalents | 146,236 | 165,007 | |
Restricted cash | 123,676 | 71,538 | |
Swaps | 152 | 1,127 | |
Financial Liabilities (1): | |||
Repurchase agreements | 7,952,474 | 7,828,115 | |
FHLB advances | 1,193,000 | 1,500,000 | |
Securitized debt | 11,924 | 22,057 | |
Obligation to return securities obtained as collateral | 513,409 | 507,443 | |
Senior Notes | 100,351 | 99,391 | |
Swaps | 118,893 | 70,526 | |
Agency MBS | |||
Financial Assets: | |||
Available-for-sale securities | 4,544,883 | 4,752,244 | |
Agency MBS | Carrying Value | |||
Financial Assets: | |||
Available-for-sale securities | 4,544,883 | 4,752,244 | |
Agency MBS | Estimated Fair Value | |||
Financial Assets: | |||
Available-for-sale securities | 4,544,883 | 4,752,244 | |
Non-Agency MBS, including MBS transferred to consolidated VIEs | |||
Financial Assets: | |||
Available-for-sale securities | 6,100,757 | 6,420,817 | |
Non-Agency MBS, including MBS transferred to consolidated VIEs | Carrying Value | |||
Financial Assets: | |||
Available-for-sale securities | 6,100,757 | 6,420,817 | |
Non-Agency MBS, including MBS transferred to consolidated VIEs | Estimated Fair Value | |||
Financial Assets: | |||
Available-for-sale securities | 6,100,757 | 6,420,817 | |
CRT securities | |||
Financial Assets: | |||
Available-for-sale securities | 215,803 | 183,582 | |
CRT securities | Carrying Value | |||
Financial Assets: | |||
Available-for-sale securities | 215,803 | 183,582 | |
CRT securities | Estimated Fair Value | |||
Financial Assets: | |||
Available-for-sale securities | 215,803 | 183,582 | |
Residential Whole Loans | Carrying Value | |||
Financial Assets: | |||
Residential whole loans, at carrying value | 376,235 | 271,845 | |
Residential whole loans, at fair value | 647,360 | 623,276 | |
Residential Whole Loans | Estimated Fair Value | |||
Financial Assets: | |||
Residential whole loans, at carrying value | 392,924 | 289,696 | |
Residential whole loans, at fair value | $ 647,360 | $ 623,276 | |
[1] | Securitized debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that eliminate on consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 14 and 19 for further discussion.) |
Use of Special Purpose Entiti90
Use of Special Purpose Entities and Variable Interest Entities (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | |||
Feb. 29, 2012 | Mar. 31, 2016 | Mar. 31, 2015 | Dec. 31, 2015 | ||
Variable Interest Entity [Line Items] | |||||
Outstanding amount of Senior Bonds at March 31, 2016 | [1] | $ 11,821 | $ 21,868 | ||
Available-for-sale securities | 10,861,443 | 11,356,643 | |||
Residential whole loans | 1,024,000 | 895,100 | |||
Residential whole loans at carrying value | 376,235 | 271,845 | |||
Residential whole loans, at fair value | $ 647,360 | 623,276 | |||
Ownership percentage by parent | 100.00% | ||||
Interest income residential whole loans held at carrying value | $ 4,496 | $ 3,591 | |||
Net gain on residential whole loans held at fair value | 11,881 | $ 2,034 | |||
Non-Agency MBS | |||||
Variable Interest Entity [Line Items] | |||||
Available-for-sale securities | 6,100,757 | 6,420,817 | |||
Non-Agency MBS | Recurring basis | |||||
Variable Interest Entity [Line Items] | |||||
Available-for-sale securities | 6,100,757 | 6,420,817 | |||
Non-Agency MBS | Recurring basis | Level 3 | |||||
Variable Interest Entity [Line Items] | |||||
Available-for-sale securities | 0 | 0 | |||
Residential Whole Loans | Recurring basis | |||||
Variable Interest Entity [Line Items] | |||||
Residential whole loans, at fair value | 647,360 | 623,276 | |||
Residential Whole Loans | Recurring basis | Level 3 | |||||
Variable Interest Entity [Line Items] | |||||
Residential whole loans, at fair value | 647,360 | 623,276 | |||
WFMLT Series 2012-RR1 | |||||
Variable Interest Entity [Line Items] | |||||
Principal value of Non-Agency MBS sold | $ 433,347 | ||||
Face amount of Bonds issued by the VIE and purchased by 3rd party investors | $ 186,691 | ||||
Outstanding amount of Senior Bonds at March 31, 2016 | 11,924 | 22,100 | |||
Pass-through rate for Senior Bonds issued, percentage | 2.85% | ||||
Cash received | $ 186,691 | ||||
Notional amount acquired of non-rated, interest only senior certificates | $ 186,691 | ||||
Unamortized deferred costs | 103 | ||||
WFMLT Series 2012-RR1 | Senior-support certificates | |||||
Variable Interest Entity [Line Items] | |||||
Face amount of Senior Support Certificates received by the Company | 216,603 | ||||
Variable Interest Entity, Primary Beneficiary | |||||
Variable Interest Entity [Line Items] | |||||
Taxable income from unwind of resecuritization transaction | $ 70,900 | ||||
Taxable income from unwind of resecuritization transaction (in dollars per share) | $ 0.19 | ||||
Variable Interest Entity, Primary Beneficiary | Non-Agency MBS | |||||
Variable Interest Entity [Line Items] | |||||
Available-for-sale securities | [2] | $ 198,500 | $ 598,300 | ||
Trust, ownership in residential whole loans | |||||
Variable Interest Entity [Line Items] | |||||
Ownership percentage by parent | 100.00% | ||||
[1] | Securitized debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that eliminate on consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 14 and 19 for further discussion.) | ||||
[2] | Non-Agency MBS transferred to consolidated VIEs represent assets of the consolidated VIEs that can be used only to settle the obligations of each respective VIE. |